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General introduction 
 
Societal challenges of aging populations 
Aging is defined as a series of morphological and functional changes that take place over time 
[1]. The term also refers to the deterioration of biological functions after an organism has 
attained its maximum reproductive potential [2, 3]. 
Nowadays, extended lifetime and life expectancy can be seen as a success story for public 
health policies and socioeconomic development. However, it also challenges societies to adapt 
in order to maximize health and functional capacity of older people as well as ensure their 
social participation and security [3].  
Life expectancy is defined as the average total number of years that a human is expected to 
live. Differently, life span is the maximum number of years that a human can live. While the 
human life span has remained unchanged for the past 100,000 years at ~125 years, life 
expectancy has sensibly increased (~27 years during the last century), especially in Western 
countries [4]. The substantial improvement of life expectancy and extension of the length of 
time being in optimal health (health span) [5] occurred mainly due to the elimination of most 
infectious childhood diseases, better hygiene, and the implementation of antibiotics and 
vaccines [6]. 
Because aging is positively related to the homeostatic imbalance and incidence of pathology, 
death remains the ultimate consequence of aging [7]. Therefore, the prevention of pathology is 
the key to increased health span during the aging process [6].  
The major theories of aging such as the free radical theory [8], the immunologic theory [9], 
the inflammation theory [10] and the mitochondrial theory [11] are all specific of a particular 
cause of aging. These theories provide useful and important insights for the understanding of 
physiological changes occurring with aging. They simultaneously define key target 
physiological deficiencies to be addressed by preventive and therapeutic interventions to 
improve the aging process. In particular, preventive and therapeutic interventions for 
ameliorating the aging process are focused on lowering the risk for pandemic pathologies and 
deficiencies such as the metabolic syndrome (MetS), type 2 diabetes mellitus, sarcopenia and 
cardiovascular dysfunctions [12-14]. 
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Metabolic malfunction accelerates the aging process 
According to the World Health Organization (WHO) MetS and its components are a major 
public health challenge of the twenty-first century [15, 16]. It is estimated that around 20-25% 
of the population in the world fulfill the criteria for MetS. These people are three times as 
likely to have a heart attack or stroke compared to people without the syndrome. Additionally, 
the risk for developing type 2 diabetes is fivefold greater [15]. MetS is characterized by a 
group of metabolic risk factors. The first agreement about the definition of MetS was drawn 
up during a meeting organized by the International Diabetes Federation (IDF) in 2005. As 
stated in their guidelines [17] the major contributing factor is central obesity measured by 
waist circumference and Body Mass Index (BMI). In addition to central obesity, other factors 
that have to be considered for the diagnosis of MetS involve the estimation of triglycerides, 
reduced high-density lipoprotein (HDL) cholesterol, blood pressure, or fasting plasma glucose 
[15]. The majority of patients are obese, older, sedentary, inactive and insulin-resistant. 
Determining factors are body weight, genetics, aging, lifestyle and excess caloric intake [16].  
Metabolic syndrome was defined in accordance with the harmonized criteria recommended in 
the 2009 Joint Interim Statement from multiple scientific associations [17], as the presence of 
3 or more components, including (1) abdominal obesity (men: waist circumference ≥ 102cm 
or women: waist circumference ≥ 88cm); (2) hypertension (systolic blood pressure (SBP) ≥ 
130mmHg and/or diastolic blood pressure (DBP) ≥ 85mmHg) or use of antihypertensive 
medication and a history of physician-diagnosed hypertension; (3) decreased HDL-C 
cholesterol level (men: HDL-C <40 mg/dL (<2.2 mmol/L) and women: <50 mg/dL (<2.8 
mmol/L)) or use of HDL-C-raising medication; (4) elevated triglycerides levels (triglycerides 
≥ 150 mg/dL (≥ 8.4 mmol/L)) or use of triglyceride-lowering medication and (5) elevated 
plasma fasting blood glucose level (glucose ≥ 100 mg/dL (≥ 5.6 mmol/L)) or use of glucose-
controlling medication. 
Besides the increased risk for type 2 diabetes, presence of MetS leads to an increased risk of 
cardiovascular dysfunctions, in the form of coronary or peripheral atherosclerosis and heart 
failure [15]. 
The aging process is accelerated when metabolic and cardiovascular diseases are present, 
subsequently increasing the risk for developing a functional decline/disability at an earlier 
stage in life [13]. Many predisposing age-related conditions, such as obesity, insulin 
resistance, inflammation and sarcopenia [15] contribute to the increased prevalence of 
metabolic syndrome and subsequently result in an increased risk for disability [13], a higher 


morbidity rate, increased health care costs [12, 18] and a shortened lifespan compared with 
the general population [2].  Given the worldwide growing pandemic of MetS [15], there is an 
urgent need to develop more effective strategies that prevent or reverse aforementioned 
premature aging process [13]. 
 
Figure INTRO.1 Alternative strategies to improve beneficial effects of exercise training 
during impaired aging process. 
 
MetS- metabolic syndrome; ROS- reactive oxygen species; DM2- type 2 diabetes; PA- 
physical activity; ST- sedentary time. 
 
Oxidative stress, sarcopenia and functional capacity decline increase risk for pathology 
during aging 
In agreement with the free radical theory of aging, reactive oxygen species (ROS), generated 
as by products of biological oxidations, induce casual and cumulative oxidative damage to 
macromolecules resulting in cellular dysfunction with age and eventually cell death [11]. 
Mitochondria, besides being the ‘body’s power station’ for human’s functioning, are involved 
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Metabolic malfunction accelerates the aging process 
According to the World Health Organization (WHO) MetS and its components are a major 
public health challenge of the twenty-first century [15, 16]. It is estimated that around 20-25% 
of the population in the world fulfill the criteria for MetS. These people are three times as 
likely to have a heart attack or stroke compared to people without the syndrome. Additionally, 
the risk for developing type 2 diabetes is fivefold greater [15]. MetS is characterized by a 
group of metabolic risk factors. The first agreement about the definition of MetS was drawn 
up during a meeting organized by the International Diabetes Federation (IDF) in 2005. As 
stated in their guidelines [17] the major contributing factor is central obesity measured by 
waist circumference and Body Mass Index (BMI). In addition to central obesity, other factors 
that have to be considered for the diagnosis of MetS involve the estimation of triglycerides, 
reduced high-density lipoprotein (HDL) cholesterol, blood pressure, or fasting plasma glucose 
[15]. The majority of patients are obese, older, sedentary, inactive and insulin-resistant. 
Determining factors are body weight, genetics, aging, lifestyle and excess caloric intake [16].  
Metabolic syndrome was defined in accordance with the harmonized criteria recommended in 
the 2009 Joint Interim Statement from multiple scientific associations [17], as the presence of 
3 or more components, including (1) abdominal obesity (men: waist circumference ≥ 102cm 
or women: waist circumference ≥ 88cm); (2) hypertension (systolic blood pressure (SBP) ≥ 
130mmHg and/or diastolic blood pressure (DBP) ≥ 85mmHg) or use of antihypertensive 
medication and a history of physician-diagnosed hypertension; (3) decreased HDL-C 
cholesterol level (men: HDL-C <40 mg/dL (<2.2 mmol/L) and women: <50 mg/dL (<2.8 
mmol/L)) or use of HDL-C-raising medication; (4) elevated triglycerides levels (triglycerides 
≥ 150 mg/dL (≥ 8.4 mmol/L)) or use of triglyceride-lowering medication and (5) elevated 
plasma fasting blood glucose level (glucose ≥ 100 mg/dL (≥ 5.6 mmol/L)) or use of glucose-
controlling medication. 
Besides the increased risk for type 2 diabetes, presence of MetS leads to an increased risk of 
cardiovascular dysfunctions, in the form of coronary or peripheral atherosclerosis and heart 
failure [15]. 
The aging process is accelerated when metabolic and cardiovascular diseases are present, 
subsequently increasing the risk for developing a functional decline/disability at an earlier 
stage in life [13]. Many predisposing age-related conditions, such as obesity, insulin 
resistance, inflammation and sarcopenia [15] contribute to the increased prevalence of 
metabolic syndrome and subsequently result in an increased risk for disability [13], a higher 


morbidity rate, increased health care costs [12, 18] and a shortened lifespan compared with 
the general population [2].  Given the worldwide growing pandemic of MetS [15], there is an 
urgent need to develop more effective strategies that prevent or reverse aforementioned 
premature aging process [13]. 
 
Figure INTRO.1 Alternative strategies to improve beneficial effects of exercise training 
during impaired aging process. 
 
MetS- metabolic syndrome; ROS- reactive oxygen species; DM2- type 2 diabetes; PA- 
physical activity; ST- sedentary time. 
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In agreement with the free radical theory of aging, reactive oxygen species (ROS), generated 
as by products of biological oxidations, induce casual and cumulative oxidative damage to 
macromolecules resulting in cellular dysfunction with age and eventually cell death [11]. 
Mitochondria, besides being the ‘body’s power station’ for human’s functioning, are involved 
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in the aging process [19]. In particular, these organelles are considered the main intracellular 
source of reactive oxygen species (ROS) production e.g. superoxide anion (O2 −), as well as 
the major target of free radical attack [20]. ROS produced by the mitochondrial respiratory 
chain damage mitochondrial constituents, including proteins, lipids, and mitochondrial DNA 
(mtDNA) [21]. Progressive accumulation of oxidant-induced somatic mutations in mtDNA 
during an individual's lifetime leads to a deterioration in the bioenergetic function of 
mitochondria [22]. Although this process takes place in almost every organ system, research 
shows that the level of the oxidative stress also plays a role in the sarcopenic changes and, as 
such, accelerates functional decline during the aging process [23]. Interestingly, a number of 
studies showed added value of dietary antioxidant supplements in supporting health benefits 
by preventing deleterious oxidative stress [24-26]. However, the optimal doses, type and 
timing of these supplements in relation with the exercise stimulus are equivocal and 
inadequate antioxidant interventions may even be counter-productive [27]. Therefore, 
strategies for extending life span, functional capacity and quality of life should be focused on 
reducing the risk for developing MetS and its components, preventing increased oxidative 
stress levels and reducing a decline in mass and function of both skeletal muscle and its 
mitochondria. 
 
Strategies to reduce risk for pathology and disability while aging 
Several modifiable factors such as involvement in physical activity, reducing levels of 
sedentary behavior [28] and adequate nutritional strategies [29, 30] have been shown to 
contribute extending health span and are likely to support successful aging [13]. 
In particular, there is a vast body of evidence showing that the involvement in physical 
activity and reduced levels of sedentary behavior are crucial for preventing the development 
of chronic diseases e.g. MetS and its components [31, 32], sarcopenia [33], type 2 diabetes 
[34, 35] and cardiovascular dysfunction [36, 37].  
In particular, endurance and resistance type of training interventions are highly recommended 
by health professionals for its health benefits, including improved aerobic capacity ( peak), 
muscle quality, muscle strength [14] and overall physical condition [28]. These effects are 
induced by adaptive mechanisms in response to regular training on tissue and cellular levels. 
These adaptive mechanisms include e.g. improved metabolic and mechanical function of 
skeletal muscle [33], cardiovascular and respiratory function, insulin sensitivity, glucose 
uptake [38, 39], improved efficiency of endogenous enzymatic antioxidant defense system 
2OV


[39], and increased mitochondrial biogenesis [20, 34].  
For practical, logistic as well as physiological reasons, the implementation of exercise and 
lifestyle intervention programs aimed at preventing aforementioned pathologies remains 
suboptimal. In particular, the lack of individualized and supervised exercise programs [40], 
low exercise tolerance/performance, low participation levels in physical activity [18] caused 
by advanced pathologies of the pulmonary and peripheral cardiovascular systems [41, 42] are 
major obstacles for effective health-interventions. As such, there is a clear need to develop 
more (cost-) effective and health-beneficial lifestyle intervention programs for aging 
populations [13].  
 
Outline of the thesis 
Although it is well appreciated that cognitive, behavioral and societal factors may be equally 
important, the present dissertation will mainly focus on the physiological aspects of the 
exercise-based life style interventions aiming to improve its effects, and hence antagonize the 
aging process.  
Improved longevity and quality of life are negatively related to the levels of pathology during 
the aging process. Accordingly, Figure INTRO.1 summarizes the most important life-style 
related pathologies during the aging process, which are more pronounced in a sedentary and 
unhealthy aging population (chapter 6) than in healthy individuals. In particular, sedentary 
behavior and inactivity increase the risk for chronic diseases (MetS and type 2 diabetes) and 
its components. Subsequently, inactivity and sedentary lifestyle increase the risk for disability 
and earlier death. We presented a number of potentially useful strategies to improve the 
effectiveness of exercise, and hence to more effectively reduce the pathologies of faster aging 
(Figure INTRO.1). In particular, this dissertation discusses dietary interventions and the 
impact of sedentary behavior/inactivity on the main pathologies during aging e.g. oxidative 
stress, sarcopenia, MetS and its components (chapter 1, chapter 5, chapter 6). Additionally, 
more cost-effective approaches (chapter 2) and alternative methods (chapter 3, chapter 4) 
will improve the individual approach and involvement of sizable aging populations with poor 
exercise tolerance in physical activity. The results of this dissertation emphasize that more 
active and healthier aging individuals will live longer and higher quality life.  
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more (cost-) effective and health-beneficial lifestyle intervention programs for aging 
populations [13].  
 
Outline of the thesis 
Although it is well appreciated that cognitive, behavioral and societal factors may be equally 
important, the present dissertation will mainly focus on the physiological aspects of the 
exercise-based life style interventions aiming to improve its effects, and hence antagonize the 
aging process.  
Improved longevity and quality of life are negatively related to the levels of pathology during 
the aging process. Accordingly, Figure INTRO.1 summarizes the most important life-style 
related pathologies during the aging process, which are more pronounced in a sedentary and 
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PART  1
Do dietary antioxidant supplements help 
improve effects of exercise training? 
Oxidative stress is one of the major theories of accelerated aging process [1]. Exercise training 
is one of the best ways to improve the endogenic antioxidative defense system and to prevent 
deleterious levels of oxidative stress [2]. However, it is still controversial whether adding 
supplementation with dietary antioxidants to exercise interventions may still safely improve 
these effects of exercise [3, 4], and hence eventually expand health span. Therefore, this part 
discusses effects of antioxidant supplementation in conjunction with endurance training as a 
potential alternative aid in healthy aging. 
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Abstract 
Adaptive responses to exercise training are crucial in maintaining physiological homeostasis 
and health span. Exercise-induced aerobic bioenergetic reactions in mitochondria and cytosol 
increase production of reactive oxygen species (ROS), where excess of ROS can be 
scavenged by enzymatic as well as non-enzymatic antioxidants to protect against deleterious 
oxidative stress. Free radicals, however, have recently been recognized as crucial signaling 
agents that promote adaptive mechanisms to exercise training, such as mitochondrial 
biogenesis, antioxidant (AO) enzyme activity defense system upregulation, insulin sensitivity, 
and glucose uptake in skeletal muscle. Commonly used non-enzymatic AO supplements, such 
as vitamins C and E, α-lipoic acid, and polyphenols, in combination with exercise training, 
have been proposed as ways to prevent exercise-induced oxidative stress and hence improve 
adaptation responses to endurance training. Preclinical and clinical studies to date have shown 
inconsistent results indicating either positive or negative effects of endurance training 
combined with different blends of AO supplements (mostly vitamins C and E and α-lipoic 
acid) on redox status, mitochondrial biogenesis pathways, and insulin sensitivity. Preclinical 
reports on exercise training combined with resveratrol, however, have shown consistent 
positive effects on exercise performance, mitochondrial biogenesis, and insulin sensitivity, 
with clinical trials reporting mixed effects. Relevant clinical studies have been few and have 
used inconsistent results and methodology (types of compounds, combinations, and 
supplementation time). The future studies should investigate the effects of specific 
antioxidants and other popular supplements, such as α-lipoic acid and resveratrol, on training 
effects in humans. Of particular importance are older adults who may be at higher risk of age-
related increased oxidative stress, an impaired AO enzyme defense system, and comorbidities 
such as hypertension, insulin resistance, and diabetes. 
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Introduction 
Exercise training is highly recommended by health professionals for its many health benefits, 
including improved aerobic capacity, muscle strength, peak oxygen uptake (VO2peak), and 
overall physical condition [15]. These effects are induced by adaptive responses to regular 
training, including improved insulin sensitivity and glucose uptake [57], improved efficiency 
of enzymatic antioxidant (AO) defense system [2], and increased mitochondrial biogenesis 
[51]. Exercise-induced reactive oxygen species (ROS) are one of the signaling agents for 
inducing these biologic exercise-training adaptations [23]. In preclinical models, improved 
efficiency of the enzymatic AO defense system by regular exercise protects cells against 
oxidative damage and maintains physiological homeostasis [51]. 
Although exercise-induced ROS production is an important signaling pathway to induce 
biological adaptations to training, ROS over production could also have a deleterious impact 
on cells and tissues, i.e., lipid and protein peroxidation [70]. Therefore, some experts 
suggested consuming more dietary AOs and AO-containing supplements to mitigate the ROS 
production that can cause excess oxidative stress during and after exercise [9, 36, 47, 65]. The 
belief that dietary supplements are helpful, or at least safe, when used in conjunction with an 
exercise program, however, has recently been questioned. For example, a recent study of 
Ristow et al., found that supplementation with vitamin C (1000mg/day) and E (400IU/day) 
blunted some of the beneficial effects of exercise, such as improved insulin sensitivity, 
mitochondrial biogenesis level, and AO enzyme activity, in 19 untrained and 20 pre-trained 
healthy young individuals, and that exercise alone produced a better outcome. In contrast with 
the findings of Ristow et al., previous studies have shown no blunting effects of AO 
supplementation on changes in aerobic capacity (VO2peak) [16, 74], mitochondrial biogenesis 
[74], and insulin sensitivity [74]. At present, it is unclear whether AO supplements enhance or 
attenuate exercise training adaptive biological responses in either healthy adults or lower-
functioning older adults. The purpose of this chapter, therefore, is to review relevant studies 
that have examined the effects of exercise alone and combined with AO supplementation on 
basic training adaptations (redox status, mitochondrial biogenesis, and glucose metabolism) in 
both animals and humans. 
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Abstract 
Adaptive responses to exercise training are crucial in maintaining physiological homeostasis 
and health span. Exercise-induced aerobic bioenergetic reactions in mitochondria and cytosol 
increase production of reactive oxygen species (ROS), where excess of ROS can be 
scavenged by enzymatic as well as non-enzymatic antioxidants to protect against deleterious 
oxidative stress. Free radicals, however, have recently been recognized as crucial signaling 
agents that promote adaptive mechanisms to exercise training, such as mitochondrial 
biogenesis, antioxidant (AO) enzyme activity defense system upregulation, insulin sensitivity, 
and glucose uptake in skeletal muscle. Commonly used non-enzymatic AO supplements, such 
as vitamins C and E, α-lipoic acid, and polyphenols, in combination with exercise training, 
have been proposed as ways to prevent exercise-induced oxidative stress and hence improve 
adaptation responses to endurance training. Preclinical and clinical studies to date have shown 
inconsistent results indicating either positive or negative effects of endurance training 
combined with different blends of AO supplements (mostly vitamins C and E and α-lipoic 
acid) on redox status, mitochondrial biogenesis pathways, and insulin sensitivity. Preclinical 
reports on exercise training combined with resveratrol, however, have shown consistent 
positive effects on exercise performance, mitochondrial biogenesis, and insulin sensitivity, 
with clinical trials reporting mixed effects. Relevant clinical studies have been few and have 
used inconsistent results and methodology (types of compounds, combinations, and 
supplementation time). The future studies should investigate the effects of specific 
antioxidants and other popular supplements, such as α-lipoic acid and resveratrol, on training 
effects in humans. Of particular importance are older adults who may be at higher risk of age-
related increased oxidative stress, an impaired AO enzyme defense system, and comorbidities 
such as hypertension, insulin resistance, and diabetes. 
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blunted some of the beneficial effects of exercise, such as improved insulin sensitivity, 
mitochondrial biogenesis level, and AO enzyme activity, in 19 untrained and 20 pre-trained 
healthy young individuals, and that exercise alone produced a better outcome. In contrast with 
the findings of Ristow et al., previous studies have shown no blunting effects of AO 
supplementation on changes in aerobic capacity (VO2peak) [16, 74], mitochondrial biogenesis 
[74], and insulin sensitivity [74]. At present, it is unclear whether AO supplements enhance or 
attenuate exercise training adaptive biological responses in either healthy adults or lower-
functioning older adults. The purpose of this chapter, therefore, is to review relevant studies 
that have examined the effects of exercise alone and combined with AO supplementation on 
basic training adaptations (redox status, mitochondrial biogenesis, and glucose metabolism) in 
both animals and humans. 
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Literature search 
Searching PubMed for manuscripts reporting effects of AO supplements on biological 
adaptation mechanisms to  exercise training, we used combinations of the following 
keywords: exercise training, antioxidants, ROS signaling, vitamins, animal studies, clinical 
studies, resveratrol, redox status, superoxide dismutase (SOD), glutathione peroxidase (GPx), 
catalase (CAT), oxidative stress, ROS, mitochondrial biogenesis, peroxisome proliferator-
activated receptor gamma coactivator-1 alpha (PGC-1α), metabolism, glucose, insulin, and 
insulin resistance. The goal of this literature search was to find relevant publications that will 
improve our understanding of the beneficial, neutral, or adverse effects of AO supplements on 
biologic adaptation responses in combination with endurance  exercise training. From these 
manuscripts, we selected studies that examined and compared exercise-training effects with 
and without administration of commonly used AO supplements (vitamins C and E, α-lipoic 
acid, coenzyme-Q10, carotene, resveratrol). Controversy around biological pathways of 
mitochondrial biogenesis, enzymatic AO activity, and glucose metabolism narrowed our 
search to only those studies that investigated an effect of  exercise training combined with 
non-enzymatic AOs and training alone on adaptation response to exercise. Therefore, we 
included all available key markers of redox status (cytosolic superoxide dismutase (SOD1), 
mitochondrial superoxide dismutase (SOD2), GPx, and CAT), mitochondrial biogenesis 
(PGC-1α), and glucose metabolism (adenosine monophosphate (AMP)-activated protein 
kinase (AMPK), glucose transporter 4 (GLUT4), and insulin sensitivity). Using these criteria, 
we identified only a few preclinical and clinical studies. We therefore included all AO 
supplement compounds and combinations, endurance  exercise training duration and types, 
and animal and human models. The key criterion for manuscript inclusion was a comparison 
between endurance- exercise training alone and  exercise training combined with AO 
supplementation. According to these criteria 24 studies were included. 
 
Normal adaptations of antioxidant enzymes, mitochondrial biogenesis, and broad 
metabolism to exercise training 
 
Basic biological mechanisms during exercise 
ROS, within physiological concentration, are important signaling molecules that regulate 
growth, proliferation, and differentiation, and are responsible for some key adaptations to  


exercise training at the tissue and cellular levels, e.g. AO enzyme regulation [2, 31], 
mitochondrial biogenesis [51], and skeletal muscle hypertrophy [20]. 
During exercise, oxidative homeostasis is maintained by a network of AO defense 
mechanisms capable of producing other less-reactive species or neutralizing reactive oxygen 
metabolites, i.e., SOD, GPx, CAT, and thioredoxin reductase (TRX). SOD, for instance, 
promotes the dismutation of superoxide radicals (O2●-) and forms hydrogen peroxide and 
oxygen. GPx utilizes glutathione (GSH) as a reducing equivalent for hydrogen peroxide 
(H2O2) to form oxidized GSH and water in mitochondria and cytosol. Additionally, CAT 
converts H2O2 to water and oxygen [47]. In vitro studies showed that ROS (formation induced 
by the pro-oxidant herbicide paraquat) induce upregulation of the AO enzymes (SOD, GPx, 
and CAT) activity in myotubes [12]. This mechanism maintains the oxidant-AO homeostasis 
during a skeletal muscle contraction in animal models and humans [34, 50, 62]. 
 
Adaptation of enzymatic antioxidant mechanisms to exercise training  
Because prolonged exercise results in an increased production of oxidants in skeletal muscle, 
and hence regular activation of enzymatic AO-using mechanisms, endurance  exercise 
training induces adaptations resulting in upregulation of AO enzyme activity in skeletal 
muscle, i.e., SOD1, SOD2, GPx, and CAT [18, 24, 26, 27, 31, 33, 48]. Endurance  exercise 
training increases total SOD activity in highly oxidative type I (the soleus) and IIa (red 
gastrocnemius) skeletal muscle fibers [48]. Longer and more intensive endurance training 
promotes a greater increase in both cytosolic and mitochondrial GPx activity in oxidative 
skeletal muscle (type I and IIa) fibers.  Endurance training also upregulates CAT activity in 
peroxisomes and mitochondria in highly oxidative muscles [48]. 
 
Exercise-induced oxidative stress and the mitochondrial biogenesis mechanism 
Endurance training does not result in parallel increases in both oxidant and AO enzyme 
activity [22]. The AO enzyme activity of SOD, GPx, and CAT generally increase and ROS 
concentrations decline during normal  exercise training [48]. The mismatch seems to have an 
important beneficial role in  exercise training adaptations, e.g., mitochondrial biogenesis 
(15]/mitohormesis [53]. ROS stimulate the mitochondrial biogenesis cascade in response to 
endurance  exercise training, i.e., chronic muscle contractions [15]. The newly formed 
mitochondria are known to be highly efficient and produce fewer ROS for the same amount of 
produced adenosine triphosphate (ATP) [43]. Regular  exercise training increases expression 
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by the pro-oxidant herbicide paraquat) induce upregulation of the AO enzymes (SOD, GPx, 
and CAT) activity in myotubes [12]. This mechanism maintains the oxidant-AO homeostasis 
during a skeletal muscle contraction in animal models and humans [34, 50, 62]. 
 
Adaptation of enzymatic antioxidant mechanisms to exercise training  
Because prolonged exercise results in an increased production of oxidants in skeletal muscle, 
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muscle, i.e., SOD1, SOD2, GPx, and CAT [18, 24, 26, 27, 31, 33, 48]. Endurance  exercise 
training increases total SOD activity in highly oxidative type I (the soleus) and IIa (red 
gastrocnemius) skeletal muscle fibers [48]. Longer and more intensive endurance training 
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of proteins involved in mitochondrial biogenesis, i.e., PGC-1α, nuclear respiratory factor 1 
(NRF-1), and mitochondrial transcription factor A (Tfam) (Fig. 1). PGC-1α is an important 
transcriptional coactivator of nuclear genes encoding mitochondrial proteins, whilst Tfam 
regulates the expression of mitochondrial DNA [58]. For example, expression of PGC-1α in 
skeletal muscle was significantly increased following 4 weeks of endurance  exercise training 
[53], indicating a skeletal muscle contraction-stimulated mechanism of mitochondrial 
biogenesis. Mitochondria are also one of the main sources of ROS, which are products of 
oxidative lipid and glucose metabolism during muscle contraction [53]. However, the 
mitochondria are not the only sources of ROS during muscle contraction. For example, it has 
recently been shown that muscle contraction increases superoxide activity in cytosol, with a 
delayed increase in mitochondria. Therefore, it has been proposed that nicotinamide adenine 
dinucleotide phosphate-oxidase (NADPH) oxidases are the potential sources for superoxide 
generation [46]. Accordingly, ROS production (level of H2O2) was previously shown to 
increase in isolated mitochondria after acute muscle contraction in comparison with rested 
skeletal muscle biopsy sample [69]. 
Skeletal muscle contractions at high intensity increase the AMP/ATP ratio and the Ca2+ flux, 
thus causing upregulation of the gene expression and post-translational modification of PGC-
1α by the activation of AMPK, Ca2+/calmodulin-dependent kinase (CaMK), and calcineurin 
A. Co-activation of PGC-1α activates nuclear respiratory factors (NRF-1 and -2), which 
promote the expression of Tfam that directly stimulates mitochondrial DNA replication and 
transcription [28, 45]. Therefore, it consequently enhances mitochondrial biogenesis, which 
results in greater oxygen consumption [28]. 
 
Exercise-induced ROS production as a signaling pathway in insulin sensitivity  
Endurance  exercise training has been shown to improve insulin sensitivity and to enhance 
both insulin-stimulated and non-insulin mediated glucose uptake in skeletal muscle [74]. The 
exercise-induced enhancement in insulin-stimulated glucose disposal by skeletal muscle 
occurs as a result of increased protein expression of hexokinase 2 (HK2) and GLUT4 [74]. 
Muscle contraction-stimulated AMPK plays a central role in increased expression of GLUT4 
and, hence, the regulation of glucose homeostasis in response to exercise. A muscle-
contraction increase in AMPK activity has been correlated with GLUT4 translocation and also 
with non-insulin glucose transport in skeletal muscle [74]. Moreover, evidence indicates that 
exercise-induced reactive oxygen and nitrogen species (RONS) production plays an important 


role in regulating signaling pathways. Nitric oxide (NO), essential for the formation of 
reactive nitrogen species (RNS), therefore acts as a stimulator for exercise-mediated skeletal 
muscle glucose uptake, showing a possible mechanism of enhanced insulin sensitivity in 
response to  exercise training [74]. As mentioned earlier, the muscle contraction cascade leads 
to aRONS-stimulated increase in expression of PGC-1α, which is an insulin-sensitivity 
regulator [38]. The latter signaling role of RONS emphasizes its importance in insulin-
sensitizing mechanisms and glycemic control [53]. 
The current section shows the crucial role of ROS and RONS in basic adaptation mechanisms 
to  exercise training. While AO supplements may optimize the training effects by protecting 
against exercise-induced ROS overproduction, overdosed supplementation may impair  
exercise training’s beneficial adaptation effects.  
 
Dietary antioxidants: daily usage and supplementation 
Dietary AO supplements, such as vitamins, α-lipoic acid, coenzyme-Q10, and resveratrol, are 
commonly used by more than half of the adults in the United States to maintain health and 
extend life span. Vitamin C and E supplements are the most commonly used and combined 
dietary supplements among older adults (65 to 74 years in age) [49]. 
The water-soluble ascorbic acid has been suggested as a very effective donor AO [10]. 
Moreover, the fat-soluble vitamin E (mostly α-tocopherol) as an AO can scavenge lipid 
radicals [68, 71]. Oxidized vitamin E can be transformed again to an unoxidized form by other 
soluble AOs such as vitamin C. Therefore, that mechanism prevents vitamin E radicals from 
accumulating and inducing excess lipid peroxidation. The combination of vitamin C and E 
supplements, therefore, is most often used to potentially prevent oxidative stress and has been 
speculated to slow down the aging processes [68, 72]. 
According to dietary reference intakes (tolerable upper-intake levels) up to 2000 mg and 1000 
mg of vitamin C and E, respectively, was established as the maximum level of daily nutrient 
intake that is likely to pose no risk of adverse effects [39]. Some preclinical studies have 
shown that high doses of vitamins C and E may even have pro-oxidative properties and 
increase deleterious oxidative stress [29, 44]. For example, in some cases increased levels of 
oxidative stress led to a lens impairment that might have contributed to developed age-related 
cataract [75]. Supplementation of diets with smaller doses (500 mg per day of vitamin C), 
however, resulted in a significant increase in ascorbate levels in the plasma and, hence, 
decreased oxidative stress, compared with the placebo [6]. 
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with non-insulin glucose transport in skeletal muscle [74]. Moreover, evidence indicates that 
exercise-induced reactive oxygen and nitrogen species (RONS) production plays an important 
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role in regulating signaling pathways. Nitric oxide (NO), essential for the formation of 
reactive nitrogen species (RNS), therefore acts as a stimulator for exercise-mediated skeletal 
muscle glucose uptake, showing a possible mechanism of enhanced insulin sensitivity in 
response to  exercise training [74]. As mentioned earlier, the muscle contraction cascade leads 
to aRONS-stimulated increase in expression of PGC-1α, which is an insulin-sensitivity 
regulator [38]. The latter signaling role of RONS emphasizes its importance in insulin-
sensitizing mechanisms and glycemic control [53]. 
The current section shows the crucial role of ROS and RONS in basic adaptation mechanisms 
to  exercise training. While AO supplements may optimize the training effects by protecting 
against exercise-induced ROS overproduction, overdosed supplementation may impair  
exercise training’s beneficial adaptation effects.  
 
Dietary antioxidants: daily usage and supplementation 
Dietary AO supplements, such as vitamins, α-lipoic acid, coenzyme-Q10, and resveratrol, are 
commonly used by more than half of the adults in the United States to maintain health and 
extend life span. Vitamin C and E supplements are the most commonly used and combined 
dietary supplements among older adults (65 to 74 years in age) [49]. 
The water-soluble ascorbic acid has been suggested as a very effective donor AO [10]. 
Moreover, the fat-soluble vitamin E (mostly α-tocopherol) as an AO can scavenge lipid 
radicals [68, 71]. Oxidized vitamin E can be transformed again to an unoxidized form by other 
soluble AOs such as vitamin C. Therefore, that mechanism prevents vitamin E radicals from 
accumulating and inducing excess lipid peroxidation. The combination of vitamin C and E 
supplements, therefore, is most often used to potentially prevent oxidative stress and has been 
speculated to slow down the aging processes [68, 72]. 
According to dietary reference intakes (tolerable upper-intake levels) up to 2000 mg and 1000 
mg of vitamin C and E, respectively, was established as the maximum level of daily nutrient 
intake that is likely to pose no risk of adverse effects [39]. Some preclinical studies have 
shown that high doses of vitamins C and E may even have pro-oxidative properties and 
increase deleterious oxidative stress [29, 44]. For example, in some cases increased levels of 
oxidative stress led to a lens impairment that might have contributed to developed age-related 
cataract [75]. Supplementation of diets with smaller doses (500 mg per day of vitamin C), 
however, resulted in a significant increase in ascorbate levels in the plasma and, hence, 
decreased oxidative stress, compared with the placebo [6]. 
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While even smaller doses of AOs may lead to decreased ROS production, it is unknown 
whether decreased levels of free radicals may impair ROS-driven adaptations to  exercise 
training, e.g., enzymatic AO activity, mitochondrial biogenesis, and upregulated glucose 
metabolism. To our knowledge, there is not enough information on safe and effective dosing 
and interaction of vitamins and other supplements with  exercise training in clinical studies. 
Increased oxidative stress may also be deleterious in the aging process and, therefore, 
influence cognitive function. There is evidence that AO supplements may protect or improve 
cognitive function in adults aged 65 years and older [19]. Supplementation with multivitamins 
and vitamins C, E, and β-carotene, for example, was suggested to protect the brain from 
oxidative damage and delay an onset of cognitive decline [11, 35]. Results from a large, 
randomized, placebo-controlled trial, however, show that daily multivitamin supplementation 
had no benefit on delaying cognitive decline in adults aged 65 years and older after more than 
a decade of treatment intervention and follow-up [19]. Lin et al, found that none of the 
included trials reported any benefit from supplements on cognitive function in subjects aged 
69 to 95 with mild to moderate dementia [35]. Impairments of cognitive function associated 
with intake of AO supplements are not reported in older adults. Future clinical studies will 
aim to investigate the potentially beneficial effects of AO supplements on cognitive function 
in nutrient-deficient older adults.  
 
Is there evidence that antioxidant supplementation can improve or blunt beneficial 
exercise effects in animals and humans? 
Undoubtedly, the damaging effects of excess ROS concentrations may include decreased 
muscular functionality, histological changes, and muscular soreness, and may attenuate 
exercise performance [38]. This has been the rationale for consuming large quantities of non-
enzymatic AO supplements, e.g., vitamins C and E and α-lipoic acid. It also has led to 
research into whether non-enzymatic AO supplementation could prevent ROS’ damaging 
effects during exercise and thereby enhance endurance exercise performance [38] in animals 
and humans. In contrast to the initial protective hypothesis, preclinical studies and some 
recent human studies have reported controversial results on the blunting effect of non-
enzymatic AO supplementation on exercise endurance training [73]. Our focus will be mainly 
on enzymes and proteins that regulate redox biology (SOD, GPx, and CAT) and metabolism 
(GLUT4 and PGC-1α). We included in vivo animal and human studies on the effect of 
exercise training combined with non-enzymatic AOs only in skeletal muscle. 


Exercise training and antioxidant supplements in preclinical studies 
 
Redox status 
 Exercise training alone induces upregulation of the main AO enzymes activities (SOD, GPx, 
and CAT) in an animal model in comparison with untrained animals. Table 1.1 contains 
preclinical studies of the effect of exercise training combined with AO supplementation, i.e., 
vitamins C and E and α-lipoic acid [1, 16, 23, 31, 37, 64]. The results showed either no 
additional [23, 31, 32, 54, 64] or a blunting effect [16, 37] on the main AO enzyme activities. 
Authors suggested that the effect of exercise training combined with AOs may depend on the 
dosage, combination, and duration of AO supplementation, and the type of exercise training 
[1]. Mostly used supplement combinations were vitamins C and E [23, 31, 54], but also 
vitamin C and α-lipoic acid [64] and vitamin C alone [16, 37]. Interestingly, the dosages 
between those studies that reported no or a blunting effect did not differ. Composition of AO 
supplementation may also have a different AO potential, where the induced effect can be 
different, e.g., between specific combinations and individual use [1]. For example, α-lipoic 
acid increases vitamin E uptake in skeletal muscle that can amplify the overall AO effect [1]. 
The studies that reported no additional effect of AO used a combination of vitamins E and 
C/α-lipoic acid [23, 31, 64]. Remarkably, the results of Meier et al., and Gomez-Cabrera et al., 
on a blunting effect of AOs on redox status used vitamin C supplementation alone [16, 37]. 
According to results of Gomez-Cabrera et al., Vitamin C supplementation combined with 
exercise training can also impair redox status in rats [16]. The supplementation durations 
differed between the studies, but this does not seem to be a key factor in blunted expression of 
SOD and GPx, as studies showing no effect used longer, alike, or shorter time periods [23, 31, 
54, 64]. 
The reported significant reduction of AO enzyme activities does not seem to be induced by 
the duration or dosage of supplementation and training modalities. The only common factor of 
these two studies (Meier et al., and Gomez-Cabrera et al.,) out of the six listed in Table 1.1 
(preclinical studies) is that in these experiments supplementation with vitamin C alone was 
used in comparison with the other reported studies. Meier et al., combined coenzyme Q10 and 
1% N-acetyl-cysteine with vitamin C supplementation. However, it is unknown whether this 
combination had an additional blunting effect in comparison with the effect of vitamin C 
alone [37]. This warrants future studies on impact of AO supplementation using various 
clamped dosages, intervention durations and training modalities. The future studies will 
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While even smaller doses of AOs may lead to decreased ROS production, it is unknown 
whether decreased levels of free radicals may impair ROS-driven adaptations to  exercise 
training, e.g., enzymatic AO activity, mitochondrial biogenesis, and upregulated glucose 
metabolism. To our knowledge, there is not enough information on safe and effective dosing 
and interaction of vitamins and other supplements with  exercise training in clinical studies. 
Increased oxidative stress may also be deleterious in the aging process and, therefore, 
influence cognitive function. There is evidence that AO supplements may protect or improve 
cognitive function in adults aged 65 years and older [19]. Supplementation with multivitamins 
and vitamins C, E, and β-carotene, for example, was suggested to protect the brain from 
oxidative damage and delay an onset of cognitive decline [11, 35]. Results from a large, 
randomized, placebo-controlled trial, however, show that daily multivitamin supplementation 
had no benefit on delaying cognitive decline in adults aged 65 years and older after more than 
a decade of treatment intervention and follow-up [19]. Lin et al, found that none of the 
included trials reported any benefit from supplements on cognitive function in subjects aged 
69 to 95 with mild to moderate dementia [35]. Impairments of cognitive function associated 
with intake of AO supplements are not reported in older adults. Future clinical studies will 
aim to investigate the potentially beneficial effects of AO supplements on cognitive function 
in nutrient-deficient older adults.  
 
Is there evidence that antioxidant supplementation can improve or blunt beneficial 
exercise effects in animals and humans? 
Undoubtedly, the damaging effects of excess ROS concentrations may include decreased 
muscular functionality, histological changes, and muscular soreness, and may attenuate 
exercise performance [38]. This has been the rationale for consuming large quantities of non-
enzymatic AO supplements, e.g., vitamins C and E and α-lipoic acid. It also has led to 
research into whether non-enzymatic AO supplementation could prevent ROS’ damaging 
effects during exercise and thereby enhance endurance exercise performance [38] in animals 
and humans. In contrast to the initial protective hypothesis, preclinical studies and some 
recent human studies have reported controversial results on the blunting effect of non-
enzymatic AO supplementation on exercise endurance training [73]. Our focus will be mainly 
on enzymes and proteins that regulate redox biology (SOD, GPx, and CAT) and metabolism 
(GLUT4 and PGC-1α). We included in vivo animal and human studies on the effect of 
exercise training combined with non-enzymatic AOs only in skeletal muscle. 


Exercise training and antioxidant supplements in preclinical studies 
 
Redox status 
 Exercise training alone induces upregulation of the main AO enzymes activities (SOD, GPx, 
and CAT) in an animal model in comparison with untrained animals. Table 1.1 contains 
preclinical studies of the effect of exercise training combined with AO supplementation, i.e., 
vitamins C and E and α-lipoic acid [1, 16, 23, 31, 37, 64]. The results showed either no 
additional [23, 31, 32, 54, 64] or a blunting effect [16, 37] on the main AO enzyme activities. 
Authors suggested that the effect of exercise training combined with AOs may depend on the 
dosage, combination, and duration of AO supplementation, and the type of exercise training 
[1]. Mostly used supplement combinations were vitamins C and E [23, 31, 54], but also 
vitamin C and α-lipoic acid [64] and vitamin C alone [16, 37]. Interestingly, the dosages 
between those studies that reported no or a blunting effect did not differ. Composition of AO 
supplementation may also have a different AO potential, where the induced effect can be 
different, e.g., between specific combinations and individual use [1]. For example, α-lipoic 
acid increases vitamin E uptake in skeletal muscle that can amplify the overall AO effect [1]. 
The studies that reported no additional effect of AO used a combination of vitamins E and 
C/α-lipoic acid [23, 31, 64]. Remarkably, the results of Meier et al., and Gomez-Cabrera et al., 
on a blunting effect of AOs on redox status used vitamin C supplementation alone [16, 37]. 
According to results of Gomez-Cabrera et al., Vitamin C supplementation combined with 
exercise training can also impair redox status in rats [16]. The supplementation durations 
differed between the studies, but this does not seem to be a key factor in blunted expression of 
SOD and GPx, as studies showing no effect used longer, alike, or shorter time periods [23, 31, 
54, 64]. 
The reported significant reduction of AO enzyme activities does not seem to be induced by 
the duration or dosage of supplementation and training modalities. The only common factor of 
these two studies (Meier et al., and Gomez-Cabrera et al.,) out of the six listed in Table 1.1 
(preclinical studies) is that in these experiments supplementation with vitamin C alone was 
used in comparison with the other reported studies. Meier et al., combined coenzyme Q10 and 
1% N-acetyl-cysteine with vitamin C supplementation. However, it is unknown whether this 
combination had an additional blunting effect in comparison with the effect of vitamin C 
alone [37]. This warrants future studies on impact of AO supplementation using various 
clamped dosages, intervention durations and training modalities. The future studies will 
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improve our understanding of the supplement combinations and its impact on training-induced 
redox status changes. 
 
Mitochondrial biogenesis mechanism in response to exercise training combined with 
antioxidant supplementation 
Mitochondrial biogenesis is the essential adaptive response mechanism to endurance training 
and mitochondrial content in muscle is a crucial determinant of endurance capacity [1, 51]. 
Recent preclinical studies have shown either no additional [1, 23, 64] or a blunting effect of 
exercise training +AO combination on protein expression of PGC-1α [16, 37]. Expression of 
PGC-1α was blunted in studies where vitamin C supplementation alone was combined with 
endurance exercise training in animals. Gomez-Cabrera et al. suggested that vitamin C 
supplementation during endurance training blunts one of the mitochondrial biogenesis paths, 
i.e., PGC-1α—NRF-1—TFAM—cytochrome C [16]. Additionally, endurance training 
combined with vitamin C supplementation in rats blunted an improvement in running time in 
comparison with training alone (26.5% versus 186.7%, respectively), whereas there was no 
difference in peak [16]. This is in agreement with the statement that endurance capacity 
depends on mitochondrial content in skeletal muscle and that peak is also dependent on 
cardiovascular training adaptations [16]. While Meier et al. reported no differences in running 
times, found no differences in the peak power exercise tests performed at the end of the 
training period, in accordance with Gomez-Cabrera [37]. 
Moderate ROS levels are crucial for signaling pathways of mitochondrial biogenesis [1, 37]. 
Decreased expression of PGC-1α, therefore, is associated with reduced ROS-stimulated 
mitochondrial biogenesis. Supplementation with vitamin C decreased ROS levels, preventing 
enzymatic AO activity [37]. Moreover, the studies of Meier et al., and Gomez-Cabrera are in 
agreement with the statement associating blunted expression of PGC-1αwith decreased 
activity of AO enzymes (SOD, GPx, CAT), the primary endogenic AO defense system [16]. 
 
Metabolic response to exercise training combined with antioxidant supplementation in 
animal skeletal muscle 
Increased expression of GLUT4 is one of major adaptive responses to endurance exercise in 
skeletal muscle [23]. Additionally, studies on endurance training adaptations have shown that 
expression of GLUT4 is also redox-sensitive [37]. Mitochondrial biogenesis and upregulated 
2OV
2OV


expression of GLUT4 are mediated by the PGC-1α protein, which increases in response to 
acute as well as endurance exercise training [37, 51]. 
Although studies on exercise training combined with AO supplements showed inconsistent 
results regarding redox status and mitochondrial biogenesis pathway, studies on the metabolic 
response show no difference in GLUT4 expression in response to exercise training with or 
without administered AOs. 
Only two studies investigated both expressions of PGC-1α and GLUT4 in response to 
exercise training combined with AO supplements. Meier et al., found blunted PGC-
1αexpression and no effect on GLUT4 expression [37]. On the other hand, Higashida et al. 
reported no effect of the exercise training +AO combination on expression of PGC-1α and 
GLUT4 [23]. 
Taken together, animal studies have shown consistent results regarding the upregulating effect 
of exercise training alone on adaptive mitochondrial biogenesis and insulin sensitivity and 
glycemic regulation. Conversely, results on exercise training +AO were equivocal, and its 
potential suppressing effect on exercise training may depend on the dose, type of AO 
composition, and length of time.  
 
Exercise training combined with administration of antioxidant supplements in healthy 
humans 
 
Redox status 
Recent studies have addressed the effects of AO supplementation on the  exercise training 
adaptations in healthy humans [4, 45, 53, 66, 74]. Ristow et al. and Gomez-Cabrera et al. have 
reported recently that AO supplementation can decrease training efficiency and prevents 
specific cellular adaptations of  exercise training in healthy humans, e.g., mitochondrial 
biogenesis [16, 53]. Recent clinical trials suggest that various AOs that directly inhibit ROS 
production may ameliorate the benefits of exercise that depend on ROS signaling [16, 53] or 
have no different effect from  exercise training alone [66, 73].  
In Table 1.2 (clinical studies), we present relevant double-blind placebo-controlled studies 
that investigated enzymatic AO defense activity during endurance  exercise training combined 
with vitamin C and E supplementation in young healthy adults. 
Ristow et al. have studied the effect of a 4-week endurance training regimen combined with 
vitamin supplementation or placebo on training adaptation in 19 untrained and 20 pre-trained 
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improve our understanding of the supplement combinations and its impact on training-induced 
redox status changes. 
 
Mitochondrial biogenesis mechanism in response to exercise training combined with 
antioxidant supplementation 
Mitochondrial biogenesis is the essential adaptive response mechanism to endurance training 
and mitochondrial content in muscle is a crucial determinant of endurance capacity [1, 51]. 
Recent preclinical studies have shown either no additional [1, 23, 64] or a blunting effect of 
exercise training +AO combination on protein expression of PGC-1α [16, 37]. Expression of 
PGC-1α was blunted in studies where vitamin C supplementation alone was combined with 
endurance exercise training in animals. Gomez-Cabrera et al. suggested that vitamin C 
supplementation during endurance training blunts one of the mitochondrial biogenesis paths, 
i.e., PGC-1α—NRF-1—TFAM—cytochrome C [16]. Additionally, endurance training 
combined with vitamin C supplementation in rats blunted an improvement in running time in 
comparison with training alone (26.5% versus 186.7%, respectively), whereas there was no 
difference in peak [16]. This is in agreement with the statement that endurance capacity 
depends on mitochondrial content in skeletal muscle and that peak is also dependent on 
cardiovascular training adaptations [16]. While Meier et al. reported no differences in running 
times, found no differences in the peak power exercise tests performed at the end of the 
training period, in accordance with Gomez-Cabrera [37]. 
Moderate ROS levels are crucial for signaling pathways of mitochondrial biogenesis [1, 37]. 
Decreased expression of PGC-1α, therefore, is associated with reduced ROS-stimulated 
mitochondrial biogenesis. Supplementation with vitamin C decreased ROS levels, preventing 
enzymatic AO activity [37]. Moreover, the studies of Meier et al., and Gomez-Cabrera are in 
agreement with the statement associating blunted expression of PGC-1αwith decreased 
activity of AO enzymes (SOD, GPx, CAT), the primary endogenic AO defense system [16]. 
 
Metabolic response to exercise training combined with antioxidant supplementation in 
animal skeletal muscle 
Increased expression of GLUT4 is one of major adaptive responses to endurance exercise in 
skeletal muscle [23]. Additionally, studies on endurance training adaptations have shown that 
expression of GLUT4 is also redox-sensitive [37]. Mitochondrial biogenesis and upregulated 
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expression of GLUT4 are mediated by the PGC-1α protein, which increases in response to 
acute as well as endurance exercise training [37, 51]. 
Although studies on exercise training combined with AO supplements showed inconsistent 
results regarding redox status and mitochondrial biogenesis pathway, studies on the metabolic 
response show no difference in GLUT4 expression in response to exercise training with or 
without administered AOs. 
Only two studies investigated both expressions of PGC-1α and GLUT4 in response to 
exercise training combined with AO supplements. Meier et al., found blunted PGC-
1αexpression and no effect on GLUT4 expression [37]. On the other hand, Higashida et al. 
reported no effect of the exercise training +AO combination on expression of PGC-1α and 
GLUT4 [23]. 
Taken together, animal studies have shown consistent results regarding the upregulating effect 
of exercise training alone on adaptive mitochondrial biogenesis and insulin sensitivity and 
glycemic regulation. Conversely, results on exercise training +AO were equivocal, and its 
potential suppressing effect on exercise training may depend on the dose, type of AO 
composition, and length of time.  
 
Exercise training combined with administration of antioxidant supplements in healthy 
humans 
 
Redox status 
Recent studies have addressed the effects of AO supplementation on the  exercise training 
adaptations in healthy humans [4, 45, 53, 66, 74]. Ristow et al. and Gomez-Cabrera et al. have 
reported recently that AO supplementation can decrease training efficiency and prevents 
specific cellular adaptations of  exercise training in healthy humans, e.g., mitochondrial 
biogenesis [16, 53]. Recent clinical trials suggest that various AOs that directly inhibit ROS 
production may ameliorate the benefits of exercise that depend on ROS signaling [16, 53] or 
have no different effect from  exercise training alone [66, 73].  
In Table 1.2 (clinical studies), we present relevant double-blind placebo-controlled studies 
that investigated enzymatic AO defense activity during endurance  exercise training combined 
with vitamin C and E supplementation in young healthy adults. 
Ristow et al. have studied the effect of a 4-week endurance training regimen combined with 
vitamin supplementation or placebo on training adaptation in 19 untrained and 20 pre-trained 
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healthy men. They reported a significant effect of vitamins C (1000g) and E (400 IU) 
supplementation in blocking  exercise training -induced expression of AO enzyme mRNAs 
(SOD1 and GPx1) for the entire cohort of trained and untrained subjects in comparison with 
no-supplemented groups [53]. The findings are in agreement with the study results of Gomez-
Cabrera et al., and Braakhuis et al., where activity of SOD, GPx, and CAT [4] decreased in 
response to 8 weeks [16] and 9 weeks [4] of endurance training combined with antioxidants in 
untrained and trained subjects, respectively. In response to endurance and eccentric training in 
combination with vitamin C and E supplementation, there was no change in CAT activity in 
comparison with placebo [53, 66]. These results seem to indicate consistently that 
consumption of these amounts of vitamin C and E supplements blunts SOD and GPx activities 
in humans [4]. Therefore, this may be blocking exercise-dependent production of the ROS [4, 
16] essential for hormetic stimulation of adaptive mechanisms to  exercise training, e.g., the 
PGC-1α pathway of mitochondrial biogenesis. Variability in levels of significance may be 
training type- and duration-related. 
 
Mitochondrial biogenesis 
Available study results have been presented on the effects of endurance exercise training with 
vitamin C and E supplementation on PGC-1α protein expression, the mitochondrial biogenesis 
co-activator (Table 1.2). Paulsen et al., have shown that vitamin C and E supplementation 
blunted any rise in muscle cytosolic PGC-1α levels during an 11-week endurance exercise 
training program. By contrast, PGC-1α mRNA increased only in the vitamin C and E 
supplementation group, and nuclear PGC-1α protein levels were unchanged in both groups. 
The authors explain that muscle biopsies were collected 2 to 4 days after the last training 
session, and they reflect no immediate activation, nuclear translocation of PGC-1α, or gene 
expression during exercise [45]. Yfanti et al. have shown no effect of either the training or the 
supplementation on the basal mRNA expression of PGC-1α [73]. Ristow et al. reported that 
an exercise-related induction of PGC-1α expression in skeletal muscle was strongly blunted 
following 4 weeks of exercise training in comparison with the non-AO group [53]. These 
study results coincide with the opinion that prolonged exercise training (4 to 11 weeks) 
combined with vitamin C and E supplementation blunt ROS-stimulated cellular primary 
pathways of mitochondrial biogenesis that seem to block an increase in exercise performance. 
Yfanti et al. who observed no increase in PGC-1α expression, speculate that the result may be 


induced by different training modalities and the applied dose of vitamin C of 500 mg [74] 
versus 1000 mg in the rest of the relevant studies [16, 45, 53].  
 
Metabolic response to exercise training combined with antioxidant supplements 
Exercise endurance training has been shown to improve not only exercise performance, but 
also other health-related functions, such as muscular glucose uptake, insulin sensitivity 
maintenance, and insulin-resistance improvement [53]. Animal studies have shown that 
overexpression of skeletal muscle PGC-1α increases insulin-stimulated glucose disposal in 
both healthy and insulin-resistant rats. The insulin-sensitizing effects of endurance  exercise 
training seem to be blunted by decreased ROS production induced by vitamin C and E 
supplementation [53]. Ristow et al. have shown a significant effect of vitamin C and E 
supplementation on the blockage of an  exercise training -induced improvement of insulin 
sensitivity, i.e. decreased expression of PGC-1α. It was determined by glucose infusion rates 
(p<0.001) in comparison with placebo (Table 1.4). While this is controversial and has not 
been conducted in other human studies, it is in line with some animal studies [64]. 
In contrast to the latter, Yfanti et al. have shown that vitamin C and E supplementation before 
a 12-week training program had no effect on insulin-stimulated glucose uptake in skeletal 
muscle in comparison with placebo [74]. The increased insulin sensitivity was associated with 
corresponding increases in total protein kinase B (Akt), GLUT4, and HK2 in skeletal muscle 
in both supplementation and placebo groups, without significant differences [74]. The 
discrepancy between those two studies may be dependent on the dose-response of the AO 
supplements, as the vitamin C dose was lower (500 mg) [73] where there was no effect. There 
is no sufficient scientific evidence, however, of impaired insulin-sensitivity improvement in 
response to endurance training combined with vitamin C and E supplements. This warrants 
more studies on the AMPK—PGC-1α—GLUT4 pathway in response to endurance  exercise 
training with AO supplementation in human subjects. Future studies are important because the 
AOs are often combined with exercise endurance in healthy and insulin-resistant subjects. 
Dose-response studies of vitamin C and E supplements during  exercise training would 
contribute to recommendations on effective exercise performance improvements in athletic as 
well as clinical settings. 
In conclusion, evidence exists in both animal and human studies that exercise-induced ROS 
play a crucial role in stimulating the signaling pathways for enzymatic AO activity (SOD, 
GPx, and CAT), mitochondrial biogenesis (expression of PGC-1α), and glucose metabolism 
Mankowski_BW.indd   30 04-08-15   15:43
Dietary Antioxidants as Modifiers of Physiologic Adaptations to Exercise
31
C
ha
pt
er
 1


healthy men. They reported a significant effect of vitamins C (1000g) and E (400 IU) 
supplementation in blocking  exercise training -induced expression of AO enzyme mRNAs 
(SOD1 and GPx1) for the entire cohort of trained and untrained subjects in comparison with 
no-supplemented groups [53]. The findings are in agreement with the study results of Gomez-
Cabrera et al., and Braakhuis et al., where activity of SOD, GPx, and CAT [4] decreased in 
response to 8 weeks [16] and 9 weeks [4] of endurance training combined with antioxidants in 
untrained and trained subjects, respectively. In response to endurance and eccentric training in 
combination with vitamin C and E supplementation, there was no change in CAT activity in 
comparison with placebo [53, 66]. These results seem to indicate consistently that 
consumption of these amounts of vitamin C and E supplements blunts SOD and GPx activities 
in humans [4]. Therefore, this may be blocking exercise-dependent production of the ROS [4, 
16] essential for hormetic stimulation of adaptive mechanisms to  exercise training, e.g., the 
PGC-1α pathway of mitochondrial biogenesis. Variability in levels of significance may be 
training type- and duration-related. 
 
Mitochondrial biogenesis 
Available study results have been presented on the effects of endurance exercise training with 
vitamin C and E supplementation on PGC-1α protein expression, the mitochondrial biogenesis 
co-activator (Table 1.2). Paulsen et al., have shown that vitamin C and E supplementation 
blunted any rise in muscle cytosolic PGC-1α levels during an 11-week endurance exercise 
training program. By contrast, PGC-1α mRNA increased only in the vitamin C and E 
supplementation group, and nuclear PGC-1α protein levels were unchanged in both groups. 
The authors explain that muscle biopsies were collected 2 to 4 days after the last training 
session, and they reflect no immediate activation, nuclear translocation of PGC-1α, or gene 
expression during exercise [45]. Yfanti et al. have shown no effect of either the training or the 
supplementation on the basal mRNA expression of PGC-1α [73]. Ristow et al. reported that 
an exercise-related induction of PGC-1α expression in skeletal muscle was strongly blunted 
following 4 weeks of exercise training in comparison with the non-AO group [53]. These 
study results coincide with the opinion that prolonged exercise training (4 to 11 weeks) 
combined with vitamin C and E supplementation blunt ROS-stimulated cellular primary 
pathways of mitochondrial biogenesis that seem to block an increase in exercise performance. 
Yfanti et al. who observed no increase in PGC-1α expression, speculate that the result may be 


induced by different training modalities and the applied dose of vitamin C of 500 mg [74] 
versus 1000 mg in the rest of the relevant studies [16, 45, 53].  
 
Metabolic response to exercise training combined with antioxidant supplements 
Exercise endurance training has been shown to improve not only exercise performance, but 
also other health-related functions, such as muscular glucose uptake, insulin sensitivity 
maintenance, and insulin-resistance improvement [53]. Animal studies have shown that 
overexpression of skeletal muscle PGC-1α increases insulin-stimulated glucose disposal in 
both healthy and insulin-resistant rats. The insulin-sensitizing effects of endurance  exercise 
training seem to be blunted by decreased ROS production induced by vitamin C and E 
supplementation [53]. Ristow et al. have shown a significant effect of vitamin C and E 
supplementation on the blockage of an  exercise training -induced improvement of insulin 
sensitivity, i.e. decreased expression of PGC-1α. It was determined by glucose infusion rates 
(p<0.001) in comparison with placebo (Table 1.4). While this is controversial and has not 
been conducted in other human studies, it is in line with some animal studies [64]. 
In contrast to the latter, Yfanti et al. have shown that vitamin C and E supplementation before 
a 12-week training program had no effect on insulin-stimulated glucose uptake in skeletal 
muscle in comparison with placebo [74]. The increased insulin sensitivity was associated with 
corresponding increases in total protein kinase B (Akt), GLUT4, and HK2 in skeletal muscle 
in both supplementation and placebo groups, without significant differences [74]. The 
discrepancy between those two studies may be dependent on the dose-response of the AO 
supplements, as the vitamin C dose was lower (500 mg) [73] where there was no effect. There 
is no sufficient scientific evidence, however, of impaired insulin-sensitivity improvement in 
response to endurance training combined with vitamin C and E supplements. This warrants 
more studies on the AMPK—PGC-1α—GLUT4 pathway in response to endurance  exercise 
training with AO supplementation in human subjects. Future studies are important because the 
AOs are often combined with exercise endurance in healthy and insulin-resistant subjects. 
Dose-response studies of vitamin C and E supplements during  exercise training would 
contribute to recommendations on effective exercise performance improvements in athletic as 
well as clinical settings. 
In conclusion, evidence exists in both animal and human studies that exercise-induced ROS 
play a crucial role in stimulating the signaling pathways for enzymatic AO activity (SOD, 
GPx, and CAT), mitochondrial biogenesis (expression of PGC-1α), and glucose metabolism 
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(insulin sensitivity (GLUT4 expression) and glucose uptake). Moreover, adaptation to regular 
moderate ROS production during  exercise training allows for more effective enzymatic ROS 
scavenging, increases mitochondrial oxidative capacity and its efficiency (new, more efficient 
mitochondria) and, hence, prevents deleterious overproduction of ROS. Study results are 
unclear about a potential suppressive role of AO supplements in impairing these  exercise 
training -induced adaptive effects.  
High consumption of AOs in middle-aged and older adults may impair desired goals to 
improve metabolic status (obesity, lipid profile, insulin resistance, poor physical condition). 
Additionally, Higashida et al. (23] have suggested that the separate reports of Ristow et al. 
[53] and Gomez-Cabrera et al.  [16], describing a suppressive role of AO supplements on  
exercise training, have to be treated with caution because of its methodology. On the other 
hand, Gomez-Cabrera et al. [17] contrast with Higashida et al. [23] Therefore, the unknown 
effects of supplemental composition, dose, and time duration on adaptive training effects 
necessitate further studies to establish safe AO supplement types, doses, and composition 
without suppressing  exercise training’s beneficial effects.  
 
Resveratrol as an “alternative antioxidant” and its role as an antioxidant in exercise 
training adaptation in preclinical and clinical studies 
Resveratrol is a polyphenolic and fat-soluble compound present mainly in grapes [7]. To date, 
there have been a number of in vitro and preclinical [25, 56, 60, 61], but also clinical studies 
investigating resveratrol’s AO features [14, 41, 42, 52]. Resveratrol has a short biological 
half-life (8 to 14 minutes) [67], labile properties, and rapid metabolism and elimination. 
Because of its poor water solubility and instability, it converts to a less active cis form, and its 
beneficial AO impact is not fully understood [67].  
 
Resveratrol as an antioxidant and gene regulator 
Resveratrol has been studied as an AO supplement that decreases deleterious amounts of 
ROS, but also as a stimulant of energetic cellular sirtuin 1 (SIRT1)- and AMPK-dependent 
pathways [38], both important for PGC1α activation. Study results, however, are equivocal 
perhaps because of resveratrol’s poor bioavailability and solubility [3]. There is some 
evidence of in vitro results showing improved availability and uptake of resveratrol by 
composing it chemically with liposomal carriers. Vanaja et al., for example, found that 
liposomal forms of resveratrol improved its antioxidative properties and, hence, decreased 


oxidative damage in isolated leukocytes [67]. Therefore, this could potentially improve 
resveratrol’s bioavailability and AO effects in preclinical and clinical studies, but further 
studies are needed. Despite the controversies regarding the bioavailability and delivery of 
resveratrol, spectacular improvements on metabolism and performance induced by resveratrol 
supplementation have been documented (mostly in animal studies) [22, 30, 40, 52]. 
 
Effects of exercise training combined with resveratrol in preclinical and human studies 
While a number of studies have focused on resveratrol’s effects on  exercise training results in 
animal models (Table 1.7) [8, 22, 30, 40, 52], we are only aware of two studies that 
investigated a synergistic effect of combined  exercise training with resveratrol 
supplementation in humans [14, 41].   
 
Preclinical studies 
Hart et al. speculated that resveratrol may have induced post-training improvements in aerobic 
capacity by simultaneously activating different molecular pathways related to mitochondrial 
function [22]. Indeed, some authors reported improved peak and running time in response 
to resveratrol combined with exercise training [22, 40]. Other authors reported increased 
expression of PGC-1α and, hence, improved mitochondrial biogenesis [8, 22]. In accordance 
with an improved PGC-1α signaling pathway, an enhanced metabolic adaptive response was 
also reported by increased GLUT4 expression, insulin sensitivity, and glucose uptake [40].  
Additionally, two studies of the same group (Hart et al., 2014 and Hart et al., 2013) have 
investigated the effects of resveratrol in conjunction with exercise training on running 
distance in low capacity runner (LCR) and high capacity runner (HCR) rats, respectively. 
Interestingly, resveratrol supplementation combined with exercise training reduced running 
distance in LCR [21] and improved running distance in HCR rats [22]. To explain this 
inconsistency, it was suggested that in some models resveratrol supplementation induces 
different results in obese prone and obese resistant rats and its effects could be influenced by 
metabolic status [21]. 
Taken together, the authors speculate that these synergistic effects may manifest as a result of 
providing resveratrol when cellular energy demand is high but also in rats with high levels of 
performance. From these basic and preclinical studies, it seems that this potential additional 
effect of resveratrol on training effects provides the mechanistic action through which 
2OV
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(insulin sensitivity (GLUT4 expression) and glucose uptake). Moreover, adaptation to regular 
moderate ROS production during  exercise training allows for more effective enzymatic ROS 
scavenging, increases mitochondrial oxidative capacity and its efficiency (new, more efficient 
mitochondria) and, hence, prevents deleterious overproduction of ROS. Study results are 
unclear about a potential suppressive role of AO supplements in impairing these  exercise 
training -induced adaptive effects.  
High consumption of AOs in middle-aged and older adults may impair desired goals to 
improve metabolic status (obesity, lipid profile, insulin resistance, poor physical condition). 
Additionally, Higashida et al. (23] have suggested that the separate reports of Ristow et al. 
[53] and Gomez-Cabrera et al.  [16], describing a suppressive role of AO supplements on  
exercise training, have to be treated with caution because of its methodology. On the other 
hand, Gomez-Cabrera et al. [17] contrast with Higashida et al. [23] Therefore, the unknown 
effects of supplemental composition, dose, and time duration on adaptive training effects 
necessitate further studies to establish safe AO supplement types, doses, and composition 
without suppressing  exercise training’s beneficial effects.  
 
Resveratrol as an “alternative antioxidant” and its role as an antioxidant in exercise 
training adaptation in preclinical and clinical studies 
Resveratrol is a polyphenolic and fat-soluble compound present mainly in grapes [7]. To date, 
there have been a number of in vitro and preclinical [25, 56, 60, 61], but also clinical studies 
investigating resveratrol’s AO features [14, 41, 42, 52]. Resveratrol has a short biological 
half-life (8 to 14 minutes) [67], labile properties, and rapid metabolism and elimination. 
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composing it chemically with liposomal carriers. Vanaja et al., for example, found that 
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oxidative damage in isolated leukocytes [67]. Therefore, this could potentially improve 
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performance. From these basic and preclinical studies, it seems that this potential additional 
effect of resveratrol on training effects provides the mechanistic action through which 
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exercise training combined with resveratrol supplementation (REX) may be a feasible and 
efficacious intervention for maintaining functional status in humans. 
 
Figure 1.1. Adequate production level of reactive oxygen species (ROS) as a signaling 
agent in adaptation response to exercise training (ET). This simplified scheme shows a 
clear potential blunting effect of antioxidant (AO) supplements on biological 
mechanisms when combined with exercise training.
 
Human studies 
Contrary to the aforementioned animal results on improved exercise performance following 
REX, one human study has shown a 45% larger improvement of peak in response to 
placebo after 8 weeks of high intensity training in comparison with resveratrol-supplemented 
subjects (Table 1.8) [14]. The latter and other human study of Olesen et al., consistently 
reported that exercise training combined with resveratrol supplementation had no additional 
effect on PGC-1α, SIRT1, and AMPK-induced energetic mechanisms as compared to a 
placebo group [14, 41]. Additionally, Scribbans et al. have also reported no additional effects 
of resveratrol supplementation on exercise performance and speculated that resveratrol 
supplementation may have a blunting effect on skeletal muscle gene expression of PGC-1α, 
SIRT1, and SOD2 [59]. Moreover, Gliemann et al. have reported that resveratrol might have 
blunted a beneficial effect of exercise training on lipid profile. They have shown that REX 
eliminated the training effect on low-density lipoprotein (LDL), total cholesterol/high-density 
lipoprotein (TC/HDL) ratio, and TGs [14]. 
Contrary to animal study results, resveratrol did not improve exercise performance in healthy 
older adults. Interestingly, resveratrol has been shown to impair the observed exercise training 
-induced improvements in lipid profile. Moreover, resveratrol impaired a beneficial effect of 
the exercise training -induced improvement in mean arterial pressure (MAP) [14] and the 
muscle protein expression of vascular endothelial growth factor (VEGF) [13].  
Given the inconsistency of existing animal data on REX and the few human studies indicating 
impairments in exercise performance and abolished exercise-induced lipid profile 
improvement following resveratrol supplementation, we suggest that this isolated human 
report of Gliemann et al., should not be a barrier to further investigation of resveratrol as a 
potential aid in improving exercise training effects in healthy subjects and in a clinical setting 
(hypertension, poor physical activity, reduced oxidative capacity) [14]. Moreover, other 
authors are also critical about the reported negative effects of resveratrol and have questioned 
Gliemann’s methodology and analyses [5, 63]. 
 
Conclusion 
The review investigated basic biological adaptive mechanisms to exercise training in 
preclinical and clinical studies in response to exercise training combined with commonly used 
AO supplements. Most of the relevant animal and human studies showed neither additional 
nor adverse effects of exercise training combined with AO supplements on redox status, 
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preclinical and clinical studies in response to exercise training combined with commonly used 
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mitochondrial biogenesis, and glucose metabolism. Only a few animal and human studies 
have shown a blunting effect of exercise training combined with vitamin AOs on adaptive 
responses to exercise training in healthy subjects. The reason for this inconsistency could 
possibly lie in different AO compositions, doses, duration time of supplementation, and 
exercise training modalities. Additionally, the reported blunting effects of AO on training 
results could also be misleading by chosen methodology of study protocols. Moreover, it is 
difficult to speculate about adverse or positive clinical effects of resveratrol because of a 
narrow body of evidence and because experiments were conducted in only healthy subjects. 
To date, a blunting influence of AO supplementation during exercise training in healthy 
humans remains speculative. The lack of strong evidence indicating adverse and/or positive 
effects and the unclear methods of AO administration in combination with exercise training, 
however, warrant future studies in healthy aging populations and individuals with chronic 
health conditions such as sarcopenia, hypertension, and poor physical aerobic condition, for 
whom training adaptations are crucial for health improvement. 
 
Future directions 
The review highlights studies on AO supplements’ adverse blunting effects on mitochondrial 
biogenesis pathways and suggests ROS-induced impaired signaling mechanisms. Enzymatic 
AO activity seems to be an efficient and effective defense against oxidative stress during 
exercise training in healthy young and middle-aged adults. Therefore, future double-blinded 
placebo-controlled studies should focus on investigating a potential positive or negative effect 
of AO supplements on key exercise training adaptation mechanisms in deficient older adults. 
Such studies may evaluate exercise responses for relevant biologic factors such as 
mitochondrial biogenesis, insulin, skeletal muscle glucose uptake, and redox status. Though 
speculative, adverse and/or positive effects of AO supplementation on exercise training 
results may depend on doses, compounds, combinations, and endurance training modalities. 
To address this hypothesis, dose-response clinical trials are needed to determine safe and 
training-efficient supplementation strategies combined with exercise training in both healthy 
and unhealthy older adults. 
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C
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 m
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ra
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w
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ra
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 d
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 re
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 m
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 m
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T
ab
le
 1
.7
. F
in
di
ng
s f
ro
m
 p
re
cl
in
ic
al
 st
ud
ie
s o
f c
om
bi
ne
d 
ef
fe
ct
s o
f r
es
ve
ra
tr
ol
 a
nd
 p
hy
si
ca
l e
xe
rc
is
e 
in
 a
ni
m
al
s, 
co
m
pa
ri
ng
 e
xe
rc
is
e 
tr
ai
ni
ng
 a
lo
ne
 to
 e
xe
rc
is
e 
tr
ai
ni
ng
 c
om
bi
ne
d 
w
ith
 r
es
ve
ra
tr
ol
 su
pp
le
m
en
ta
tio
n 
(R
E
X
). 
St
ud
y 
Sp
ec
ie
s 
A
ge
 
D
os
ag
e 
of
 
re
sv
er
at
r
ol
 
D
ur
at
io
n 
an
d 
ty
pe
 o
f 
tr
ai
ni
ng
 
R
es
po
ns
e 
to
 E
T
 v
s. 
se
de
nt
ar
y 
R
es
po
ns
e 
to
 R
E
X
 
M
ur
as
e 
et
 
al
. [
43
] 
M
al
e 
se
ne
sc
en
ce
-
ac
ce
le
ra
te
d 
m
ic
e 
13
 
w
ee
ks
 
0.
2%
 o
f a
 
di
et
 
12
 w
ee
ks
 
So
le
us
 a
nd
 e
xt
en
so
r d
ig
ito
ru
m
 
lo
ng
us
 (E
D
L)
: i
nc
re
as
ed
 m
us
cl
e 
w
ei
gh
t, 
te
ta
ni
c 
co
nt
ra
ct
io
n 
fo
rc
e;
 
re
du
ce
d 
gl
uc
os
e,
 tr
ig
ly
ce
rid
es
 
(T
G
s)
, i
ns
ul
in
; r
ed
uc
ed
 se
ru
m
 a
nd
 
m
us
cl
e 
(E
D
L)
 th
io
ba
rb
itu
ric
 a
ci
d 
re
ac
tiv
e 
su
bs
ta
nc
es
 (T
B
A
R
S)
; 
in
cr
ea
se
d 
PG
C
-1
α 
an
d 
G
LU
T4
; 
in
cr
ea
se
d 
V
O
2 a
nd
 li
pi
d 
ox
id
at
io
n 
So
le
us
 a
nd
 E
D
L:
 in
cr
ea
se
d 
m
us
cl
e 
w
ei
gh
t, 
te
ta
ni
c 
co
nt
ra
ct
io
n 
fo
rc
e;
 re
du
ce
d 
gl
uc
os
e,
 
TG
s, 
in
su
lin
; r
ed
uc
ed
 se
ru
m
 a
nd
 m
us
cl
e 
(E
D
L)
 T
B
A
R
S;
 in
cr
ea
se
d 
PG
C
-1
α 
an
d 
G
LU
T4
; i
nc
re
as
ed
 V
O
2 a
nd
 li
pi
d 
ox
id
at
io
n 
D
ol
in
sk
y 
et
 
al
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 m
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 m
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l o
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ra
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at
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sp
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M
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ar
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w
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ra
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m
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C
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m
R
N
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m
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ce
; r
ed
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Fa
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R
N
A
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C
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ex
tra
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pe
rf
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ce
 (o
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so
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l e
ff
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t o
f r
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ve
ra
tro
l; 
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 e
ff
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t o
f r
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ve
ra
tro
l o
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m
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ho
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(A
M
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 p
ro
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M
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re
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ro
l i
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du
ce
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re
du
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 m
R
N
A
 
G
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at
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PART  2
Acute effects of modified oxygen 
conditions during exercise 
Exercise training is effective to improve health span during the aging process. However, many 
older adults cannot be involved in standard exercise training interventions caused by very 
low exercise tolerance [1]. Therefore, this part presents a potential alternative approach to the 
nutritional (antioxidant) interventions that may be applied to improve the effects of exercise in 
deficient elderly populations. Acute modulation of oxygen content in ambient air is a safe and 
well-accepted ergogenic aid during exercise training [2-4]. However, there are still conflicting 
data as to whether manipulation of the oxygen content of the inspired air during exercise 
would be beneficial for exercise tolerance improvement. Several studies in diabetes [5-7] and 
COPD [8, 9] patients have shown added therapeutic value of acute hypoxic and hyperoxic 
exercise, respectively. However, it is still unclear whether exercise tolerance is limited mainly 
by oxygen delivery (cardiovascular dysfunction) and/or consumption (mitochondrial mass 
and function). Additional oxygen availability may acutely improve oxygen delivery for better 
exercise tolerance in ‘oxygen-delivery-limited’ older adults. Therefore, part 2 of this thesis 
discusses a potential role of hyperoxic exercise to detect oxygen delivery limitations and 
determine effective doses of hyperoxic air to improve exercise tolerance and to be applied 
in future tailored training interventions. Additionally, challenging hypoxic conditions were 
applied to assess sensitivity of potentially useful measuring devices to monitor the individual 
response to hypo or hyperoxic exercise conditions.
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The experimental setup for the FiO2 study during the measurement 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend: 
1. One of the gas cylinders with a mixture – oxygen in nitrogen (14%/21%/35% of O2). 
2. A laptop registering a bioimpedance signal through 6 electrodes placed on the upper body 
of a subject (heart rate, cardiac output, stroke volume). 
3. A laptop registering a signal from the near-infrared spectroscopy (NIRS) device placed on 
a dominant (right) thigh. 
4. A computer registering the spiro-ergometry data.  
5. A cycle-ergometer 






	




Mankowski_BW.indd   54 04-08-15   15:43
55


References 
1. Schrager, M.A., J.A. Schrack, E.M. Simonsick, et al., Association between energy 
availability and physical activity in older adults. Am J Phys Med Rehabil, 2014. 
93(10): p. 876-83. 
2. Snider, G.L., Enhancement of exercise performance in COPD patients by hyperoxia: a 
call for research. Chest, 2002. 122(5): p. 1830-6. 
3. Millet, G.P., B. Roels, L. Schmitt, et al., Combining hypoxic methods for peak 
performance. Sports Med, 2010. 40(1): p. 1-25. 
4. de Mol, P., S.T. de Vries, E.J. de Koning, et al., Physical activity at altitude: 
challenges for people with diabetes: a review. Diabetes Care, 2014. 37(8): p. 2404-13. 
5. Mackenzie, R., et al., Acute hypoxia and exercise improve insulin sensitivity (S(I) 
(2*)) in individuals with type 2 diabetes. Diabetes Metab Res Rev, 2011. 27(1): p. 94-
101. 
6. Mackenzie, R., et al., The effect of hypoxia and work intensity on insulin resistance in 
type 2 diabetes. J Clin Endocrinol Metab, 2012. 97(1): p. 155-62. 
7. Mackenzie, R., et al., Intermittent Exercise with and without Hypoxia Improves 
Insulin Sensitivity in Individuals with Type 2 Diabetes. J Clin Endocrinol Metab, 
2012. 
8. Emtner, M., et al., Benefits of supplemental oxygen in exercise training in 
nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care 
Med, 2003. 168(9): p. 1034-42. 
9. Gosselin, N., et al., Effect of acute hyperoxia during exercise on quadriceps electrical 
activity in active COPD patients. Acta Physiol Scand, 2004. 181(3): p. 333-43. 
 


The experimental setup for the FiO2 study during the measurement 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend: 
1. One of the gas cylinders with a mixture – oxygen in nitrogen (14%/21%/35% of O2). 
2. A laptop registering a bioimpedance signal through 6 electrodes placed on the upper body 
of a subject (heart rate, cardiac output, stroke volume). 
3. A laptop registering a signal from the near-infrared spectroscopy (NIRS) device placed on 
a dominant (right) thigh. 
4. A computer registering the spiro-ergometry data.  
5. A cycle-ergometer 
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6. Air from the cylinder flew to a Douglas bag where a subject was breathing the air 
misxture form. 
7. Another laptop to note the baseline data and from during the measurement (blood 
pressure and cycling frequency). 
8. A manual blood pressure measuring device used before, during and after the 
measurement. 
9. Hanger for an air tube leading from the cylinder to a Douglas bag. 
10.  The valve system: a subject could breathe the exact air mixture from the bag and breathe 
out in to the laboratory environment without mixing.   
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Abstract 
Although spiro-ergometry is the established ‘gold standard’ for determination of the second 
ventilatory threshold  (VT2), it is a costly and rather time-consuming method. Previous studies 
suggest that assessing the second anaerobic threshold (AT2) on the basis of heart rate variability 
(HRV) during exercise may be a more cost-effective and non-invasive manner. Appropriate 
validation studies, however, are still lacking. 
Aim: To test the reliability and sensitivity of the second HRV threshold (HRVT2) assessment 
method against VT2 in healthy young adults. 
Methods: Eleven healthy, moderately-trained subjects underwent three incremental exercise 
tests. Ventilation, oxygen uptake ( ), CO2 production ( ) and HRV were measured 
continuously. Exercise testing was performed in three oxygen (FiO2) conditions of inspired air 
(14%, 21% and 35% of oxygen). Participants and assessors were blinded to the FiO2 conditions. 
Two research teams assessed VT2s and HRVT2s independently from each other. Agreement 
between HRV and VT2 was determined by Bland and Altman analysis. Differences between the 
3 conditions were determined by a General Linear Model for repeated measures. 
Results: Mean workloads corresponding to VT2 and HRVT2 in hypoxia were respectively 
19±17 % (p=0.01) and 15±15% (p=0.1) lower in comparison with hyperoxic conditions. Bland 
and Altman analysis showed low estimation bias (2.2%) and acceptably precise 95% limits of 
agreement for workload -15.7% to 20.1%.  
Conclusion:  HRV-based VT2 assessment has clinically acceptable agreement with VT2 and 
showed appropriate sensitivity to the manipulated inspiratory oxygen. In accordance with good 
agreement, HRV-based VT2 assessment has potential applications for exercise monitoring and 
altitude training purposes. 
 
Keywords  
Exercise, Maximal Testing, Cost-Effective, Healthy Subjects, Hypoxia, Hyperoxia 
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Introduction 
The second anaerobic threshold (AT2) is frequently used to design and monitor exercise training 
programs for healthy people, athletes and patients with chronic diseases (9, 17, 26). Specifically, 
properly determined AT2 (~90% HRmax) is crucial for establishing appropriate training 
workloads and intensity needed to effectively improve exercise performance and to prevent 
injuries and overtraining (11). However, the ‘gold standard’ assessments of AT2 can only be 
determined through costly, time-consuming spiro-ergometry testing often in combination with 
invasive methods such as multiple blood samples of lactate concentrations [La] (5, 6).  
Recently, heart-rate variability threshold (HRVT) was introduced as a non-invasive, cost-
effective and more straightforward method than the currently practiced ‘gold standard’ to assess 
AT1 and AT2 in an individual (4). The method has also been proposed to design and monitor 
individualized training programs in athletes and patients undergoing cardiac and pulmonary 
rehabilitation (12). However, appropriate validation and sensitivity analyses to detect changes in 
individual training status are still lacking. 
The HRVT represents a transition point between lower and higher activity of the sympathetic 
nervous system (SNS), which is strongly correlated with an increase in [La], catecholamine 
concentrations and minute ventilation (Ve) that occurs at the AT1(10).  
One of the most commonly used methods for determining HRVT is the root mean square of the 
successive differences (HRVT-RMSSD) (19). Another method is based on the Poincaré plotting 
technique, from which the instantaneous variability of beat-to-beat data is derived by means of 
SD1 (HRVT- SD1) (22) (25). 
In healthy subjects, Sales et al. reported strong correlations between the HRVT1 and the ‘gold 
standard’ AT1 assessments (HRVT-RMSSD r=0.91 and HRVT-SD1 r=0.93) (22). So far, most 
comparative studies have used single measurements to investigate agreement between these two 
AT determination methods (6, 10, 22). These group-based validation studies, however, do not 
provide information on the sensitivity of HRVT method to detect e.g. changes in an individual’s 
AT. Furthermore, there is evidence that determination of AT2 is more reproducible than AT1 in 
trained cyclists (27). Therefore, a comparison of VT2 and HRVT2 was selected for the purpose 
of this validation study. To test the sensitivity of HRVT for detecting an acute change in 
physiological stress, we propose a new validation method based on an acute shift in AT2 by 
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Abstract 
Although spiro-ergometry is the established ‘gold standard’ for determination of the second 
ventilatory threshold  (VT2), it is a costly and rather time-consuming method. Previous studies 
suggest that assessing the second anaerobic threshold (AT2) on the basis of heart rate variability 
(HRV) during exercise may be a more cost-effective and non-invasive manner. Appropriate 
validation studies, however, are still lacking. 
Aim: To test the reliability and sensitivity of the second HRV threshold (HRVT2) assessment 
method against VT2 in healthy young adults. 
Methods: Eleven healthy, moderately-trained subjects underwent three incremental exercise 
tests. Ventilation, oxygen uptake ( ), CO2 production ( ) and HRV were measured 
continuously. Exercise testing was performed in three oxygen (FiO2) conditions of inspired air 
(14%, 21% and 35% of oxygen). Participants and assessors were blinded to the FiO2 conditions. 
Two research teams assessed VT2s and HRVT2s independently from each other. Agreement 
between HRV and VT2 was determined by Bland and Altman analysis. Differences between the 
3 conditions were determined by a General Linear Model for repeated measures. 
Results: Mean workloads corresponding to VT2 and HRVT2 in hypoxia were respectively 
19±17 % (p=0.01) and 15±15% (p=0.1) lower in comparison with hyperoxic conditions. Bland 
and Altman analysis showed low estimation bias (2.2%) and acceptably precise 95% limits of 
agreement for workload -15.7% to 20.1%.  
Conclusion:  HRV-based VT2 assessment has clinically acceptable agreement with VT2 and 
showed appropriate sensitivity to the manipulated inspiratory oxygen. In accordance with good 
agreement, HRV-based VT2 assessment has potential applications for exercise monitoring and 
altitude training purposes. 
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Introduction 
The second anaerobic threshold (AT2) is frequently used to design and monitor exercise training 
programs for healthy people, athletes and patients with chronic diseases (9, 17, 26). Specifically, 
properly determined AT2 (~90% HRmax) is crucial for establishing appropriate training 
workloads and intensity needed to effectively improve exercise performance and to prevent 
injuries and overtraining (11). However, the ‘gold standard’ assessments of AT2 can only be 
determined through costly, time-consuming spiro-ergometry testing often in combination with 
invasive methods such as multiple blood samples of lactate concentrations [La] (5, 6).  
Recently, heart-rate variability threshold (HRVT) was introduced as a non-invasive, cost-
effective and more straightforward method than the currently practiced ‘gold standard’ to assess 
AT1 and AT2 in an individual (4). The method has also been proposed to design and monitor 
individualized training programs in athletes and patients undergoing cardiac and pulmonary 
rehabilitation (12). However, appropriate validation and sensitivity analyses to detect changes in 
individual training status are still lacking. 
The HRVT represents a transition point between lower and higher activity of the sympathetic 
nervous system (SNS), which is strongly correlated with an increase in [La], catecholamine 
concentrations and minute ventilation (Ve) that occurs at the AT1(10).  
One of the most commonly used methods for determining HRVT is the root mean square of the 
successive differences (HRVT-RMSSD) (19). Another method is based on the Poincaré plotting 
technique, from which the instantaneous variability of beat-to-beat data is derived by means of 
SD1 (HRVT- SD1) (22) (25). 
In healthy subjects, Sales et al. reported strong correlations between the HRVT1 and the ‘gold 
standard’ AT1 assessments (HRVT-RMSSD r=0.91 and HRVT-SD1 r=0.93) (22). So far, most 
comparative studies have used single measurements to investigate agreement between these two 
AT determination methods (6, 10, 22). These group-based validation studies, however, do not 
provide information on the sensitivity of HRVT method to detect e.g. changes in an individual’s 
AT. Furthermore, there is evidence that determination of AT2 is more reproducible than AT1 in 
trained cyclists (27). Therefore, a comparison of VT2 and HRVT2 was selected for the purpose 
of this validation study. To test the sensitivity of HRVT for detecting an acute change in 
physiological stress, we propose a new validation method based on an acute shift in AT2 by 
Mankowski_BW.indd   59 04-08-15   15:43
Chapter 2
60
C
hapter 2


manipulating inspiratory oxygen fraction (FiO2). For a given workload SNS activity level will be 
increased during hypoxic exercise (29), and lower under hyperoxic conditions (14). In 
accordance, AT2 should be reached at a lower workload during hypoxic as opposed to a 
normoxic or hyperoxic exercise stress test.  
To our knowledge, this is the first study to validate the sensitivity of HRVT2 assessment relative 
to that of AT2 on the basis of the breath-by-breath gas analysis method during multiple 
incremental exercise tests under decreased and increased FiO2 conditions. 
In accordance, we hypothesized that HRVT2-based workload is strongly associated with the 
spiro-ergometry VT2 based workload during incremental exercise test performed under both low, 
normal and high FiO2 conditions. In addition, we hypothesized that a shift in HRVT2 is 
associated with a shift in VT2. 
 
Methods 
Subjects  
A total of 11 (8 males / 3 females) healthy and medium-trained young adults volunteered to 
participate in this study. The study protocol was approved by the regional Medical Ethics 
Committee of the Erasmus University Medical Centre in Rotterdam, the Netherlands (MEC; 
number: 2012-128; (NTR3777)). All participants provided written informed consent.  
 
Experimental design 
Subjects completed 3 incremental exercise tests until exhaustion on a the same cycle ergometer 
(Jaeger ER800, CareFusion, Houten, The Netherlands) on different days. Each test was 
performed under either hypoxic (14.04%O2), normoxic (21.2%O2) or hyperoxic (35.08%O2) 
conditions. The tests were separated by at least 72 hours and were performed in a randomized 
order at the same time of the day. Randomization occurred by drawing opaque sealed envelopes 
containing the order of the three FiO2 conditions.  Both temperature (21oC) and humidity (35-
45%) in the laboratory were held constant. Subjects were asked to refrain from strenuous exercise 
on the day before the test. Furthermore, they were asked to refrain from caffeinated drinks at least 
12 hours before the exercise test. 
 


Testing procedures 
Incremental exercise test 
All the exercise tests were performed at the Clinical Exercise Performance Laboratory (CEPL) 
from the Erasmus University Medical Center in Rotterdam, the Netherlands in presence of an 
exercise physiologist and a sports physician. All subjects were scheduled to perform a symptom 
limited exercise stress test. This standard ramp test started with a 2 min. rest period followed by 4 
min. of unloaded cycling as warming-up. Next, the workload increased with a slope of 1.8 watt/6 
sec (men) or a 1.2 watt/6 sec. (women). Subjects were instructed to cycle until exhaustion with a 
pedal frequency of 60-80 rpm. The loaded phase was terminated when pedaling frequency 
dropped below 60 rpm. A 5 min. unloaded recovery phase ended the exercise stress test. During 
warming-up, workload and recovery phase of the exercise protocol, ,  2, minute 
ventilation (Ve), (Oxycon Pro, Carefusion, Houten, The Netherlands) were monitored. Peak 
oxygen uptake, workload, heart rate and respiratory exchange ratio (RER) were documented. 
Immediately after each exercise test subjects were asked to rate their perceived exertion on a 
scale from 6 to 20 using the Borg scale (2).  
 
Table 2.1. Subjects’ characteristics. 
N=11 Hypoxia (N=11) 
Mean ±SD 
Normoxia (N=11) 
Mean ±SD 
Hyperoxia (N=9) 
Mean ±SD 
Age (yrs)  23.6±2.2  
Weight (kg)  69.1±9.8  
 Height (cm)  177.9±8.2  
BMI (kg/m2)  22.0±1.7  
VO2peak (ml/kg/min) 46.8±5.3 54.6±7.0 54.2±6.7 
Wmax (Watt) 289±48 324±54 336±55 
Borg score 16.4±0.7 16.3±0.8 16.2±0.8 
 
Heart rate and heart rate variability 
Beat-to beat Heart rate (HR) was measured continuously using an HR monitor (Zephyr 
BioHarnessTM 3, Annapolis, USA). The real-time HR data were recorded on an external server 
2OV
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manipulating inspiratory oxygen fraction (FiO2). For a given workload SNS activity level will be 
increased during hypoxic exercise (29), and lower under hyperoxic conditions (14). In 
accordance, AT2 should be reached at a lower workload during hypoxic as opposed to a 
normoxic or hyperoxic exercise stress test.  
To our knowledge, this is the first study to validate the sensitivity of HRVT2 assessment relative 
to that of AT2 on the basis of the breath-by-breath gas analysis method during multiple 
incremental exercise tests under decreased and increased FiO2 conditions. 
In accordance, we hypothesized that HRVT2-based workload is strongly associated with the 
spiro-ergometry VT2 based workload during incremental exercise test performed under both low, 
normal and high FiO2 conditions. In addition, we hypothesized that a shift in HRVT2 is 
associated with a shift in VT2. 
 
Methods 
Subjects  
A total of 11 (8 males / 3 females) healthy and medium-trained young adults volunteered to 
participate in this study. The study protocol was approved by the regional Medical Ethics 
Committee of the Erasmus University Medical Centre in Rotterdam, the Netherlands (MEC; 
number: 2012-128; (NTR3777)). All participants provided written informed consent.  
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performed under either hypoxic (14.04%O2), normoxic (21.2%O2) or hyperoxic (35.08%O2) 
conditions. The tests were separated by at least 72 hours and were performed in a randomized 
order at the same time of the day. Randomization occurred by drawing opaque sealed envelopes 
containing the order of the three FiO2 conditions.  Both temperature (21oC) and humidity (35-
45%) in the laboratory were held constant. Subjects were asked to refrain from strenuous exercise 
on the day before the test. Furthermore, they were asked to refrain from caffeinated drinks at least 
12 hours before the exercise test. 
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Testing procedures 
Incremental exercise test 
All the exercise tests were performed at the Clinical Exercise Performance Laboratory (CEPL) 
from the Erasmus University Medical Center in Rotterdam, the Netherlands in presence of an 
exercise physiologist and a sports physician. All subjects were scheduled to perform a symptom 
limited exercise stress test. This standard ramp test started with a 2 min. rest period followed by 4 
min. of unloaded cycling as warming-up. Next, the workload increased with a slope of 1.8 watt/6 
sec (men) or a 1.2 watt/6 sec. (women). Subjects were instructed to cycle until exhaustion with a 
pedal frequency of 60-80 rpm. The loaded phase was terminated when pedaling frequency 
dropped below 60 rpm. A 5 min. unloaded recovery phase ended the exercise stress test. During 
warming-up, workload and recovery phase of the exercise protocol, ,  2, minute 
ventilation (Ve), (Oxycon Pro, Carefusion, Houten, The Netherlands) were monitored. Peak 
oxygen uptake, workload, heart rate and respiratory exchange ratio (RER) were documented. 
Immediately after each exercise test subjects were asked to rate their perceived exertion on a 
scale from 6 to 20 using the Borg scale (2).  
 
Table 2.1. Subjects’ characteristics. 
N=11 Hypoxia (N=11) 
Mean ±SD 
Normoxia (N=11) 
Mean ±SD 
Hyperoxia (N=9) 
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BMI (kg/m2)  22.0±1.7  
VO2peak (ml/kg/min) 46.8±5.3 54.6±7.0 54.2±6.7 
Wmax (Watt) 289±48 324±54 336±55 
Borg score 16.4±0.7 16.3±0.8 16.2±0.8 
 
Heart rate and heart rate variability 
Beat-to beat Heart rate (HR) was measured continuously using an HR monitor (Zephyr 
BioHarnessTM 3, Annapolis, USA). The real-time HR data were recorded on an external server 
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(through a laptop and Bluetooth2.0 connection) with dedicated software (AppSolute Training, 
ADTS, 1.2 beta version, Vital BV, Hazerswoude-Rijndijk, the Netherlands).  Heart rate 
variability (HRV) was quantified every 30 seconds by first calculating the root mean square of 
successive differences of R-R intervals (RMSSD), then dividing this by the average R-R interval 
over the corresponding 30 second period, to calculate normalized RMSSD (nRMSSD). 
 
Medical gasses 
According to legal requirements in the Netherlands, each test was performed using medically 
certified oxygen/nitrogen mixtures stored in 50 L 200 bar gas cylinders (Linde Gas Benelux/BOC 
Morden, London, UK). The 3 different air mixtures were blinded to the subject and inspired 
through a Douglas bag (20 liter) connected to an oro-nasal 7400 VmaskTM and a 2730 2-way Y-
shapeTM non-rebreathing valve (Hans Rudolph, inc. Kansas, USA). 
 
Data analysis 
Determination of the 2nd VT 
Obtained values of , 2, RER and (Ve) were averaged for each 30 seconds time window. 
VT2 was determined independently by 2 sports physicians, both having more than 5 years of 
experience with clinical assessment of CPET. All tests results were encoded and both assessors 
were completely blinded to the 3 different FiO2 test conditions. For the present study, VT2 was 
defined by the second nonlinear increase of the /2 curve (21). When VT2s differed 
between the 2 assessors, consensus on VT2 was obtained by reviewing each other’s assessment. 
Ventilatory threshold was expressed as workload (Watt) level corresponding with VT2. 
 
Determination of 2nd heart rate variability threshold 
HRVT2 was determined by 2 independent researchers also blinded to the different FiO2 test 
conditions. The values of nRMSSD were displayed every 30 seconds. HRVT2 was determined 
by visual inspection. It was defined as the breakpoint representing the start of a substantial 
increase in nRMSSD, after having reached a minimum value (Figure 2.2). The threshold was 
expressed as workload (Watt) corresponding with the HRVT2. Inflection points (HRVT2) that 
could not be determined visually be the independent assessors were excluded from the analysis. 
2OV
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Statistical analysis 
The subjects were characterized by descriptive analysis of the data (mean±SD). Bland and 
Altman plot analysis was used for comparing workload values obtained from the 2 AT 
assessment methods (agreement between VT2 and HRVT2). The obtained AT2s under the 3 FiO2 
conditions were compared using a General Linear Model with repeated measures. For all 
statistical tests, P values less than 0.05 were considered as significant. Bonferroni adjustment was 
applied accordingly (IBM SPSS Statistics version 20).  
 
Results 
Table 2.1 presents subjects’ characteristics. Participants were moderately trained ( peak 
54.6±7.0 ml/min/kg). A total of two HRVT2 inflection points during hyperoxic exercise could 
not be determined and were excluded from our analysis.  Mean workloads corresponding to VT2 
and HRVT2 (Table 2.2) in hypoxia were respectively 19±17 % (p=0.01) and 15±15% (p=0.1) 
lower in comparison with hyperoxic conditions. The mean (± SD) workload of the VT2 methods 
was 242.4 ± 42.8W, compared with 246.7 ± 49W for the HRVT2 method. Figure 2.1 shows the 
Bland and Altman plots with the bias and 95% limits of agreement (LoA). The LoA for workload 
(W) were -15.7% to 20.1%. Although HRVT2 gives an acceptably precise agreement of 2.2 % 
with VT2, the positive bias (systematic error) occurred in 17 out of 31 cases. 
 
Table 2.2. Comparison of the mean AT2s between three different oxygen conditions.  
Conditions Mean ±SD (Watt) p-value 
VT2 Normoxia vs VT2 Hypoxia 251±45 vs. 218.6±39.0 0.3 
VT2 Normoxia vs VT2 Hyperoxia 251±45 vs. 258±37 1.0 
VT2 Hypoxia vs VT2 Hyperoxia 219±39 vs. 258±37 0.01 
HRVT2 Normoxia vs HRVT2 Hypoxia 244±44 vs. 223±49 1.0 
HRVT2 Normoxia vs HRVT2 Hyperoxia 244±44 vs. 263±48 1.0 
HRVT2 Hypoxia vs HRVT2 Hyperoxia 223±49 vs. 263±48 0.1 
 
 
 
2OV
Mankowski_BW.indd   62 04-08-15   15:43
Heart-rate variability threshold as an alternative method for spiro-ergometry testing: a validation study
63
C
ha
pt
er
 2


(through a laptop and Bluetooth2.0 connection) with dedicated software (AppSolute Training, 
ADTS, 1.2 beta version, Vital BV, Hazerswoude-Rijndijk, the Netherlands).  Heart rate 
variability (HRV) was quantified every 30 seconds by first calculating the root mean square of 
successive differences of R-R intervals (RMSSD), then dividing this by the average R-R interval 
over the corresponding 30 second period, to calculate normalized RMSSD (nRMSSD). 
 
Medical gasses 
According to legal requirements in the Netherlands, each test was performed using medically 
certified oxygen/nitrogen mixtures stored in 50 L 200 bar gas cylinders (Linde Gas Benelux/BOC 
Morden, London, UK). The 3 different air mixtures were blinded to the subject and inspired 
through a Douglas bag (20 liter) connected to an oro-nasal 7400 VmaskTM and a 2730 2-way Y-
shapeTM non-rebreathing valve (Hans Rudolph, inc. Kansas, USA). 
 
Data analysis 
Determination of the 2nd VT 
Obtained values of , 2, RER and (Ve) were averaged for each 30 seconds time window. 
VT2 was determined independently by 2 sports physicians, both having more than 5 years of 
experience with clinical assessment of CPET. All tests results were encoded and both assessors 
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defined by the second nonlinear increase of the /2 curve (21). When VT2s differed 
between the 2 assessors, consensus on VT2 was obtained by reviewing each other’s assessment. 
Ventilatory threshold was expressed as workload (Watt) level corresponding with VT2. 
 
Determination of 2nd heart rate variability threshold 
HRVT2 was determined by 2 independent researchers also blinded to the different FiO2 test 
conditions. The values of nRMSSD were displayed every 30 seconds. HRVT2 was determined 
by visual inspection. It was defined as the breakpoint representing the start of a substantial 
increase in nRMSSD, after having reached a minimum value (Figure 2.2). The threshold was 
expressed as workload (Watt) corresponding with the HRVT2. Inflection points (HRVT2) that 
could not be determined visually be the independent assessors were excluded from the analysis. 
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The subjects were characterized by descriptive analysis of the data (mean±SD). Bland and 
Altman plot analysis was used for comparing workload values obtained from the 2 AT 
assessment methods (agreement between VT2 and HRVT2). The obtained AT2s under the 3 FiO2 
conditions were compared using a General Linear Model with repeated measures. For all 
statistical tests, P values less than 0.05 were considered as significant. Bonferroni adjustment was 
applied accordingly (IBM SPSS Statistics version 20).  
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Table 2.2. Comparison of the mean AT2s between three different oxygen conditions.  
Conditions Mean ±SD (Watt) p-value 
VT2 Normoxia vs VT2 Hypoxia 251±45 vs. 218.6±39.0 0.3 
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Discussion 
To the best of our knowledge, this is the first study that investigated the level of agreement 
between 2 independent methods for assessing AT2 based on spiro-ergometry (VT2) and HRV 
(HRVT2) under different FiO2 conditions. The main finding is that the agreement between VT2 
and HRVT2 was acceptably precise. Additionally, the VT method showed significant sensitivity 
for detecting a shift in AT2 when comparing hypoxic with hyperoxic exercise conditions. 
Although statistically not significant, a similar shift was also present in our HRVT method. The 
latter finding indicates that an acutely and externally induced shift in physiological stress results 
in a simultaneous shift of ventilatory threshold as well as HRVT2. Therefore, the outcome of the 
present study supports our hypothesis that the proposed HRVT2 method can serve as an 
appropriate alternative for detecting VT2 without having to use costly spiro-ergometry 
equipment. 
 
Comparison with other studies on agreement between VT2 and HRVT2 
Our Bland and Altman concordance analysis shows an acceptably precise agreement between the 
VT 2 and HRVT 2 assessment methods. These results are in line with other studies (4, 5, 20). For 
example, Quinart et al. also reported a good agreement between VT2 and HRVT2 (VT2 
expressed in Watts). They investigated 20 obese adolescents (14 girls and 6 boys) who underwent 
two mixed protocols (combining exercise stages of 3 min duration at the start of the test, and then 
1 min duration) before and after a 9-month exercise intervention program (20). Despite the fact 
that their Bland and Altman analysis demonstrated a low estimation bias and overall good 
agreement between the two measures (20),  their mixed protocol was regarded a study limitation 
potentially impairing their VT2 accuracy (20). In accordance with their recommendations, we 
performed linear incremental exercise tests till exhaustion, allowing for optimal detection of VT2 
through spiro-ergometry. Although our Bland and Altman analysis shows sufficient agreement 
between VT2 and HRVT2, future studies using different exercise loading protocols are probably 
warranted to establish the best protocol for assessing HRVT2. 
In the current study, VT2 based on the spiro-ergometry data was used as a ‘gold standard’ and 
compared to the HRVT2 results. The bias (2.2%), mean absolute difference (7.2%) and limits of 
agreement (-15.7% to 20.1%) do not confirm a perfect agreement between those 2 methods in 


comparison to other authors (4, 20). However, it has been shown previously that an inter-
observer error in VT assessments on the basis of ventilatory equivalents for oxygen was ~15% 
(7). In contrast, Sinclair et al. and others have shown that the inter-observer error between 
assessed VT based on the V-slope method data ranged between 5.6 - 8.1%, which was considered 
clinically acceptable (24). In the present study, 22 cases out of 31 (71%) showed a difference 
≤8.1%. Therefore, the level of error in other spiro-ergometry VT assessments suggests that 
acceptably precise HRVT2 results may support relevance of the HRVT concept to replace costly 
VT measurements in a clinical setting. 
 
Figure 2.1 Bland-Altman scatter plot. 
 
Empty circles – hypoxia; half-filled circles – normoxia; filled circles – hyperoxia; LoA – limit of 
agreement. 
 
Sensitivity of VT and HRVT 
As far as we know, only 1 study previously investigated the sensitivity of the HRVT method to 
detect training adaptations (13). Exercise training modifies anthropometric features, improves 
cardio-respiratory variables and lowers activity of the sympathetic nervous system (SNS) during 
sub-maximal exercise (22). In accordance, Quinart et al. were able to observe improvement in 
training status. In particular, they observed similarly increased workload corresponding to VT2 
(~17.5%) and HRVT2 (~15%). The present study extends on their results by showing a rather 
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Discussion 
To the best of our knowledge, this is the first study that investigated the level of agreement 
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and HRVT2 was acceptably precise. Additionally, the VT method showed significant sensitivity 
for detecting a shift in AT2 when comparing hypoxic with hyperoxic exercise conditions. 
Although statistically not significant, a similar shift was also present in our HRVT method. The 
latter finding indicates that an acutely and externally induced shift in physiological stress results 
in a simultaneous shift of ventilatory threshold as well as HRVT2. Therefore, the outcome of the 
present study supports our hypothesis that the proposed HRVT2 method can serve as an 
appropriate alternative for detecting VT2 without having to use costly spiro-ergometry 
equipment. 
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1 min duration) before and after a 9-month exercise intervention program (20). Despite the fact 
that their Bland and Altman analysis demonstrated a low estimation bias and overall good 
agreement between the two measures (20),  their mixed protocol was regarded a study limitation 
potentially impairing their VT2 accuracy (20). In accordance with their recommendations, we 
performed linear incremental exercise tests till exhaustion, allowing for optimal detection of VT2 
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between VT2 and HRVT2, future studies using different exercise loading protocols are probably 
warranted to establish the best protocol for assessing HRVT2. 
In the current study, VT2 based on the spiro-ergometry data was used as a ‘gold standard’ and 
compared to the HRVT2 results. The bias (2.2%), mean absolute difference (7.2%) and limits of 
agreement (-15.7% to 20.1%) do not confirm a perfect agreement between those 2 methods in 
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similar difference in workload capacity for VT2 when manipulating FiO2 conditions. Higher FiO2 
(hyperoxia) decreases and lower FiO2 (hypoxia) increases the activity of SNS during exercise 
(14, 29). In comparison with a medium or long-term training intervention study, our approach 
was intended as a more direct method to test the sensitivity of the HRVT assessment method in 
response to a change of physiological stress. Although our shift in VT2 under hypoxic and 
hyperoxic conditions is well in line with previous reports (23)., the HRVT2 method appears less 
sensitive as the shift in HRVT2 did not reach statistical significance. The latter may also be 
explained by a type II error as we had to exclude two HRVT measurements under hyperoxic 
conditions due to difficulties to determine a clear inflection point. The lack of statistical 
difference between normoxia and hypoxia may also be caused by limited statistical power in our 
study. Another explanation, in line with the high standard deviations of our measurements, is the 
recently described variation in the individual response to hypoxia/hyperoxia. The latter may have 
further reduced the contrast and explain why our study protocol was unable to detect a significant 
change in VT2 or HRVT2 (Figure 2.2 A, B and C) when comparing normoxia with hypoxia and 
hyperoxia (8, 15, 18).  
 
Choice and accuracy and methodological aspects of the HRVT assessment methods  
In the present study, an upward inflection in the time-domain HRV measure nRMSSD (RMSSD: 
RRI ratio) was used to determine HRVT2 as opposed to frequency domain measures (3, 4). By 
comparison, frequency domain measures should not be applied to a time window of less than 10 
times the lower bound of the frequency band (i.e. 67 seconds for a high-frequency lower bound 
of 0.15 Hz) (1).  
Therefore, the present study employed the time-domain measure nRMSSD (RMSSD: RRI ratio), 
utilizing 30s windows, which was perhaps the simplest to perform (1). 
HRV measurements are sensitive to the autonomic nervous system disturbances in pathologies 
(e.g. Parkinson’s disease, diabetes-related autonomic neuropathy (28) and to exercise 
performance improvement. Especially, during exercise the HRV signal can also be influenced by 
non-neural factors (16). In particular, the non-neural influences of respiration on the sino-atrial 
node, particularly during exercise at and above VT2, likely contribute to the upward inflection of  
 


Figure 2.2 Example of assessed AT2 based on minute ventilation and nRMSSD data sets 
under hypoxic (A), normoxic (B) and hyperoxic (C) conditions. 
  
Mankowski_BW.indd   66 04-08-15   15:43
Heart-rate variability threshold as an alternative method for spiro-ergometry testing: a validation study
67
C
ha
pt
er
 2


similar difference in workload capacity for VT2 when manipulating FiO2 conditions. Higher FiO2 
(hyperoxia) decreases and lower FiO2 (hypoxia) increases the activity of SNS during exercise 
(14, 29). In comparison with a medium or long-term training intervention study, our approach 
was intended as a more direct method to test the sensitivity of the HRVT assessment method in 
response to a change of physiological stress. Although our shift in VT2 under hypoxic and 
hyperoxic conditions is well in line with previous reports (23)., the HRVT2 method appears less 
sensitive as the shift in HRVT2 did not reach statistical significance. The latter may also be 
explained by a type II error as we had to exclude two HRVT measurements under hyperoxic 
conditions due to difficulties to determine a clear inflection point. The lack of statistical 
difference between normoxia and hypoxia may also be caused by limited statistical power in our 
study. Another explanation, in line with the high standard deviations of our measurements, is the 
recently described variation in the individual response to hypoxia/hyperoxia. The latter may have 
further reduced the contrast and explain why our study protocol was unable to detect a significant 
change in VT2 or HRVT2 (Figure 2.2 A, B and C) when comparing normoxia with hypoxia and 
hyperoxia (8, 15, 18).  
 
Choice and accuracy and methodological aspects of the HRVT assessment methods  
In the present study, an upward inflection in the time-domain HRV measure nRMSSD (RMSSD: 
RRI ratio) was used to determine HRVT2 as opposed to frequency domain measures (3, 4). By 
comparison, frequency domain measures should not be applied to a time window of less than 10 
times the lower bound of the frequency band (i.e. 67 seconds for a high-frequency lower bound 
of 0.15 Hz) (1).  
Therefore, the present study employed the time-domain measure nRMSSD (RMSSD: RRI ratio), 
utilizing 30s windows, which was perhaps the simplest to perform (1). 
HRV measurements are sensitive to the autonomic nervous system disturbances in pathologies 
(e.g. Parkinson’s disease, diabetes-related autonomic neuropathy (28) and to exercise 
performance improvement. Especially, during exercise the HRV signal can also be influenced by 
non-neural factors (16). In particular, the non-neural influences of respiration on the sino-atrial 
node, particularly during exercise at and above VT2, likely contribute to the upward inflection of  
 


Figure 2.2 Example of assessed AT2 based on minute ventilation and nRMSSD data sets 
under hypoxic (A), normoxic (B) and hyperoxic (C) conditions. 
  
Mankowski_BW.indd   67 04-08-15   15:43
Chapter 2
68
C
hapter 2


nRMSSD (1). This makes the time-domain method practically useful as a proxy measure for VT2 
detection. 
 
Study limitations 
The current study has some limitations. In particular, regarding the identification of HRVT2, a 
clear upward inflection point could not always be identified. Therefore, 2 measurements were 
excluded, as both of the 2 independent assessors could not detect an inflection point 
corresponding to HRVT2.  
The currently used, and as far we know, best available VT and HRV methods both require a 
visual assessment of inflection points in both ventilation and HRV data. As there is no gold 
standard for determining VT, either of the methods may have introduced some level of bias or 
error. Although computationally simple and achieving a high temporal resolution, time-domain 
HRV measures such as nRMSSD have not previously been validated for determining VT2. 
Previously, frequency-domain measures such as the product of HF power and HF frequency (3, 
4) have been employed. Future research could be directed towards refining the application of 
time-domain or alternative HRV analysis to estimate ventilation thresholds. 
 
Conclusion 
In the present study it was shown that there is acceptably precise agreement between the VT2 and 
HRVT2 assessment methods to detect a shift in ventilatory threshold under different FiO2 
conditions. This opens up new avenues for a cost-efficient and non-invasive HRVT method that 
could be easily applied to determine, monitor and individualize the appropriate workload 
intensity in different types of aerobic exercise training modalities and potentially also for altitude 
training purposes.  
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Abstract 
It is still equivocal whether oxygen uptake recovery kinetics are limited by oxygen delivery and 
can be improved by increased availability of oxygen. Given its potential application for 
optimising an exercise-based rehabilitation program, the present study aimed to investigate 
whether combined non-invasive measurements of muscle and pulmonary oxygen uptake kinetics 
can be used to assess oxygen delivery limitations in healthy subjects.  
Methods: Sixteen healthy young adults performed three sub-maximal exercise tests (6 min at 
40% Wmax) under hypoxic (14%O2), normoxic (21%O2) and hyperoxic (35%O2) conditions on 
separate days in randomized order. Both Pulmonary  and near infra red spectroscopy (NIRS) 
based Tissue Saturation Index (TSI) offset kinetics were calculated using mono-exponential 
curve fitting models.   
Results: Time constant τ of  offset kinetics under hypoxic (44.9±7.3s) conditions were 
significantly larger than τ of the offset kinetics under normoxia (37.9±8.2s) and hyperoxia 
(37.0±6.0). TSI mean response time (MRT) of the offset kinetics under hypoxic conditions 
(25.5±13.0s) was significantly slower than under normoxic (15.0±7.7) and hyperoxic (13.0±7.3) 
conditions. Overall, in our healthy subjects, τ values of  were significantly larger than MRT 
TSI (p=0.0001) under all three oxygen conditions. Hyperoxia had no effect on baseline, steady-
state and amplitude of , TSI or total blood volume (tHb) values in comparison with 
normoxic conditions.  NIRS and spirometry-based recovery kinetics were both sensitive to detect 
oxygen delivery limitations during hypoxic exercise conditions. 
Conclusion: Since oxygen uptake kinetics of healthy subjects do not benefit from supplementary 
oxygen, our results indicate that performing acute submaximal exercise bouts under normoxic 
and hyperoxic conditions may assist in detecting oxygen delivery limitations in skeletal muscle 
of e.g. cardiovascular or pulmonary compromised patients with exercise intolerance. The latter 
information can potentially be used to discriminate on forehand between responders and non-
responders before prescribing hyperoxic exercise training.  
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Introduction 
The rate of change of pulmonary oxygen uptake ( ) following an acute bout of submaximal 
exercise, also defined as  offset kinetics, reflect the ability of an individual to recover from 
exercise [1, 2]. Changes in cardiac output as well as the balance between oxygen delivery and 
utilization in activated muscle tissue are the main contributing factors influencing oxygen uptake 
kinetics. In accordance, slower recovery kinetics in patients with an impaired cardiovascular 
function appear to represent an oxygen delivery limitation [3], either due to impaired blood flow 
and/or endothelial dysfunction in skeletal muscle [3, 4]. Despite the fact that over the past 
decennium the application of oxygen uptake kinetics has gained more interest from the field of 
clinical exercise physiology [2],  off-set kinetics alone still provide insufficient information 
regarding the limiting factor determining exercise tolerance or intolerance. From the theoretical 
point of view that physiology is aimed at balancing oxygen delivery and consumption in skeletal 
muscle, it has been suggested that when lowering the inspiratory oxygen fraction (FiO2) during 
submaximal exercise, oxygen delivery is the rate-limiting step in recovering from a submaximal 
exercise bout [5]. In comparison with assessing  kinetics at the onset of exercise, the offset 
oxygen kinetics appear a more sensitive measureto detect oxygen delivery limitations under 
hypoxic conditions [6]. However, the few available studies have been inconclusive. Some 
research suggests that exercise tolerance and  onset kinetics can be improved by increased 
oxygen availability through a higher inspiratory fraction of oxygen (FiO2 =30%) [7], whilst 
others did not show any improvement [8, 9]. Despite these equivocal findings, these studies 
suggest that manipulating FiO2 might be a useful strategy to determine whether oxygen delivery 
is a performance-limiting factor. 
In summary, the offset kinetics following a submaximal bout of exercise under both hypoxic, 
normoxic and hyperoxic conditions has the potential to serve as a diagnostic tool to assess 
skeletal muscle oxygen delivery dysfunction in an individual. Simultaneous measurements of 
muscle tissue oxygenation (SmO2) derived from spatially resolved near infrared spectroscopy 
(NIRS) can be used as a measure of fractional oxygen extraction. In this way, the relationship 
between oxygen delivery and consumption can be determined at the skeletal muscle level, 
exposing the peripheral contributors to slowing or speeding of pulmonary oxygen kinetics. 
Speeding of muscle oxygenation kinetics in the presence of, for instance, hyperoxia will indicate 
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Abstract 
It is still equivocal whether oxygen uptake recovery kinetics are limited by oxygen delivery and 
can be improved by increased availability of oxygen. Given its potential application for 
optimising an exercise-based rehabilitation program, the present study aimed to investigate 
whether combined non-invasive measurements of muscle and pulmonary oxygen uptake kinetics 
can be used to assess oxygen delivery limitations in healthy subjects.  
Methods: Sixteen healthy young adults performed three sub-maximal exercise tests (6 min at 
40% Wmax) under hypoxic (14%O2), normoxic (21%O2) and hyperoxic (35%O2) conditions on 
separate days in randomized order. Both Pulmonary  and near infra red spectroscopy (NIRS) 
based Tissue Saturation Index (TSI) offset kinetics were calculated using mono-exponential 
curve fitting models.   
Results: Time constant τ of  offset kinetics under hypoxic (44.9±7.3s) conditions were 
significantly larger than τ of the offset kinetics under normoxia (37.9±8.2s) and hyperoxia 
(37.0±6.0). TSI mean response time (MRT) of the offset kinetics under hypoxic conditions 
(25.5±13.0s) was significantly slower than under normoxic (15.0±7.7) and hyperoxic (13.0±7.3) 
conditions. Overall, in our healthy subjects, τ values of  were significantly larger than MRT 
TSI (p=0.0001) under all three oxygen conditions. Hyperoxia had no effect on baseline, steady-
state and amplitude of , TSI or total blood volume (tHb) values in comparison with 
normoxic conditions.  NIRS and spirometry-based recovery kinetics were both sensitive to detect 
oxygen delivery limitations during hypoxic exercise conditions. 
Conclusion: Since oxygen uptake kinetics of healthy subjects do not benefit from supplementary 
oxygen, our results indicate that performing acute submaximal exercise bouts under normoxic 
and hyperoxic conditions may assist in detecting oxygen delivery limitations in skeletal muscle 
of e.g. cardiovascular or pulmonary compromised patients with exercise intolerance. The latter 
information can potentially be used to discriminate on forehand between responders and non-
responders before prescribing hyperoxic exercise training.  
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Introduction 
The rate of change of pulmonary oxygen uptake ( ) following an acute bout of submaximal 
exercise, also defined as  offset kinetics, reflect the ability of an individual to recover from 
exercise [1, 2]. Changes in cardiac output as well as the balance between oxygen delivery and 
utilization in activated muscle tissue are the main contributing factors influencing oxygen uptake 
kinetics. In accordance, slower recovery kinetics in patients with an impaired cardiovascular 
function appear to represent an oxygen delivery limitation [3], either due to impaired blood flow 
and/or endothelial dysfunction in skeletal muscle [3, 4]. Despite the fact that over the past 
decennium the application of oxygen uptake kinetics has gained more interest from the field of 
clinical exercise physiology [2],  off-set kinetics alone still provide insufficient information 
regarding the limiting factor determining exercise tolerance or intolerance. From the theoretical 
point of view that physiology is aimed at balancing oxygen delivery and consumption in skeletal 
muscle, it has been suggested that when lowering the inspiratory oxygen fraction (FiO2) during 
submaximal exercise, oxygen delivery is the rate-limiting step in recovering from a submaximal 
exercise bout [5]. In comparison with assessing  kinetics at the onset of exercise, the offset 
oxygen kinetics appear a more sensitive measureto detect oxygen delivery limitations under 
hypoxic conditions [6]. However, the few available studies have been inconclusive. Some 
research suggests that exercise tolerance and  onset kinetics can be improved by increased 
oxygen availability through a higher inspiratory fraction of oxygen (FiO2 =30%) [7], whilst 
others did not show any improvement [8, 9]. Despite these equivocal findings, these studies 
suggest that manipulating FiO2 might be a useful strategy to determine whether oxygen delivery 
is a performance-limiting factor. 
In summary, the offset kinetics following a submaximal bout of exercise under both hypoxic, 
normoxic and hyperoxic conditions has the potential to serve as a diagnostic tool to assess 
skeletal muscle oxygen delivery dysfunction in an individual. Simultaneous measurements of 
muscle tissue oxygenation (SmO2) derived from spatially resolved near infrared spectroscopy 
(NIRS) can be used as a measure of fractional oxygen extraction. In this way, the relationship 
between oxygen delivery and consumption can be determined at the skeletal muscle level, 
exposing the peripheral contributors to slowing or speeding of pulmonary oxygen kinetics. 
Speeding of muscle oxygenation kinetics in the presence of, for instance, hyperoxia will indicate 
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improved O2 delivery relative to utilization, whilst the opposite can be achieved by lowering O2 
delivery under hypoxic conditions. Given its potential application for designing an exercise-based 
rehabilitation program, the present study aimed to investigate whether combined non-invasive 
measurements of muscle and pulmonary oxygen uptake kinetics can be used to assess oxygen 
delivery limitations in healthy subjects. Based on the available research, we hypothesized a priori 
that in moderately trained subjects hyperoxia would improve oxygen uptake recovery kinetics, 
while hypoxia would do the opposite. 
 
Methods 
Subjects  
Sixteen healthy, young adults (BMI: 22.0 ± 1.5kg/m2, (22±2 yrs) were recruited through social 
media at Erasmus University Medical Centre in Rotterdam, the Netherlands and agreed to 
participate in the study (Table 1). The study protocol, which was a sub study of a larger clinical 
trial on optimization of exercise therapy in type 2 diabetes patients, was approved by the regional 
Medical Ethics Committee of the Erasmus University Medical Centre in Rotterdam, the 
Netherlands (MEC; number: 2012-128; and registered at the Dutch Trial Registry number: 
NTR3777.  
 
Experimental protocol 
Subjects visited the Clinical Exercise Performance Laboratory (CEPL) four times. An interview, 
physical examination and all exercise tests (1 maximal + 3 submaximal tests) were at the 
Erasmus University Medical Center in Rotterdam, the Netherlands within a time frame of 4 
weeks. During the first appointment a sports physician performed an interview and physical 
examination. To assess maximal workload (Wmax) and maximal oxygen uptake ( peak) 
subjects were asked to perform a standard incremental exercise test on a cycle ergometer 
(protocols: ramp 120 (2 Watt/10 seconds) for women and a ramp 180 (3 Watt/second) for men). 
Perceived exertion level after the incremental exercise test was rated using a Borg Scale [10].  
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Blinding procedure 
During the next three visits (with 7 days washout periods) participants underwent a sub-maximal 
exercise test under various inspiratory fractions of oxygen (FiO2) 14%, 21% and 35% O2 (BOC 
Morden, London, UK). The subjects were blinded to the randomized order of FiO2 during the 
submaximal tests by drawing an opaque sealed envelope. The sub-maximal exercise test protocol 
was as follows: 10 minutes of rest, 3 minutes of unloaded cycling, 6 minutes of cycling at 40% of 
their Wmax and 5 minutes of recovery. Subjects were instructed to maintain cadence between 60 
and 80 revolutions per minute (rpm).  
 
Table 3.1. Subjects’ characteristics 
n = 16 (10 male and 6 female) Mean ± SD 
Age (years) 22.3 ± 2.4 
Weight (kg) 77.4 ± 11.9 
Height (cm) 183 ± 9 
BMI (kg/m²) 23.0 ± 2.3 
peak (ml/min/kg) 45.6 ± 8.8 
Wmax (Watt) 315.2 ± 63.0 
ATT (mm) 6.1 ± 3 
BMI - Body Mass Index; peak maximum oxygen uptake; ATT adipose tissue 
thickness;  
 
Medical gasses 
Each test was performed under either mixture of 14%, 21% and 35% of oxygen in nitrogen - 50 
liter cylinders (BOC Morden, London, UK). The control oxygen conditions (21% of oxygen in 
nitrogen) were ordered and prepared in the EMC and delivered to the CEPL by the internal 
medical gasses distributor (Linde Gas, The Netherlands). The air was inspired from a cylinder 
through a Douglas bag (20 liter) connected to an oro-nasal 7400 VmaskTM and a 2730 2-way Y-
shapeTM non-rebreathing  two-way valve (Hans Rudolph, inc. Kansas, USA). 
 
 
 
2OV
2OV
Mankowski_BW.indd   76 04-08-15   15:43
Oxygen delivery is not a limiting factor during post-exercise recovery in healthy young adults
77
C
ha
pt
er
 3

improved O2 delivery relative to utilization, whilst the opposite can be achieved by lowering O2 
delivery under hypoxic conditions. Given its potential application for designing an exercise-based 
rehabilitation program, the present study aimed to investigate whether combined non-invasive 
measurements of muscle and pulmonary oxygen uptake kinetics can be used to assess oxygen 
delivery limitations in healthy subjects. Based on the available research, we hypothesized a priori 
that in moderately trained subjects hyperoxia would improve oxygen uptake recovery kinetics, 
while hypoxia would do the opposite. 
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examination. To assess maximal workload (Wmax) and maximal oxygen uptake ( peak) 
subjects were asked to perform a standard incremental exercise test on a cycle ergometer 
(protocols: ramp 120 (2 Watt/10 seconds) for women and a ramp 180 (3 Watt/second) for men). 
Perceived exertion level after the incremental exercise test was rated using a Borg Scale [10].  
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Morden, London, UK). The subjects were blinded to the randomized order of FiO2 during the 
submaximal tests by drawing an opaque sealed envelope. The sub-maximal exercise test protocol 
was as follows: 10 minutes of rest, 3 minutes of unloaded cycling, 6 minutes of cycling at 40% of 
their Wmax and 5 minutes of recovery. Subjects were instructed to maintain cadence between 60 
and 80 revolutions per minute (rpm).  
 
Table 3.1. Subjects’ characteristics 
n = 16 (10 male and 6 female) Mean ± SD 
Age (years) 22.3 ± 2.4 
Weight (kg) 77.4 ± 11.9 
Height (cm) 183 ± 9 
BMI (kg/m²) 23.0 ± 2.3 
peak (ml/min/kg) 45.6 ± 8.8 
Wmax (Watt) 315.2 ± 63.0 
ATT (mm) 6.1 ± 3 
BMI - Body Mass Index; peak maximum oxygen uptake; ATT adipose tissue 
thickness;  
 
Medical gasses 
Each test was performed under either mixture of 14%, 21% and 35% of oxygen in nitrogen - 50 
liter cylinders (BOC Morden, London, UK). The control oxygen conditions (21% of oxygen in 
nitrogen) were ordered and prepared in the EMC and delivered to the CEPL by the internal 
medical gasses distributor (Linde Gas, The Netherlands). The air was inspired from a cylinder 
through a Douglas bag (20 liter) connected to an oro-nasal 7400 VmaskTM and a 2730 2-way Y-
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Respiratory gas measurements 
The analysis of oxygen uptake ( ) and production of carbon dioxide (2) levels were 
continuously measured through a metabolic cart (Oxycon Pro, Jaeger, Mannheim, Germany).  
 
NIRS measurements 
The methodology of the NIRS measurement procedures as well as data collection of an absolute 
measure of tissue oxygen saturation (tissue saturation index (TSI), have been described elsewhere 
[11]. Given the thickness of the subcutaneous adipose tissue may confound the NIRS signal 
amplitude, the skinfold thickness was measured and reported. In particular, a skinfold measured 
with a calliper was divided by 2 to give adipose tissue thickness (ATT) [11].  
 
Absolute values 
The methodology of calculating all and TSI absolute values (amplitude, baseline and 
steady-state) were described in detail in a reproducibility study of Niemeijer et al. [11]. 
 
Pulmonary VO2 kinetics 
Fitting of mono-exponential curves of onset and offset oxygen uptake kinetics was performed in 
Python 2.7 (Python Software Foundation), in order to calculate the time constant and increase in 
oxygen uptake. Two formulas were used for offset kinetics, as described before [12].  
 
 (t) =  steady state – B * (1 – e – (t – Td) / τ)  
 
B = -amplitude during exercise (ml/min), Td = time delay (s) and τ = time constant tau (s).  
 
NIRS kinetics analysis 
Time constants (τ) of recovery were calculated by fitting the TSI data to a first-order 
(mono-exponential) model using the non-linear least squares method (Python 2.7, Python 
Software Foundation). Additionally, the mean response time (MRT) was calculated as the sum of 
tau and time delay (MRT = τ + Td). Considering better reproducibility, we used MRT TSI for the 
kinetics comparisons with tau . The coefficient of determination (r²) was applied to 
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determine how well the fitted mono-exponential curve approximated the real data points. 
Additionally, r² ranges from 0 to 1 with 1 as an indicator for a line that perfectly fits the real data. 
The methodological details of the recovery TSI kinetics are available elsewhere [11].  
 
Statistical analysis 
Subject’ characteristics were expressed as mean±SD. The obtained results under the three oxygen 
conditions were compared using a General Linear Model with repeated measures (IBM SPSS 
Statistics version 20). Level of significance was set at p < 0.05.  The Bonferroni post-hoc analysis 
was used in multiple comparisons.  
 
Results 
VO2 kinetics 
Curve fitting level was sufficiently accurate for hypoxia (r2=0.89±0.07), normoxia (r2=0.92±0.04) 
and hyperoxia (r2=0.92±0.04). The τ of  offset kinetics under hypoxic conditions was 
respectively 7±9 and 8±11 seconds larger than τ of the offset kinetics under normoxia (p=0.02) 
and hyperoxia (p=0.04) (Table 3.3). However, there was no significant difference in τ between 
normoxic and hyperoxic conditions (Table 3.3).  
 
TSI kinetics 
Monoexponential curve fitting was sufficiently accurate for hypoxia (r2=0.97±0.02), normoxia 
(r2=0.93±0.06) and hyperoxia (r2=0.90±0.11). The MRT of TSI offset kinetics under hypoxic 
conditions was respectively 10±11 and 12±13 seconds larger than τ of the offset kinetics under 
normoxia (p=0.007) and hyperoxia (p=0.008) (Table 3.3). Hyperoxic conditions did not speed the 
offset kinetics. The τ values of  were significantly larger than MRT of TSI (p=0.0001) 
under the oxygen conditions (Table 3.3).  
 
Absolute baseline and steady-state values of VO2 and TSI 
The absolute steady-state values of  were not different in normoxia (  p=1.0) and 
hyperoxia (  p=1.0) than in hypoxia. Only the absolute steady-state values of TSI were 
significantly different in hypoxia compared with normoxia (p=0.0001) and hyperoxia (p=0.003). 
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Respiratory gas measurements 
The analysis of oxygen uptake ( ) and production of carbon dioxide (2) levels were 
continuously measured through a metabolic cart (Oxycon Pro, Jaeger, Mannheim, Germany).  
 
NIRS measurements 
The methodology of the NIRS measurement procedures as well as data collection of an absolute 
measure of tissue oxygen saturation (tissue saturation index (TSI), have been described elsewhere 
[11]. Given the thickness of the subcutaneous adipose tissue may confound the NIRS signal 
amplitude, the skinfold thickness was measured and reported. In particular, a skinfold measured 
with a calliper was divided by 2 to give adipose tissue thickness (ATT) [11].  
 
Absolute values 
The methodology of calculating all and TSI absolute values (amplitude, baseline and 
steady-state) were described in detail in a reproducibility study of Niemeijer et al. [11]. 
 
Pulmonary VO2 kinetics 
Fitting of mono-exponential curves of onset and offset oxygen uptake kinetics was performed in 
Python 2.7 (Python Software Foundation), in order to calculate the time constant and increase in 
oxygen uptake. Two formulas were used for offset kinetics, as described before [12].  
 
 (t) =  steady state – B * (1 – e – (t – Td) / τ)  
 
B = -amplitude during exercise (ml/min), Td = time delay (s) and τ = time constant tau (s).  
 
NIRS kinetics analysis 
Time constants (τ) of recovery were calculated by fitting the TSI data to a first-order 
(mono-exponential) model using the non-linear least squares method (Python 2.7, Python 
Software Foundation). Additionally, the mean response time (MRT) was calculated as the sum of 
tau and time delay (MRT = τ + Td). Considering better reproducibility, we used MRT TSI for the 
kinetics comparisons with tau . The coefficient of determination (r²) was applied to 
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determine how well the fitted mono-exponential curve approximated the real data points. 
Additionally, r² ranges from 0 to 1 with 1 as an indicator for a line that perfectly fits the real data. 
The methodological details of the recovery TSI kinetics are available elsewhere [11].  
 
Statistical analysis 
Subject’ characteristics were expressed as mean±SD. The obtained results under the three oxygen 
conditions were compared using a General Linear Model with repeated measures (IBM SPSS 
Statistics version 20). Level of significance was set at p < 0.05.  The Bonferroni post-hoc analysis 
was used in multiple comparisons.  
 
Results 
VO2 kinetics 
Curve fitting level was sufficiently accurate for hypoxia (r2=0.89±0.07), normoxia (r2=0.92±0.04) 
and hyperoxia (r2=0.92±0.04). The τ of  offset kinetics under hypoxic conditions was 
respectively 7±9 and 8±11 seconds larger than τ of the offset kinetics under normoxia (p=0.02) 
and hyperoxia (p=0.04) (Table 3.3). However, there was no significant difference in τ between 
normoxic and hyperoxic conditions (Table 3.3).  
 
TSI kinetics 
Monoexponential curve fitting was sufficiently accurate for hypoxia (r2=0.97±0.02), normoxia 
(r2=0.93±0.06) and hyperoxia (r2=0.90±0.11). The MRT of TSI offset kinetics under hypoxic 
conditions was respectively 10±11 and 12±13 seconds larger than τ of the offset kinetics under 
normoxia (p=0.007) and hyperoxia (p=0.008) (Table 3.3). Hyperoxic conditions did not speed the 
offset kinetics. The τ values of  were significantly larger than MRT of TSI (p=0.0001) 
under the oxygen conditions (Table 3.3).  
 
Absolute baseline and steady-state values of VO2 and TSI 
The absolute steady-state values of  were not different in normoxia (  p=1.0) and 
hyperoxia (  p=1.0) than in hypoxia. Only the absolute steady-state values of TSI were 
significantly different in hypoxia compared with normoxia (p=0.0001) and hyperoxia (p=0.003). 
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TSI amplitude values were significantly different in between normoxia and hyperoxia (p=0.01) 
and normoxia and hypoxia (p=0.001) (Table 3.2). Additionally, there was no difference (p=1.00) 
in amplitude of total blood volume in the muscle (tHb) between the FiO2 conditions. 
 
Discussion 
In the present study we investigated whether higher FiO2 can be used to determine a 
musculoskeletal oxygen delivery limitation during recovery following a constant-load 
submaximal bout of exercise. In contrast with our hypothesis, the main finding of this study was 
that the higher FiO2 conditions did not accelerate the recovery kinetics and that oxygen delivery 
during normoxic and submaximal exercise was not a limiting factor in healthy and moderately 
trained participants. 
 
Oxygen uptake and muscle oxygenation offset kinetics under hyperoxic conditions 
To date, it is still equivocal whether additional oxygen availability in inspired air can be 
beneficial in improving oxygen-delivery-dependent exercise tolerance. The effect of the higher 
FiO2 on the recovery kinetics rate may both depend on cardiovascular function [9] and individual 
sensitivity to manipulated FiO2 conditions [17]. Although cardiovascular compromised patients 
may show improved exercise tolerance from extra oxygen [18], it is still challenging to 
differentiate responders from non-responders. Although the present study was performed in 
healthy subjects without any known cardiovascular impairments, intra-individual comparisons 
and differences in recovery kinetics between hypoxic and normoxic conditions suggest that 
manipulating FiO2 can be used to test whom potentially may benefit from an increased FiO2 
during submaximal exercise conditions.  
Opposite to our original hypothesis, we did not find beneficial effects of hyperoxia on neither 
 or muscle oxygenation offset kinetics (Table 3.3). As such, our results extend on the study 
by Macdonald et al. who performed submaximal exercise test below the ventilatory threshold in 
normoxia and hyperoxia (70% O2) and reported no additional benefits of hyperoxia on 
offset kinetics [8]. Both our and their results indicate that during submaximal exercise muscle 
oxygen delivery is not a limiting factor in healthy subjects. This raises the question whether other 
subjects with impairments in cardiovascular and/or pulmonary oxygen delivery might improve 
their exercise tolerance by additional oxygen availability in inspired air during submaximal 
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exercise. For example, Payen et al. reported that hyperoxic air accelerated recovery time by 36% 
in COPD patients with diminished oxygen delivery function[19]. Following the same line of 
thought, Kemps et al. have suggested that faster offset kinetics were associated with better 
exercise tolerance in CHF patients with peripheral O2 delivery deficit [20]. In accordance, both 
cardiovascular and pulmonary compromised patients could potentially benefit from testing 
submaximal recovery oxygen kinetics under normoxic and hyperoxic exercise conditions to 
assess whether hyperoxia could reduce the mismatch between oxygen delivery and consumption. 
Despite previous work by Grassi et al. suggests that muscle oxygen kinetics are closely related to 
pulmonary oxygen uptake kinetics [21]. The reported results on slower kinetics of both muscle 
oxygenation and pulmonary  under hypoxic conditions than under normoxic and hyperoxic 
conditions in the present study extend on these results (Table 3.3). As it also has been reported 
that muscle oxygenation rate has similar recovery kinetics as PCr following a submaximal 
exercise bout [22], recovery kinetics assessment using NIRS onlycan potentially be a more 
straight forward and cost-effective method.  
Regarding the peripheral oxygen delivery limitations, Belardinelly et al. have shown that the
 and muscle oxygenation recovery kinetics in CHF patients were slower than in healthy 
subjects. Interestingly, the authors reported no difference in MRT of  and muscle 
oxygenation kinetics speed in CHF patients (0% difference) while these kinetics measures were 
clearly different in healthy subjects (48% difference). The authors try to explain this by 
suggesting that muscle blood flow was reduced in CHF patients because of the peripheral 
cardiovascular dysfunction i.e. inability to increase blood flow in peripheral arteries to meet 
oxygen delivery needs [4]. The latter could be a potential explanation for our results as our 
healthy subjects without oxygen delivery limitations have shown a significant difference between 
tau  and the MRT TSI recovery kinetics under hypoxia (20±16s), normoxia (23±10s) and 
hyperoxia (24±9s). Additionally, MRT has been reported as more reproducible for muscle 
oxygenation kinetics than tau [16]. 
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TSI amplitude values were significantly different in between normoxia and hyperoxia (p=0.01) 
and normoxia and hypoxia (p=0.001) (Table 3.2). Additionally, there was no difference (p=1.00) 
in amplitude of total blood volume in the muscle (tHb) between the FiO2 conditions. 
 
Discussion 
In the present study we investigated whether higher FiO2 can be used to determine a 
musculoskeletal oxygen delivery limitation during recovery following a constant-load 
submaximal bout of exercise. In contrast with our hypothesis, the main finding of this study was 
that the higher FiO2 conditions did not accelerate the recovery kinetics and that oxygen delivery 
during normoxic and submaximal exercise was not a limiting factor in healthy and moderately 
trained participants. 
 
Oxygen uptake and muscle oxygenation offset kinetics under hyperoxic conditions 
To date, it is still equivocal whether additional oxygen availability in inspired air can be 
beneficial in improving oxygen-delivery-dependent exercise tolerance. The effect of the higher 
FiO2 on the recovery kinetics rate may both depend on cardiovascular function [9] and individual 
sensitivity to manipulated FiO2 conditions [17]. Although cardiovascular compromised patients 
may show improved exercise tolerance from extra oxygen [18], it is still challenging to 
differentiate responders from non-responders. Although the present study was performed in 
healthy subjects without any known cardiovascular impairments, intra-individual comparisons 
and differences in recovery kinetics between hypoxic and normoxic conditions suggest that 
manipulating FiO2 can be used to test whom potentially may benefit from an increased FiO2 
during submaximal exercise conditions.  
Opposite to our original hypothesis, we did not find beneficial effects of hyperoxia on neither 
 or muscle oxygenation offset kinetics (Table 3.3). As such, our results extend on the study 
by Macdonald et al. who performed submaximal exercise test below the ventilatory threshold in 
normoxia and hyperoxia (70% O2) and reported no additional benefits of hyperoxia on 
offset kinetics [8]. Both our and their results indicate that during submaximal exercise muscle 
oxygen delivery is not a limiting factor in healthy subjects. This raises the question whether other 
subjects with impairments in cardiovascular and/or pulmonary oxygen delivery might improve 
their exercise tolerance by additional oxygen availability in inspired air during submaximal 
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exercise. For example, Payen et al. reported that hyperoxic air accelerated recovery time by 36% 
in COPD patients with diminished oxygen delivery function[19]. Following the same line of 
thought, Kemps et al. have suggested that faster offset kinetics were associated with better 
exercise tolerance in CHF patients with peripheral O2 delivery deficit [20]. In accordance, both 
cardiovascular and pulmonary compromised patients could potentially benefit from testing 
submaximal recovery oxygen kinetics under normoxic and hyperoxic exercise conditions to 
assess whether hyperoxia could reduce the mismatch between oxygen delivery and consumption. 
Despite previous work by Grassi et al. suggests that muscle oxygen kinetics are closely related to 
pulmonary oxygen uptake kinetics [21]. The reported results on slower kinetics of both muscle 
oxygenation and pulmonary  under hypoxic conditions than under normoxic and hyperoxic 
conditions in the present study extend on these results (Table 3.3). As it also has been reported 
that muscle oxygenation rate has similar recovery kinetics as PCr following a submaximal 
exercise bout [22], recovery kinetics assessment using NIRS onlycan potentially be a more 
straight forward and cost-effective method.  
Regarding the peripheral oxygen delivery limitations, Belardinelly et al. have shown that the
 and muscle oxygenation recovery kinetics in CHF patients were slower than in healthy 
subjects. Interestingly, the authors reported no difference in MRT of  and muscle 
oxygenation kinetics speed in CHF patients (0% difference) while these kinetics measures were 
clearly different in healthy subjects (48% difference). The authors try to explain this by 
suggesting that muscle blood flow was reduced in CHF patients because of the peripheral 
cardiovascular dysfunction i.e. inability to increase blood flow in peripheral arteries to meet 
oxygen delivery needs [4]. The latter could be a potential explanation for our results as our 
healthy subjects without oxygen delivery limitations have shown a significant difference between 
tau  and the MRT TSI recovery kinetics under hypoxia (20±16s), normoxia (23±10s) and 
hyperoxia (24±9s). Additionally, MRT has been reported as more reproducible for muscle 
oxygenation kinetics than tau [16]. 
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Table 3.2. Mean baseline (rest) and steady-state absolute values of  and TSI 
under hypoxic, normoxic and hyperoxic conditions. 
 Hypoxia Normoxia Hyperoxia P-value 
 Baseline 
 
(ml/kg/min)  
2.9±0.4 3.0±0.5* 3.2±0.5** 0.06*; 0.8**; 1.0*** 
TSI (%) 
tHb (μM_cm) 
67.2±5.3 
118.6±38.9 
68.4±4.8* 
115.1±39.1* 
70.8±7.8** 
115.5±37.8** 
0.8*; 0.3**; 0.6*** 
0.4*; 0.68**; 1.0*** 
 Steady-state 
 
(ml/kg/min)  
20±3.1 19±2.9* 18.9±2.9** 1.0*; 1.0**; 1.0*** 
TSI (%) 
tHb (μM_cm) 
60.3±7.6 
109.7±36.4 
65.4±6* 
106.4±36.1* 
66.1±8.9** 
106.7±34.8** 
0.0001*; 0.003**; 1.0*** 
0.28*; 0.56**; 1.0*** 
 Amplitude of Recovery 
 
(ml/kg/min) 
15.6±2.4 15.3±2.4* 15.4±2.4** 1.0*; 1.0**; 1.0*** 
TSI (%) 
tHb (μM_cm) 
9.7±5.0 
-8.8±4.5 
6.4±4.1* 
-8.7±4.4* 
5.8±2.7** 
-8.7±5.9** 
0.001*; 0.01**; 1.0*** 
1.0*; 1.0**; 1.0*** 
Amount of ‘*’ assigns the statistical difference between FiO2 conditions (*-hypoxia with 
normoxia; **-hypoxia with hyperoxia and ***-normoxia with hyperoxia) to a p-value. 
 
Taken together, these results suggest that recovery kinetics following a moderate-intensity bout 
of exercise under hyperoxic conditions were not limited by oxygen delivery in young and healthy 
subjects. Using both the and muscle oxygenation recovery kinetics measurements under 
increased FiO2 may help detecting cardiovascular oxygen delivery limitations in deficient 
subjects. Acutely improved muscle oxygenation and  kinetics may be used to decide on the 
potential benefit of additional oxygen concentrations during exercise training in subjects with 
oxygen delivery limitations. 
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Oxygen uptake and muscle oxygenation offset kinetics under hypoxic conditions 
In order to investigate the sensitivity of NIRS and  measurements we investigated offset 
kinetics of  and TSI under hypoxic conditions as a model to artificially induce an oxygen 
delivery limitation in healthy subjects. In line with previous work in this area [1]  we found 
slower oxygen uptake and muscle oxygenation kinetics (Table 3.3). Slower recovery kinetics 
under lower FiO2 conditions may suggest a blunted compensatory hyperemic vasodilatory 
response (decreased blood volume) [4] in older/diseased subjects [23]. In particular, subjects with 
more severe circulatory dysfunction had slower recovery  kinetics [4]. In our study there 
was no difference in the amplitude of the total volume of blood (tHb) between the FiO2 
conditions. This suggests that there was no need for compensatory vasodilation to increase 
oxygen delivery under hypoxic conditions. 
 
Table 3.3. Mean τ values of  and TSI offset kinetics under hypoxic, normoxic and 
hyperoxic conditions. 
 Hypoxia Normoxia Hyperoxia P-value 
 Offset kinetics 
τ   (s) 44.9±7.3 37.9±8.2* 37.0±6.0** 0.02*; 0.04**; 1.0*** 
MRT TSI (s) 25.5±13.0 15.0±7.7* 13.0±7.3** 0.007*; 0.008**; 0.8*** 
Amount of ‘*’ assigns the statistical difference between FiO2 conditions (*-hypoxia with 
normoxia; **-hypoxia with hyperoxia and ***-normoxia with hyperoxia) to a p-value. 
 
These results suggest that hypoxia may induce higher oxygen consumption demand in skeletal 
muscle despite low exercise intensity (table 3.2). However, a higher TSI amplitude could also be 
induced by higher relative intensity at steady-state under hypoxic conditions (RER=1.02±0.1) in 
comparision with normoxia (0.96±0.1) and hyperoxia (0.92±0.1).  
Taken together, slower TSI and  recovery kinetics under hypoxic conditions show good 
sensitivity of NIRS and spiro-ergometry measurements and the kinetics assessment methods as 
the lack of sensitivity to hypoxia would suggest an unreliable detection of oxygen delivery 
limitation under hyperoxic conditions. 
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subjects. Using both the and muscle oxygenation recovery kinetics measurements under 
increased FiO2 may help detecting cardiovascular oxygen delivery limitations in deficient 
subjects. Acutely improved muscle oxygenation and  kinetics may be used to decide on the 
potential benefit of additional oxygen concentrations during exercise training in subjects with 
oxygen delivery limitations. 
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In summary, the present study design extends on previous studies by applying both hypoxic and 
hyperoxic conditions in assessing oxygen uptake recovery kinetics. The slower recovery kinetics 
during hypoxia suggest good sensitivity of  and TSI kinetics measurement methods. On the 
other hand, no improvement in the recovery kinetics on both pulmonary ( ) and muscle 
(TSI) levels under higher FiO2 indicates that healthy medium-trained subjects have no oxygen 
delivery limitation during submaximal exercise under normoxic condtions and will probably 
show no benefit of hyperoxic exercise training 
As we were only able to study healthy young subjects, our results warrant future studies in CHF, 
type 2 diabetes and COPD patients. Furthermore, because of the interpersonal-response 
variability to hyperoxic conditions, it stills needs to be seen whether observations following acute 
exposure to different levels of hyperoxia can be translated or be used to predict the medium and 
long-term response to hyperoxic exercise training.  
 
Conclusion 
Since oxygen uptake kinetics of healthy subjects do not benefit from supplementary oxygen, the 
present study indicates that performing acute submaximal exercise bouts under normoxic and 
hyperoxic conditions may assist in detecting oxygen delivery limitations in skeletal muscle of 
e.g. cardiovascular or pulmonary compromised patients with exercise intolerance. The latter 
information can potentially be used to discriminate on forehand between responders and non-
responders before prescribing hyperoxic exercise training. 
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Hyperoxia increases arterial oxygen pressure 
during exercise in type 2 diabetes patients: 
a feasibility study  
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Abstract 
Objective: The study investigated the feasibility and potential outcome measures during 
acute hyperoxic in type 2 diabetes patients (DM2).  
Methods: Eleven DM2 patients (7 men and 4 women) were included in the study.  The 
patients cycled (30 min at 20% Wmax) while breathing 3 different supplemental oxygen flows 
(SOF, 5, 10, 15 L/min). During hyperoxic exercise arterial blood gases and intra-arterial 
blood pressure measurements were obtained. 
Results: Arterial pO2 levels increased significantly (ANOVA, p<0.05) with SOF: 13.9±1.2 (0 
L/min); 18.5±1.5 (5L/min); 21.7±1.7 (10 L/min); 24.0±2.3 (15 L/min). HR (HR) and pH 
increased significantly after terminating administration of hyperoxic air. 
Conclusions: A SOF of 15 L/min appears to be more effective than 5 or 10 L/min. Moreover, 
HR, blood pressure, blood lactate, pH are not recommended as primary outcome measures. 
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Introduction 
Breathing a hyperoxic gas mixture has been shown to acutely enhance power output (W) by 8 
-13% [1-6], increase oxygen uptake ( 2OV ) by 10-14% [2, 3, 6-10], decrease blood lactate 
level [11] and lower perceived exertion [7] during aerobic type of exercise. Both healthy 
subjects and COPD patients show improved exercise performance with hyperoxia [12-14]. 
These findings suggest that certain other clinical populations with impaired cardiovascular 
and./or -pulmonary fitness levels, might benefit from exercise under hyperoxic conditions as 
well. Patients with type 2 diabetes (DM2) might be good candidates for hyperoxic exercise 
training as previous research indicated that DM2 patients frequently have a reduced diffusion 
capacity of the lungs (8-25%), inversely related to blood glucose levels as well as duration 
and severity of DM2 [15-17]. Pathophysiological mechanisms explaining the impaired 
pulmonary function may be micro-angiopathy, chronic inflammation and autonomic 
neuropathy [16, 18] resulting in a diminished alveolar micro-vascular reserve [15, 17, 19-21]. 
Impaired alveolar gas exchange in DM2 patients has been shown to correlate with a lower 
2OV  and workload capacity during aerobic type of exercise [22].  
Although beneficial effects of exercise under hyperoxic conditions have been reported for 
different types of chronic disease populations [1, 4, 8, 23-26], experimental data on an 
effective dose of hyperoxic air during exercise in DM2 patients are still lacking. Despite the 
ongoing debate on oxygen transport and consumption [50], increased oxygen availability in 
arterial blood may improve intracellular transport and uptake of active muscle tissue, and 
subsequently improve exercise performance. In accordance, the aim of the present feasibility 
study was to establish an effective dose of supplemental oxygen in deconditioned DM2 
population as a basis to guide and optimise future hyperoxic exercise training protocols.  
 
Methods 
Subjects 
Eleven patients diagnosed with DM2 for at least 2 years and not taking anti-hypertensive 
medication were screened and included at the outpatient clinic at Erasmus University Medical 
Center in Rotterdam, the Netherlands. The characteristics of the eligible patients are presented 
in Table 4.1. Out of 22 screened patients, a total of six patients were not willing to participate 
in the hyperoxic exercise intervention following the maximal exercise test. Four patients were 
excluded from the hyperoxic experiment because it was not possible to introduce an intra-
arterial catheter in the radial artery. One patient was excluded from our study because of 
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capacity of the lungs (8-25%), inversely related to blood glucose levels as well as duration 
and severity of DM2 [15-17]. Pathophysiological mechanisms explaining the impaired 
pulmonary function may be micro-angiopathy, chronic inflammation and autonomic 
neuropathy [16, 18] resulting in a diminished alveolar micro-vascular reserve [15, 17, 19-21]. 
Impaired alveolar gas exchange in DM2 patients has been shown to correlate with a lower 
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Although beneficial effects of exercise under hyperoxic conditions have been reported for 
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effective dose of hyperoxic air during exercise in DM2 patients are still lacking. Despite the 
ongoing debate on oxygen transport and consumption [50], increased oxygen availability in 
arterial blood may improve intracellular transport and uptake of active muscle tissue, and 
subsequently improve exercise performance. In accordance, the aim of the present feasibility 
study was to establish an effective dose of supplemental oxygen in deconditioned DM2 
population as a basis to guide and optimise future hyperoxic exercise training protocols.  
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Subjects 
Eleven patients diagnosed with DM2 for at least 2 years and not taking anti-hypertensive 
medication were screened and included at the outpatient clinic at Erasmus University Medical 
Center in Rotterdam, the Netherlands. The characteristics of the eligible patients are presented 
in Table 4.1. Out of 22 screened patients, a total of six patients were not willing to participate 
in the hyperoxic exercise intervention following the maximal exercise test. Four patients were 
excluded from the hyperoxic experiment because it was not possible to introduce an intra-
arterial catheter in the radial artery. One patient was excluded from our study because of 
Mankowski_BW.indd   89 04-08-15   15:43
Chapter 4
90
C
hapter 4

abnormally high lactate levels during exercise and was diagnosed with mitochondrial 
encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome afterwards. 
Baseline characteristics of excluded patients were not different from the experimental group. 
Included subjects gave their informed consent to participate in the study, approved by the 
medical ethical committee of the Erasmus University Medical Center in Rotterdam (ISRCTN 
number: NTR2299).  
 
Table 4.1. Subject characteristics 
(n=11) Mean±SD 
Sex (male: female) 7:4 
Age (yr) 56.3±6.3 
T2D duration (yr) 10.5±6.6 
Weight (kg) 87.7±16.5 
Length (cm) 171.1±11.0 
BMI (kg/m2) 30.1±6.1 
Abdominal circumference (cm) 100±13 
Fat percentage* (%) 33.9±9.1 
Fasting glucose (mmol/L) 11.3±3.0 
HbA1c (%) 8.3±1.3 
* based on skinfold measurements (Durnin & Womersly) (Durnin & Womersley, 1969) No 
significant differences (p<0.05) 
 
Procedures 
Prior to the hyperoxic exercise session all subjects performed a maximal exercise test on a 
cycle ergometer (Jaeger ER800) using an incremental workload (1.85 Watt/6 s for men, 1.2 
Watt/6s for women). The oxygen uptake ( 2OV ) (Oxycon Pro, Viasys, Houten, Netherlands) 
and HR (HR) (Polar wear-link, Finland) were measured continuously. A second visit was 
scheduled within 1-3 wks following a maximal exercise test. During the second visit subjects 
performed a hyperoxic exercise session. The bout consisted of 25 min of submaximal cycling 
at 20% of the maximal workload capacity (Wmax). The workload was chosen to ensure that the 
subjects reach steady-state, based on the assumption that the anaerobic threshold is at least 
40% Wmax in DM2 patients. After calibration, beat-to-beat blood pressure was obtained 
through a percutaneous intra-articular catheter in the radial artery of the non-dominant hand 

[51]. Data were registered in a computer and analysed using specialized software (Beat scope, 
Finapres Medical Systems, Amsterdam, the Netherlands). The intra-articular catheter was 
inserted following the Allen’s test. It was performed to minimize the risk of ischemia of the 
hand. The exercise protocol consisted of 6 phases: 5 min of rest without supplemental oxygen 
flow (SOF), 10 min without SOF, 5 min with 5 L/min SOF, 5 min with 10 L/min SOF, 5 min 
with 15 L/min SOF, 5 min without SOF (figure 4.1). Stage duration of 5 min was chosen to 
reach steady-state during, at least, the last 2 min of each stage [27, 28]. The last stage was 
added to assess the effect of cessation of SOF.  
The SOF was administered directly into a face mask (without a reservoir bag, Teleflex Inc. 
Hudson RCI adult Multi-Vent air entrainment mask), allowing the inhalation of room air to 
meet the subjects’ ventilatory demands. In our study we chose to dose oxygen as a fixed flow 
quantity, instead of a fixed inspirational fraction with a maximum of 15 L/min. This design 
was chosen to match the possibilities of the standard facilities for supplemental oxygen 
available in most primary and secondary healthcare settings. During the last min of each 
phase arterial blood gas and the rate of perceived exertion (Borg score) [29] was obtained.  
 
Statistical Analysis 
An independent sample T-test was used to analyse the baseline characteristics and maximal 
exercise test. We used a single factor ANOVA with repeated measures to compare the means 
of the given variables during different hyperoxic exercise phases. Differences with a p-value 
<0.05 were considered as significant. The Bonferroni adjustment was applied. Data were 
presented as mean ± SD. 
 
Results 
Participants 
The characteristics of the included participants are presented in Table 4.1. 
 
Maximal exercise test 
The average maximal oxygen uptake ( peak) of the subjects was 1.83±0.59 L/min. The 
mean peak was on average ~24% (p<0.05) below the average of a healthy population of 
the same age, weight, length and sex based on the regression equations by Fairbarn et al. [30]. 
Maximal HR was not significantly different form the predicted values according to the 
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abnormally high lactate levels during exercise and was diagnosed with mitochondrial 
encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome afterwards. 
Baseline characteristics of excluded patients were not different from the experimental group. 
Included subjects gave their informed consent to participate in the study, approved by the 
medical ethical committee of the Erasmus University Medical Center in Rotterdam (ISRCTN 
number: NTR2299).  
 
Table 4.1. Subject characteristics 
(n=11) Mean±SD 
Sex (male: female) 7:4 
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T2D duration (yr) 10.5±6.6 
Weight (kg) 87.7±16.5 
Length (cm) 171.1±11.0 
BMI (kg/m2) 30.1±6.1 
Abdominal circumference (cm) 100±13 
Fat percentage* (%) 33.9±9.1 
Fasting glucose (mmol/L) 11.3±3.0 
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* based on skinfold measurements (Durnin & Womersly) (Durnin & Womersley, 1969) No 
significant differences (p<0.05) 
 
Procedures 
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cycle ergometer (Jaeger ER800) using an incremental workload (1.85 Watt/6 s for men, 1.2 
Watt/6s for women). The oxygen uptake ( 2OV ) (Oxycon Pro, Viasys, Houten, Netherlands) 
and HR (HR) (Polar wear-link, Finland) were measured continuously. A second visit was 
scheduled within 1-3 wks following a maximal exercise test. During the second visit subjects 
performed a hyperoxic exercise session. The bout consisted of 25 min of submaximal cycling 
at 20% of the maximal workload capacity (Wmax). The workload was chosen to ensure that the 
subjects reach steady-state, based on the assumption that the anaerobic threshold is at least 
40% Wmax in DM2 patients. After calibration, beat-to-beat blood pressure was obtained 
through a percutaneous intra-articular catheter in the radial artery of the non-dominant hand 
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[51]. Data were registered in a computer and analysed using specialized software (Beat scope, 
Finapres Medical Systems, Amsterdam, the Netherlands). The intra-articular catheter was 
inserted following the Allen’s test. It was performed to minimize the risk of ischemia of the 
hand. The exercise protocol consisted of 6 phases: 5 min of rest without supplemental oxygen 
flow (SOF), 10 min without SOF, 5 min with 5 L/min SOF, 5 min with 10 L/min SOF, 5 min 
with 15 L/min SOF, 5 min without SOF (figure 4.1). Stage duration of 5 min was chosen to 
reach steady-state during, at least, the last 2 min of each stage [27, 28]. The last stage was 
added to assess the effect of cessation of SOF.  
The SOF was administered directly into a face mask (without a reservoir bag, Teleflex Inc. 
Hudson RCI adult Multi-Vent air entrainment mask), allowing the inhalation of room air to 
meet the subjects’ ventilatory demands. In our study we chose to dose oxygen as a fixed flow 
quantity, instead of a fixed inspirational fraction with a maximum of 15 L/min. This design 
was chosen to match the possibilities of the standard facilities for supplemental oxygen 
available in most primary and secondary healthcare settings. During the last min of each 
phase arterial blood gas and the rate of perceived exertion (Borg score) [29] was obtained.  
 
Statistical Analysis 
An independent sample T-test was used to analyse the baseline characteristics and maximal 
exercise test. We used a single factor ANOVA with repeated measures to compare the means 
of the given variables during different hyperoxic exercise phases. Differences with a p-value 
<0.05 were considered as significant. The Bonferroni adjustment was applied. Data were 
presented as mean ± SD. 
 
Results 
Participants 
The characteristics of the included participants are presented in Table 4.1. 
 
Maximal exercise test 
The average maximal oxygen uptake ( peak) of the subjects was 1.83±0.59 L/min. The 
mean peak was on average ~24% (p<0.05) below the average of a healthy population of 
the same age, weight, length and sex based on the regression equations by Fairbarn et al. [30]. 
Maximal HR was not significantly different form the predicted values according to the 
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Tanaka regression equation [31]. The results of the maximal exercise test are presented in 
Table 4.2.  
 
Hyperoxic exercise: blood gas analysis 
All included subjects were able to complete 25 min of submaximal hyperoxic exercise. 
Arterial pO2 levels (Figure 4.2a) did not change immediately after starting the exercise (T1-
2). The arterial pO2 increased significantly with increased SOF (T2-T5) in a dose-dependent 
manner and returned to baseline after cessation of the SOF administration (T5-T6). The 
arterial pCO2 (Figure 4.2b) did not change significantly in response to exercise under different 
SOF. There was a decreasing trend of the pH (Figure 4.2c) at the onset of the exercise bout 
(T1-T2), while pH increased significantly (p-value) during the last step when the 
supplemental oxygen flow administration was stopped (T5-T6).  
 
Hyperoxic exercise: HR, blood pressure and rate of perceived exertion 
The HR (Figure 4.3a) increased significantly after the onset of the exercise bout (T1-T2), and 
remained unchanged during the SOF phases (T2-T5) and increased after stopping the SOF 
(T5-T6). After an initial increase of systolic and diastolic blood pressure after starting the 
exercise (T1-2), systolic, diastolic and mean arterial blood pressure (Figure 4.3b-d) did not 
change during the SOF. Furthermore, the rate pressure product (Figure 4.3e) showed a 
significant increase after stopping the SOF (T5-T6). The rate of perceived exertion (Figure 
4.3f) increased with the start of exercise (T1-2) and did not increase significantly during 
exercise (T2-T6). 
 
Discussion 
We tested the feasibility of hyperoxic exercise and dose-response in deconditioned type 2 
diabetes patients. The main finding of this feasibility study was that exercise under a 
supplemental oxygen flow of 15 L/min increased pO2 more effectively than lower doses (5 
and 10 L/min) in DM2 patients.  
 
Technical feasibility 
From a technical perspective our results demonstrate that supplemental oxygen, applied with 
a standard open facemask (5-15 L/min), results in significant increases in arterial pO2 levels 
during exercise. Higher pO2 at increased SOF (i.e. 5, 10 and 15 L/min) suggests a dose- 

Table 4.2. Maximal exercise test (n=11) 
 Maximal Predicted % predicted AT Ratio 
AT/max. 
Load (watt) 145.5±61.9 182.1±74.3† 84±24* 85.1±38.5 0.58±0.1* 
Load/weight (watt/kg) 1.70±0.7 2.52±0.82 69±23* 0.99±0.4 0.58±0.1* 
 (ml/min) 1830±593 2499±773† 76±21* 1334±354 0.75±0.1* 
 (ml/min.kg) 21.4±7.0 28.9±8.8 76±24* 15.5±4.0 0.75±0.1* 
HR (bpm) 155±18 169±5‡ 92±10 128±17 0.83±0.1* 
RER 1.09±0.1   0.92±0.1 0.85±0.1* 
SBP (mmHg) 180±30     
DBP (mmHg) 79±12     
RPE (Borg) 15.8±2.8     
AT: anaerobic threshold using a V-slope method; SBP: systolic blood pressure; DBP: 
diastolic blood pressure; * Significant difference (p<0.05) 
† Using the Fairbarn & Wasserman equations (Fairbarn et al., 1994; Wasserman & Whipp, 
1975) 
‡ Using the Tanaka equation (Tanaka et al., 2001) 
 
dependent effect.  The pO2 levels obtained from the radial artery during hyperoxic exercise in 
the present study (24.0±2.3 kPa) were comparable with the arterial pO2 levels measured by 
Plet et al. in healthy subjects. Administration of 55% of oxygen improved maximal oxygen 
uptake by 12% during cycle-ergometry in comparison with normoxic exercise [9].  Other 
studies investigating the influence of hyperoxia during exercise found slightly higher pO2 
levels of approximately 40 kPa obtained from the femoral artery with an inspired oxygen 
fraction of 60% [32-34].  Taken together, our data show that supplemental oxygen applied 
during submaximal exercise via a standard open face mask increases arterial pO2 levels. 
Additional oxygen availability could compensate for the diminished diffusion capacity, 
endothelial function and low aerobic capacity seen in most deconditioned DM2 patients [15, 
17, 19-21]. The latter suggests that a hyperoxic training study in deconditioned DM2 patients 
could be a potential solution in a medical fitness centre, since no special equipment is needed 
other than an open facemask and standard gas cylinders with O2. However, before 
investigating training effects under hyperoxic conditions, this warrants further controlled 
trials on cardiovascular and pulmonary function in DM2 patients. The results will improve 
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Tanaka regression equation [31]. The results of the maximal exercise test are presented in 
Table 4.2.  
 
Hyperoxic exercise: blood gas analysis 
All included subjects were able to complete 25 min of submaximal hyperoxic exercise. 
Arterial pO2 levels (Figure 4.2a) did not change immediately after starting the exercise (T1-
2). The arterial pO2 increased significantly with increased SOF (T2-T5) in a dose-dependent 
manner and returned to baseline after cessation of the SOF administration (T5-T6). The 
arterial pCO2 (Figure 4.2b) did not change significantly in response to exercise under different 
SOF. There was a decreasing trend of the pH (Figure 4.2c) at the onset of the exercise bout 
(T1-T2), while pH increased significantly (p-value) during the last step when the 
supplemental oxygen flow administration was stopped (T5-T6).  
 
Hyperoxic exercise: HR, blood pressure and rate of perceived exertion 
The HR (Figure 4.3a) increased significantly after the onset of the exercise bout (T1-T2), and 
remained unchanged during the SOF phases (T2-T5) and increased after stopping the SOF 
(T5-T6). After an initial increase of systolic and diastolic blood pressure after starting the 
exercise (T1-2), systolic, diastolic and mean arterial blood pressure (Figure 4.3b-d) did not 
change during the SOF. Furthermore, the rate pressure product (Figure 4.3e) showed a 
significant increase after stopping the SOF (T5-T6). The rate of perceived exertion (Figure 
4.3f) increased with the start of exercise (T1-2) and did not increase significantly during 
exercise (T2-T6). 
 
Discussion 
We tested the feasibility of hyperoxic exercise and dose-response in deconditioned type 2 
diabetes patients. The main finding of this feasibility study was that exercise under a 
supplemental oxygen flow of 15 L/min increased pO2 more effectively than lower doses (5 
and 10 L/min) in DM2 patients.  
 
Technical feasibility 
From a technical perspective our results demonstrate that supplemental oxygen, applied with 
a standard open facemask (5-15 L/min), results in significant increases in arterial pO2 levels 
during exercise. Higher pO2 at increased SOF (i.e. 5, 10 and 15 L/min) suggests a dose- 
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† Using the Fairbarn & Wasserman equations (Fairbarn et al., 1994; Wasserman & Whipp, 
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dependent effect.  The pO2 levels obtained from the radial artery during hyperoxic exercise in 
the present study (24.0±2.3 kPa) were comparable with the arterial pO2 levels measured by 
Plet et al. in healthy subjects. Administration of 55% of oxygen improved maximal oxygen 
uptake by 12% during cycle-ergometry in comparison with normoxic exercise [9].  Other 
studies investigating the influence of hyperoxia during exercise found slightly higher pO2 
levels of approximately 40 kPa obtained from the femoral artery with an inspired oxygen 
fraction of 60% [32-34].  Taken together, our data show that supplemental oxygen applied 
during submaximal exercise via a standard open face mask increases arterial pO2 levels. 
Additional oxygen availability could compensate for the diminished diffusion capacity, 
endothelial function and low aerobic capacity seen in most deconditioned DM2 patients [15, 
17, 19-21]. The latter suggests that a hyperoxic training study in deconditioned DM2 patients 
could be a potential solution in a medical fitness centre, since no special equipment is needed 
other than an open facemask and standard gas cylinders with O2. However, before 
investigating training effects under hyperoxic conditions, this warrants further controlled 
trials on cardiovascular and pulmonary function in DM2 patients. The results will improve 
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our understanding on whether additional oxygen during exercise may improve oxidative 
metabolism in populations such as DM2 with deficient cardiovascular and respiratory 
function. 
 
Patient recruitment and study population 
Despite the invasive nature of our study and the fact that use of antihypertensive medication 
was an exclusion criterion for the present study, the majority (76%) of the eligible DM2 
patients that were approached in our outpatient clinic were willing to participate in our 
feasibility study. Although, a training study requires a more long-term commitment, the 
willingness to participate in our feasibility study indicates that it might be possible to recruit a 
sufficient and representative proportion of subjects for a randomized clinical trial on the 
medium-term effects of hyperoxic exercise training. 
In accordance with previous studies [35-38], the mean peak of the investigated patient 
sample is well below the average of the healthy population, even when corrected for a high 
BMI. High HbA1c and fasting glucose levels showed that our deconditioned and overweight 
subjects had poorly regulated DM2. As such, the present study population may not be 
representative for the general, well-controlled DM2 population. Long-term adherence has 
been reported to vary substantially (10-80%) in conventional exercise programs for DM2 
patients [39-44]. However, effects of hyperoxic exercise training in other deconditioned 
patient populations, with a reduced alveolar and capillary diffusion capacity [12-14], showed 
the anticipated increase in exercise capacity. Less perceived exercise intensity and 
improvement of exercise performance will also motivate deconditioned, overweight and 
poorly regulated patients with DM2 to adhere to hyperoxic exercise training.  
 
Potential outcome measures 
In contrast with previous hyperoxic exercise studies [8, 9, 33, 45-47], we observed no change 
in HR, blood pressure or rate of perceived exertion during exercise while increasing the 
supplemental oxygen flow during exercise. However, after stopping administration of SOF 
we observed a significant increase in HR and rate pressure product (HR * systolic blood 
pressure (SBP)). The cardiovascular response during phase 6 indicates that hyperoxia lowers 
the cardiovascular burden during submaximal steady state exercise in deconditioned patients 
with DM2. A number of physiological mechanisms might explain why, in comparison with 
previous hyperoxic exercise studies, SOF did not lower HR and systemic blood pressure 
2OV

during phase 3-5 in our experimental set up. First, it is possible that even at an exercise 
intensity of 20% 2OV peak, our deconditioned patients were not completely in a steady- state 
condition during phase 3-5. Second, in comparison with previous hyperoxic exercise studies, 
the absolute exercise intensity may have been too low to cause a significant drop in HR, blood 
pressure or the rate of perceived exertion (Borg score). Third, the arterial wall stiffening in 
combination with the diabetes-related endothelial dysfunction may have impaired a normal 
vascular response to hyperoxia [48, 49].  
 
Limitations of the study 
Unfortunately, for medical ethical reasons (invasive study) it was difficult to add a healthy 
control group or different oxygen conditions.  Because of this limitation we can only 
speculate about the physiological reason for this abnormal response to hyperoxic exercise. 
Arterial blood gas collection (arterial blood withdrawal) was vastly limited because of 
impaired structure of arterial walls in the DM2 patients. Nevertheless, the present feasibility 
study suggests that HR, blood pressure and rate of perceived exertion may not be suitable 
primary outcome measures for a hyperoxic training study in unfit DM2 patients. Instead, 
direct assessment of the peak or potentially the use of  and/or NIRS kinetics (see 
chapter 3) should be considered in a hyperoxic training study to monitor and document 
change in exercise performance. 
 
Conclusions 
Based on arterial pO2 measurements, a supplemental oxygen flow of 15 L/min appears 
sufficient to compensate for impaired alveolar and capillary oxygen transport and/or 
consumption in deconditioned DM2 patients. Based on this feasibility study and the results 
presented in chapter 3, we propose to first investigate acute effects of various inspiratory 
oxygen fractions on the cardio-respiratory system and speed of oxygen uptake or NIRS 
kinetics. This will improve our understanding on potential exercise performance enhancement 
benefits of supplementary oxygen. This would warrant future studies to investigate the 
medium-and long-term benefits of hyperoxic exercise training in patients with DM2.  
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pressure or the rate of perceived exertion (Borg score). Third, the arterial wall stiffening in 
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Figure 4.2. Blood gas analysis 
 
(a) pO2 levels during hyperoxic exercise. * T3-5 are significantly different from T1, T2 and 
T6, and each other (p<0.05). (b) pCO2 levels during hyperoxic exercise. No significant 
changes (p<0.05). (c) pH levels during hyperoxic exercise. * T6 is significantly higher than 
T2 and T3 (p<0.05). (d) Lactate levels during hyperoxic exercise. No significant changes 
(p<0.05)
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Figure 4.3. Cardiovascular response and rate of perceived exertion 
 
(a) HR during hyperoxic exercise. * T1 is significantly lower than T2-6. T6 is significantly 
higher than T1, T3, and T4 (p<0.05). (b) Systolic blood pressure during hyperoxic exercise. * 
T1 is significantly lower than T2, T3 and T6 (p<0.05). (c) Diastolic blood pressure during 
hyperoxic exercise. No significant changes (p<0.05). (d) Mean arterial blood pressure during 
hyperoxic exercise. No significant changes (p<0.05). (e) Rate-pressure product during 
hyperoxic exercise. * T1 is significantly lower than T2-6. T6 is significantly higher than T1 
and T3 (p<0.05). (f) Rate of perceived exertion (Borg score) during hyperoxic exercise. * T1 
is significantly lower T2-T6 (p<0.05). 
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T6, and each other (p<0.05). (b) pCO2 levels during hyperoxic exercise. No significant 
changes (p<0.05). (c) pH levels during hyperoxic exercise. * T6 is significantly higher than 
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Figure 4.3. Cardiovascular response and rate of perceived exertion 
 
(a) HR during hyperoxic exercise. * T1 is significantly lower than T2-6. T6 is significantly 
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PART  3
Impact of lack of PA and sedentary behavior 
in elderly persons on muscle mass loss and risk 
for metabolic syndrome 
Part 3 of this thesis discusses the consequences of the lack of physical activity and increased 
sedentary behavior. This part emphasizes the magnitude of the problem of the increasingly 
higher risk for the metabolic syndrome and mobility disability in older age. As discussed in 
the previous two parts, we present data to support the notion that alternative approaches are 
warranted to improve the effectiveness and access to physical activity interventions. More 
effective physical activity interventions will target the main pathologies of the aging process, 
improve quality of life and expand health and life span.
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CHAPTER  5
The Role of Muscle Mass, Muscle Quality, 
and Body Composition in Risk for the 
Metabolic Syndrome and Functional Decline 
in Older Adults 
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Abstract 
Age-related body composition changes include both loss of muscle mass (sarcopenia) and 
increase in fat mass, which jointly contribute to a decline in metabolic functions. Muscle 
quality is positively related to functional capacity and a lower risk for the development of the 
metabolic syndrome in aging populations. Muscle quality and muscle strength have become 
more reliable measures of functional capacity and mobility disability than muscle mass 
quantity. Recent reports also suggest that excess fat mass in older adults may impair muscle 
quality and that combination of excess body fat and muscle loss, a condition termed 
sarcopenic obesity, has even greater consequences on the muscle architecture and function 
than age-related muscle loss alone. A current challenge for clinicians and researchers is to 
develop interventions that will help decrease fat mass levels and maintain good muscle 
quality and strength levels in high risk older adults.  
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Introduction  
Skeletal muscle is metabolically one of the most active tissue in the human body [1] . Due to 
the combination of aging and corresponding reduction in activity levels, muscle mass loss 
progresses faster, leading to disability in older age [2-4]. This age-related muscle loss 
(sarcopenia) diminishes the metabolic (e.g. glucose regulation) and mechanical (e.g. muscle 
strength and functional capacity) function of the skeletal muscle [5-8]. There is a growing 
body of evidence that indicates that the overall quantity of muscle mass may be less important 
than muscle quality (muscle strength/muscle mass unit) for the metabolic and mechanical 
function of skeletal muscle [9-12]. Therefore, muscle quality (muscle strength/muscle mass 
unit) has been suggested to be a more important treatment target than muscle mass [11, 13, 
14]. 
There is also a growing body of evidence, which suggests that excess weight or obesity may 
attenuate the structure of skeletal muscle and its function. Obesity dramatically increases the 
risk of functional decline and mobility disability in older adults. Unfortunately, the 
combination of unhealthy weight gain and reduction in lean body mass that occurs during 
aging can directly contribute to impairments in functional capacity [15]. Moreover, the co-
occurrence of excess adipose tissue and low muscle mass can lead to a high risk condition 
termed sarcopenic obesity [16, 17]. Some studies, however, suggest a protective function of 
higher levels of fat mass in older adults [18, 19].  
The progressive reduction of the structural and mechanical function of skeletal muscle during 
aging can ultimately lead to impairments in the functional capacity [15] and contribute to 
metabolic disease conditions (e.g., metabolic syndrome) [20]. Moreover, impairments in 
functional capacity and associated reductions in physical activity can increase risk for 
metabolic disease conditions (e.g., metabolic syndrome) and disability in older adults [20].  
Thus, high functional capacity, associated with healthy skeletal muscle function, is crucial in 
older age and important to be maintained throughout one’s life.  
The complexity of the association between age-related body composition changes with 
reductions in functional capacity and metabolic function during aging warrants further 
investigation. The purpose of this review is to summarize the association between muscle 
quality and muscle strength with body composition, functional capacity, and the metabolic 
syndrome in obese and non-obese aging populations. The first section describes the impact of 
aging on changes in body composition. The next section describes the relationship between 
muscle quality and unhealthy weight gain during aging. Subsequently, we review the 
relationship between muscle quality, muscle strength, muscle mass and functional capacity in 
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muscle quality and unhealthy weight gain during aging. Subsequently, we review the 
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older adults. This relationship is distinguished between obese and non-obese individuals. 
Finally, the last section focuses on the relationship between muscle quality, muscle strength, 
muscle mass, and the metabolic syndrome in older adults.  
 
Effect of aging on body composition 
Aging is associated with unhealthy changes in body composition (e.g. muscle loss and 
increased fat mass) that contribute to a decline in function and significantly increases the risk 
for disability even when body weight remains stable [21-23]. These changes [24] are 
associated with increased fat depots within the muscle as well as a loss in muscle strength 
[24] and muscle power [25]. Age-related changes in muscle composition appear to be even 
more pronounced in obese individuals [9, 26], and the combination of muscle loss and fat 
gain may act synergistically to increase risk of physical disability in obese older adults [21-
23]. This is of concern as the rise in the prevalence of obesity has been particularly dramatic 
among older adults who now represent thirty-three percent of older American adults (age > 60 
years) [27] . Moreover, the combination of muscle loss and fat gain may act synergistically to 
increase risk of physical disability in older adults [27-29].  
In addition to obesity, sedentary lifestyle appears to contribute to the unhealthy body 
composition changes that promote age related functional decline [30-32]. Emerging evidence 
suggests high levels of sedentary behavior (sitting) contributes to lipid accumulation [33-35], 
metabolic impairments [36], and loss of muscle mass during aging [37], all of which strongly 
contribute to functional decline [20, 28, 38, 39]. Recent systematic reviews and meta-analyses 
have found a particularly strong relationship between sedentary time with type 2 diabetes [40] 
, functional decline [41], and increased risk of all-cause mortality and functional decline in 
both middle-age and older adults [40, 42]. Inactivity decreases whole skeletal muscle 
contractile performance, which can lead to reductions in functional capacity [43] . Thus, the 
detrimental metabolic effects of prolonged sedentary behavior are likely related to the 
dramatic reduction in the activity of large muscle groups, which are responsible for up to 80% 
of the body’s blood glucose disposal [44-46]. These findings are of concern as the majority of 
middle-age adults in affluent countries spend over half their waking day (~8-9 hours) engaged 
in sedentary pursuits [44, 47].  
The specific biological mechanism through which obesity and aging contribute to muscle 
degradation and functional decline is not currently known. Accumulating evidence suggests 
that reductions in mitochondrial (Mt) function have a pivotal role in the pathogenesis of 
muscle degradation and age-related functional decline [48, 49], though these relationships 


have primarily been found in pre-clinical models and cross-sectional studies. Emerging 
findings have also highlighted the importance of the intracellular quality control process of 
autophagy in the maintenance of healthy muscle and regulation of body lipid stores [50, 51]. 
In line with this, both aging and obesity are characterized by a reduction in efficiency of 
cellular maintenance, repair, and turnover mechanisms, resulting in the accumulation of lipids 
and damaged biomolecules and organelles [52-55]. Once accumulated, excess body fat can 
also adversely affect autophagy through direct effects on the autophagic machinery [56, 57], 
or through increased production of ROS primarily from damaged mitochondria [48, 49].  The 
complex role of the autophagic-lysosome system in contributing to changes in Mt function, 
body weight, muscle composition and physical function during aging, however, has not been 
well studied in humans. 
 
Relationship between muscle quality and obesity 
A number of studies from the Health ABC cohort have studied the relationship between the 
level of adipose tissue and muscle quality [9, 11, 58-66]. Initially, Reed et al. [60] studied the 
relationship between body weight and muscle quality in 100 men and 117 women aged 65 
and over. The authors [60] observed that higher body weight is related to higher muscle 
quality in both older men and women. Despite this, it is difficult to determine whether these 
individuals were in a healthier metabolic state since the body composition distribution was 
not available. With prospective data from 728 men and 783 women whose BMI was 
measured at regular intervals from the age of 15 until the age of 60-64, Cooper et al. [61] 
showed that those located above the 80th percentile of muscle quality had significantly less 
fat than those located below the 20th percentile. They also observed that significant BMI gain 
in their lives (regardless of the period), increased their risk to have low muscle quality [61]. 
More specifically, it seems that becoming obese after the age of 40 increases the probability 
of having low muscle quality around 60-64 years [61]. Villareal et al. [62, 63] showed in 
people aged on average 70 years that obesity (BMI 30 ˃ 38%, respectively) was significantly 
associated with lower values of muscle quality.  
Segal et al. [64], however, observed no significant difference in muscle quality between 
different subgroups of BMI (<30, 30-35 and ˃35) in 161 men and women (52, 5%) with a 
mean age of 55 years. Koster et al. [9] • showed in 1129 men and 1178 women aged between 
70 to 79 years that leg muscle quality differs depending on the percentage of fat mass. Thus, 
in men and in women, a higher percentage of fat mass is an important contributor to low 
muscle quality in the lower extremity.  In the same cohort, Newman et al. [11] showed that 
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mean age of 55 years. Koster et al. [9] • showed in 1129 men and 1178 women aged between 
70 to 79 years that leg muscle quality differs depending on the percentage of fat mass. Thus, 
in men and in women, a higher percentage of fat mass is an important contributor to low 
muscle quality in the lower extremity.  In the same cohort, Newman et al. [11] showed that 
Mankowski_BW.indd   111 04-08-15   15:43
Chapter 5
112
C
hapter 5


this relationship is quadratic. Leg muscle quality seems optimal for a body fat percentage 
between 16 and 22% in men and between 26 and 34% in women. However, when following 
older adults during 7 years and dividing this cohort in quartile of body fat, men in the highest 
quartile of fat also had the slowest decline in muscle quality [9]. These results can be 
interpreted in two ways: (1) fat mass has a protective effect, or (2) muscle quality of those in 
the highest quartile of fat mass decreased slower because it was lower at the beginning. 
Otherwise, Peterson et al. [65] showed that muscle quality is inversely related to the amount 
of subcutaneous fat in men and women. In addition, after 12 weeks of resistance training, this 
relationship remained unchanged [65]. Additionally, both Goodpaster et al. [59] and Cawthon 
et al. [58] showed that the knee extensor muscle quality was significantly associated with 
muscle density (which is considered an indicator of extracellular lipid infiltration in muscle) 
[66] , but not with subcutaneous or inter-muscular fat (between muscles) in men and women. 
The authors found that muscle density explained 9 and 11% of the variance in muscle quality 
in men and women, respectively [59] . However, it is important to note that all these studies 
used different adiposity indicators (BMI, body fat percentage, fat subcutaneous and muscle 
density). Overall, these results suggest that a high level of adiposity (regardless of the index 
used) is associated with low muscle quality. Nevertheless, the results of Koster et al. [9] raise 
interesting questions about the potentially protective role of fat. 
 
Muscle quality, muscle mass and muscle strength (obese and non-obese) and functional 
capacity in aging 
In recent years, it has been shown that larger muscle mass only is not sufficient to maintain 
functional capacity in older age [10, 58, 67]. During aging, the process of muscle mass and 
muscle strength loss is well defined as sarcopenia [68]. It has been proposed that sarcopenia is 
diagnosed based on a low whole-body or appendicular muscle mass in combination with poor 
physical functioning [12, 68].  
Although sarcopenia is associated with increased risk of physical disability and poor quality 
of life [68, 69], a number of studies to date showed that muscle composition (muscle quality) 
rather than muscle mass is related to better physical function [10, 58]. In particular, several 
factors might influence the muscle composition e.g. architecture and fiber type (fiber size and 
number of type I and type II fibers), fat micro- and macro-infiltration, fibrosis (increase in 
collagen) and neurological modulation of contraction [10, 70]. Moreover, a number of reports 
have found that muscle strength is related to functional capacity in older adults [13, 71-73]. 
However, it is inconclusive how much increased body fat content (obesity) worsens the 


relationship between the metabolic, mechanical properties of skeletal muscle mass and poses 
higher risk on functional capacity and future disability in older adults.  
 
Figure 5.1. Importance of high muscle quality and low adipose tissue levels in improving 
life and health span in older adults. 
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In geriatrics, muscle quality is considered to be a clinically relevant determinant of physical 
performance and disability level in older adults [74]. Kennis at al. reported that the level of 
muscle mass in middle-aged individuals did not contribute to the longitudinal changes in 
muscle quality based on basic strength and only barely contributed to the longitudinal changes 
in muscle quality based on velocity-dependent muscle strength [74]. Therefore, baseline 
muscle strength is an important determinant of the decline in muscle quality based with 
advancing age [10, 74]. 
Additionally, during aging, the number of functioning motor units (muscle work efficiency) 
decreases, with an accelerated loss of fast motor units (type 2b fibers) [10]. Reinnervation of 
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muscle fibers into slow type I fibers. This conversion compromises the strength-generating 
capacity of muscle and functional capacity. Impairment of muscle quality may also be 
accelerated by higher fat mass content [10, 70, 71]. 
 
A relationship between muscle quality, muscle mass and muscle strength and functional 
capacity in obese people 
The relationship between muscle quality and physical function is influenced by: level of 
muscle mass, the degree of obesity (BMI) and age [70]. Impaired physical function can be 
caused by several factors such as high fat mass and low muscle strength [6]. In particular, 
individuals with both high fat mass and low muscle strength would have greater impairments 
in their physical function than individuals with obesity or strength loss alone [6]. 
Age-related muscle mass loss is typically accompanied by an increase in fat mass [70]. As a 
result, bodyweight in men and women might be quite stable in middle age, or slightly 
increased even though the relative amount of body fat actually increases in comparison with 
lean tissue [10]. This is an important step in the development of sarcopenic obesity [75]. It is 
suggested that mechanisms for sarcopenic obesity overlap with those proposed for age-related 
sarcopenia [70]. Net contracting mass might be smaller than estimated because of infiltration 
of skeletal muscle with fat and connective tissue (myosteatosis) [70, 76]. Moreover, abnormal 
protein synthesis rates and anabolic resistance to exercise are especially evident in sarcopenic 
obesity. In obesity, pro-inflammatory cells in fat may contribute to development of sarcopenia 
[70].  
The increased presence of enhanced reactive oxygen species and chronic inflammation related 
to an increased fatty-acid load could also result in mitochondrial damage in skeletal muscle 
[76] . It has been shown that individuals with low muscle strength are approximately two 
times more likely to be obese compared to those with normal strength after adjusting for age, 
gender and body weight [70]. Additionally, muscles that chronically function in the higher 
range of their capacity spectrum might be less energy efficient and can lead to accumulated 
muscle damage [10]. In particular, the energy expenditure, oxygen consumption and muscle 
force required for an obese person are higher than those required by a normal-weight 
individual. Taken together, co-existing obesity and muscle quality impairment can act 
synergistically in developing the risk for multiple functional deficits [70]. Obese individuals 
with large low muscle strength and high body mass are at higher risk of being disabled in the 
future [10, 12, 70].  
 


Relationship between muscle mass, muscle quality and metabolic syndrome 
Obesity, particularly abdominal obesity, has been widely recognized as a predisposing factor 
to cardiovascular diseases (CVD) and the metabolic syndrome [77]. Approximately 53% of 
older adults currently have the metabolic syndrome as compared to 18% of adults below age 
40 [78] .  Independently of abdominal obesity, aging has been shown to be associated with 
decreased muscle mass [79]. Some estimates indicate that 25 to 50% of adults aged 65 and 
older have low levels of muscle mass [80]. However, it has been also suggested that low 
muscle mass may contribute to metabolic complications and cardiovascular disease (CVD) in 
older adults [14, 16, 80, 81].  
One potential explanation for these findings is that skeletal muscle atrophy is fundamental to 
the metabolic alterations related with physical inactivity and the reduction of energy 
expenditure, leading to insulin resistance [82]. In addition, a recent epidemiological study 
suggests that low muscle mass is closely related to impairments in glucose homeostasis, 
underscoring the potential additive and negative effects of low muscle mass when combined 
with obesity on glucose regulation and insulin resistance [83].  
To our knowledge, the limited research that has been conducted on the effect of low muscle 
mass-obesity on metabolic risk factors and CVD in older adults has produced mixed findings 
[3, 17, 84-87]. Two studies [5, 84] indicate that low muscle mass-obesity has no particular 
deleterious impact on metabolic risk factors and CVD in Caucasian postmenopausal women. 
In contrast, Prado et al. [17] in their review and Lu et al. [85] showed that a low muscle mass 
and a high fat mass increased CVD risk in elderly Asian people. Yet another study by 
Castaneda et al. suggest there may be health benefits associated with low muscle mass-
obesity, as they showed that elderly Caucasian with low muscle mass and obesity have less 
diabetic risk (glucose and insulin level) than elderly Caucasians with obesity and normal 
muscle mass [86]. Goulet et al. observed also a better insulinemic profile in obese 
postmenopausal women [88]. Baumgartner et al. reported that elderly people with obesity and 
low muscle mass have less metabolic syndrome but higher type II diabetes [87].  Lebon et al. 
concluded recently that a lower muscle mass/body weight is not detrimental of insulin 
sensitivity even after adjusted for visceral fat mass in sedentary postmenopausal women [89]. 
Stephen et al. showed that low muscle mass when combined with obesity induced a modest 
increase in the risk of CVD in community dwelling older men and women aged over 65 years 
old, and that this relationship seems mediated mostly by muscle strength and muscle quality 
[3]. It is currently unknown whether excess fat mass alone radically increases the risk for the 
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metabolic syndrome and it components, however, it is clear that good muscle quality is of 
high importance for obese subjects. 
In addition, the loss of muscle mass, strength and quality are observed with aging [90]. Low 
muscle strength occurs in 60 % of adult aged 60 and older [6]. Poor muscle quality (muscle 
strength/muscle mas or muscle strength/ body weight) has been shown to be associated with 
poor cardio-respiratory function [91], a decline in mobility [12, 92], incident disability [93] 
and mortality [71, 75]. There is some evidence of a direct association between the metabolic 
syndrome and insulin resistance with low muscle quality [2, 8]; intramuscular adipose tissue 
(IMAT) [4, 59] and high blood pressure [4].  
Based on these previous observations, the combined effect of low muscle strength and/or low 
muscle quality with obesity would be predicted to contribute to a worse metabolic profile 
compared to either condition alone. These individuals represent 7.6 to 11.1% of older adults 
[3, 94]. Moreover, it has been demonstrated that both abdominal obesity and low muscular 
strength are characterized by high circulating levels of pro-inflammatory cytokines which are 
recognized as risk factors for CVD [16]. Interestingly, a recent review reported higher muscle 
strength in metabolically healthy but obese individuals despite lower skeletal muscle mass 
[18], suggesting a better muscle quality (muscle strength per unit of muscle mass) in these 
individuals. This statement is supported by the findings of Karelis et al. [7] and Atlantis et al., 
who showed that higher levels of insulin sensitivity are associated with higher levels of 
muscle quality [14]. However, Senechal et al recently showed that when combined with 
abdominal obesity, dynapenia has been associated with more metabolic alterations in adults 
50 yrs of age and older than dynapenia or obesity alone [95]. These conclusions have been 
confirmed by Barbat-Artigas et al. who recently showed that dynapenic (low muscle strength 
/body weight) and obese postmenopausal Caucasian women (mean age: 60±5 yrs) had a better 
metabolic profile and a better insulinemic profile than non-dynapenic obese postmenopausal 
women [96, 97].  
 
Conclusion 
Muscle quality and muscle strength are directly related to the levels of body composition 
changes and functional capacity during aging. Age-related decline in muscle quality may be 
amplified by excess adiposity, however, some studies suggest fat mass may provide a 
protective aspect. Thus, the relation of fat mass with muscle quality and functional decline 
during aging is still equivocal and needs more investigation. Additionally, high levels of 
adipose tissue and low muscle quality are associated with higher risk of disability and 


development of the metabolic syndrome and its components in older age. As summarized in 
Figure 5.1, high levels of muscle quality are strongly related to higher functional capacity, 
lower risk for the metabolic syndrome, and hence health-span in aging populations. 
 
Future Directions  
Future studies should focus on developing interventions that will help decrease fat mass levels 
and maintain muscle quality levels. In particular, a growing body of evidence suggest strength 
training should be an integral part of interventions for sarcopenic older adults and those who 
are at risk for the metabolic syndrome. Additionally, short bursts of high-intensity interval 
training interventions are suggested for subjects with poor fitness levels as a time-efficient 
alternative to endurance training. Individualization, effectiveness, and combinations of these 
training methods need to be further investigated in older adults with the metabolic syndrome 
and sarcopenic populations.   
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Abstract 
Background: Epidemiological and objective studies report an association between sedentary 
time and lower risk of the metabolic syndrome (MetS) and its risk factors in young and 
middle-age adults. To date, there is a lack of objective data on the association between 
sedentary time and MetS among older adults.  
Methods: The association between objectively measured sedentary time (accelerometry) with 
MetS and MetS components was examined in a large sample of older adults with mobility 
limitations (N = 1198; mean age = 78.7 ± 5.3 years) enrolled in the Lifestyle Interventions 
and Independence for Elders (LIFE) study. Participants were divided into tertiles according to 
percentage of daily sedentary time, and the relation between sedentary time with MetS and 
MetS components was examined after adjusting for age, sex, ethnicity and BMI. 
Results: Participants in the highest sedentary time tertile had significantly higher odds of 
MetS (OR=1.54) (95% CI 1.13 to 2.11) in comparison with participants in the lowest tertile 
(p=0.03). Participants in the highest sedentary time tertile had larger waist circumference 
(p=0.0001) and lower HDL-C (p=0.0003) than participants in the lowest sedentary time 
tertile.  
Conclusions: Sedentary time was strongly related to higher odds of MetS. These results, 
based on objectively measured sedentary time, suggest that sedentary time may represent an 
important risk factor for the development of MetS in older adults with high likelihood for 
disability. 
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Introduction 
The metabolic syndrome (MetS) is a combination of interrelated risk factors of metabolic 
origin that has become more prevalent in an aging population. Over half (53%) of adults aged 
60 years or older in the United States currently have MetS, whereas less than 20% of adults 
below the age of 40 have MetS [1]. This is of concern as MetS has been found to directly 
promote the development of cardiovascular disease (CVD) and type 2 diabetes mellitus 
(DM2) [2]. As older adults represent the fastest growing segment of the population [3], 
improvement of clinical management and preventive strategies directed at MetS [4] in this 
high risk population is crucial.  
With increasing age, a larger percentage of adults live a sedentary lifestyle, as defined by not 
meeting minimum level of activity recommended in current guidelines. For example, the 
prevalence of sedentary time is ~39% in adults between 30 and 44, ~46% in adults between 
45 and 59 years, and 60% in adults age 60 and older [6].  Moreover, only a small percentage 
of older adults 60 years and older, 20% and 12% of older men and women respectively [5], 
are meeting current physical activity guidelines [7, 8]. 
Traditionally, it has been thought that individuals are protected from cardio-metabolic disease 
conditions if they meet recommended levels of physical activity, regardless of their activity 
levels throughout the remainder of the day [9-11]. Recent studies have indicated, however, 
that meeting the nationally recommended levels of PA does not prevent cardio-metabolic 
disease if individuals engage in high levels of sedentary time throughout the day. For 
example, Matthews et al. found that meeting the recommended amounts of PA failed to 
mitigate cardio-metabolic health risks among American adults aged 50-71 years who reported 
television viewing for more than 7 hours per day. Specifically, these individuals were found 
to have a 50% greater risk of all-cause mortality and a two-fold greater risk of cardiovascular 
disease compared to those who spent <1hour/day on television viewing after adjusting for 
moderate to vigorous PA (MVPA) [4].  
To our knowledge, only one study has examined the association of sedentary time with MetS, 
using objective measures (i.e., accelerometry) in middle age adults. In this cross-sectional 
study, which included 521 healthy middle-age Japanese participants, activity levels were 
measured for 7 days, and the association between activity levels with MetS was evaluated 
[12]. The key finding of this study was that sedentary time was independently associated with 
the higher risk for MetS in middle-age adults (30 – 64 years), regardless of whether or not 
they engaged in recommended levels of physical activity [12].   
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The metabolic syndrome (MetS) is a combination of interrelated risk factors of metabolic 
origin that has become more prevalent in an aging population. Over half (53%) of adults aged 
60 years or older in the United States currently have MetS, whereas less than 20% of adults 
below the age of 40 have MetS [1]. This is of concern as MetS has been found to directly 
promote the development of cardiovascular disease (CVD) and type 2 diabetes mellitus 
(DM2) [2]. As older adults represent the fastest growing segment of the population [3], 
improvement of clinical management and preventive strategies directed at MetS [4] in this 
high risk population is crucial.  
With increasing age, a larger percentage of adults live a sedentary lifestyle, as defined by not 
meeting minimum level of activity recommended in current guidelines. For example, the 
prevalence of sedentary time is ~39% in adults between 30 and 44, ~46% in adults between 
45 and 59 years, and 60% in adults age 60 and older [6].  Moreover, only a small percentage 
of older adults 60 years and older, 20% and 12% of older men and women respectively [5], 
are meeting current physical activity guidelines [7, 8]. 
Traditionally, it has been thought that individuals are protected from cardio-metabolic disease 
conditions if they meet recommended levels of physical activity, regardless of their activity 
levels throughout the remainder of the day [9-11]. Recent studies have indicated, however, 
that meeting the nationally recommended levels of PA does not prevent cardio-metabolic 
disease if individuals engage in high levels of sedentary time throughout the day. For 
example, Matthews et al. found that meeting the recommended amounts of PA failed to 
mitigate cardio-metabolic health risks among American adults aged 50-71 years who reported 
television viewing for more than 7 hours per day. Specifically, these individuals were found 
to have a 50% greater risk of all-cause mortality and a two-fold greater risk of cardiovascular 
disease compared to those who spent <1hour/day on television viewing after adjusting for 
moderate to vigorous PA (MVPA) [4].  
To our knowledge, only one study has examined the association of sedentary time with MetS, 
using objective measures (i.e., accelerometry) in middle age adults. In this cross-sectional 
study, which included 521 healthy middle-age Japanese participants, activity levels were 
measured for 7 days, and the association between activity levels with MetS was evaluated 
[12]. The key finding of this study was that sedentary time was independently associated with 
the higher risk for MetS in middle-age adults (30 – 64 years), regardless of whether or not 
they engaged in recommended levels of physical activity [12].   
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The relative contribution that sedentary time, measured objectively, has in relation to the 
probability of MetS and associated MetS components in an older adult population is not 
currently known. Based on findings from epidemiological studies and recent clinical trials in 
middle-aged adults [4, 12], we hypothesized that more time spent being sedentary would be 
associated with a higher prevalence of MetS and MetS components in older adults with 
mobility limitations. 
 
Methods 
Participants 
All participants volunteered to participate in a long-term lifestyle intervention study 
(minimum 24 months up to 42 months), the Lifestyle Interventions and Independence for 
Elders (LIFE) study, which tested whether a long-term structured physical activity program is 
more effective than a health education program (also referred to as a Successful Aging 
program) in lowering the likelihood for major disability. A total of 1635 sedentary men and 
women aged 70 to 89 years were recruited across eight clinical sites [13].  Participants were 
eligible to participate if they had physical limitations, defined as a score on the Short Physical 
Performance Battery (SPPB) [14] of 9 or below, but were able to walk 400 meters.  Detailed 
descriptions of participant characteristics, as well as inclusion and exclusion criteria, have 
previously been provided [15].  A key exclusion factor for the LIFE study was self-reported 
activity, defined as spending less than 20 min/wk in the past month getting regular physical 
activity and reporting less than 125 min/wk of moderate PA (<125 min/wk).The analytical 
sample for the present study included LIFE participants with validated baseline accelerometry 
and laboratory data. 
 
Sedentary and Physical Activity monitoring 
The Actigraph tri-axial accelerometer (Model GT3X; Actigraph Inc., Pensacola, FL) was used 
to objectively measure sedentary and physical activity time. Participants were asked to wear 
an accelerometer for 7 days immediately following their baseline clinic visit. During the 7-
day monitoring period, participants were asked to put the monitor on each morning (after 
dressing) and remove the monitor just prior to going to bed at night. Sedentary time was 
recorded only during awake time, as participants did not wear accelerometers while sleeping. 
The monitor was removed for bathing, showering, or any other activity that might result in 
exposure to water. Activity was recorded using 1-second epochs, which were added up 60 s 
epochs [16]. Non-wear time was defined as a 60-minute window of zero counts in all three 


axes, allowing for up to two minutes of non-zero counts (cts)<100 in the vertical axis. A cut 
point of <100 cts/min was used to designate sedentary time, For sedentary time, the vast 
majority of studies have used a cut-point of <100 counts per min to designate sedentary time 
with additional checks during data cleaning to identify periods of no-wear time [17]. For the 
data to be included in this study, participants had to wear the accelerometer during at least 3 
consecutive daysfor 10 hours per day in free-living conditions. 
 
MetS classification 
MetS was defined in accordance with the harmonized criteria recommended in the 2009 Joint 
Interim Statement from multiple scientific associations [18], as the presence of 3 or more 
components, including (1) abdominal obesity (men: waist circumference ≥ 102cm or women: 
waist circumference ≥ 88cm); (2) hypertension (systolic blood pressure (SBP) ≥ 130mmHg 
and/or diastolic blood pressure (DBP) ≥ 85mmHg) or use of antihypertensive medication and 
a history of physician-diagnosed hypertension; (3) decreased HDL-C cholesterol level (men: 
HDL-C <40 mg/dL and women: <50 mg/dL) or use of HDL-C-raising medication; (4) 
elevated triglycerides levels (triglycerides ≥ 150 mg/dL) or use of triglyceride-lowering 
medication and (5) elevated plasma fasting blood glucose level (glucose ≥ 100 mg/dL) or use 
of glucose-controlling medication.  
 
Baseline blood analysis 
Blood samples for assessment of a lipid panel and fasting plasma glucose were collected in 
the early morning, after a 12-hour fast at the baseline assessment visit. Blood (57.5-69.5 ml) 
was collected via venipuncture into plain, serum-separation, EDTA-treated, heparin-treated, 
vacutainers by a trained phlebotomist. Baseline samples were sent to a central diagnostic 
testing laboratory for a lipid panel (triglycerides, total cholesterol, HDL-cholesterol, LDL-
cholesterol (calculated)) and fasting glucose levels. The baseline data were used to determine 
the metabolic syndrome and its components in the basis of the standardized criteria, stated 
above. 
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an accelerometer for 7 days immediately following their baseline clinic visit. During the 7-
day monitoring period, participants were asked to put the monitor on each morning (after 
dressing) and remove the monitor just prior to going to bed at night. Sedentary time was 
recorded only during awake time, as participants did not wear accelerometers while sleeping. 
The monitor was removed for bathing, showering, or any other activity that might result in 
exposure to water. Activity was recorded using 1-second epochs, which were added up 60 s 
epochs [16]. Non-wear time was defined as a 60-minute window of zero counts in all three 


axes, allowing for up to two minutes of non-zero counts (cts)<100 in the vertical axis. A cut 
point of <100 cts/min was used to designate sedentary time, For sedentary time, the vast 
majority of studies have used a cut-point of <100 counts per min to designate sedentary time 
with additional checks during data cleaning to identify periods of no-wear time [17]. For the 
data to be included in this study, participants had to wear the accelerometer during at least 3 
consecutive daysfor 10 hours per day in free-living conditions. 
 
MetS classification 
MetS was defined in accordance with the harmonized criteria recommended in the 2009 Joint 
Interim Statement from multiple scientific associations [18], as the presence of 3 or more 
components, including (1) abdominal obesity (men: waist circumference ≥ 102cm or women: 
waist circumference ≥ 88cm); (2) hypertension (systolic blood pressure (SBP) ≥ 130mmHg 
and/or diastolic blood pressure (DBP) ≥ 85mmHg) or use of antihypertensive medication and 
a history of physician-diagnosed hypertension; (3) decreased HDL-C cholesterol level (men: 
HDL-C <40 mg/dL and women: <50 mg/dL) or use of HDL-C-raising medication; (4) 
elevated triglycerides levels (triglycerides ≥ 150 mg/dL) or use of triglyceride-lowering 
medication and (5) elevated plasma fasting blood glucose level (glucose ≥ 100 mg/dL) or use 
of glucose-controlling medication.  
 
Baseline blood analysis 
Blood samples for assessment of a lipid panel and fasting plasma glucose were collected in 
the early morning, after a 12-hour fast at the baseline assessment visit. Blood (57.5-69.5 ml) 
was collected via venipuncture into plain, serum-separation, EDTA-treated, heparin-treated, 
vacutainers by a trained phlebotomist. Baseline samples were sent to a central diagnostic 
testing laboratory for a lipid panel (triglycerides, total cholesterol, HDL-cholesterol, LDL-
cholesterol (calculated)) and fasting glucose levels. The baseline data were used to determine 
the metabolic syndrome and its components in the basis of the standardized criteria, stated 
above. 
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Statistical analyses 
Demographic and clinical characteristics were summarized across sedentary time tertiles 
using means and standard deviations for continuous variables and frequencies and 
percentages for categorical variables. Means were compared across tertiles using one-way 
analysis of variance, and categorical proportions (including MetS and MetS components) 
across tertiles were compared using Wald chi-square tests from unadjusted logistic regression 
models. The odds of classification to MetS or MetS components by standardized sedentary 
time measures were estimated using logistic regression models adjusted for age, sex, and 
race/ethnicity. Next, models were repeated with additional adjustment for BMI. All analyses 
were performed using SAS v 9.3 (SAS Institute, Cary, NC). Statistical tests were performed 
assuming a Type I error rate of 0.05, and pairwise comparisons across tertiles were deemed 
significant at a Bonferroni-adjusted p=0.0167 level. 
 
Results 
Baseline characteristics of participants 
From the total of 1635 participants, 359 participants were excluded due to missing or 
insufficient accelerometry data and a further 78 participants lacked sufficient information for 
determining MetS status. The participants excluded from these analyses only differed from 
the study sample with respect to the Modified Mini-Mental State (3MS) scores (0-100 scale). 
Specifically, excluded participants had significantly lower 3MS scores (<80) than participants 
in our study sample (91.5±5.5) [19], which may have affected their ability to adhere to the 
accelerometry protocol. This led to a sample size of 1198 participants in the present study. 
The mean (± SD) age of included participants was 78.7 ± 5.3 years, 33.8% were men, and 
23.0% were racial/ethnic minorities (nonwhite). Average BMI of the participants was 30.2 ± 
6.0 kg/m2. Participants were divided into tertiles of sedentary time based on mean percent 
daily sedentary time measured over valid wear days as follows: ≤74.2% lowest tertile, 
>74.2% but ≤81.1% middle tertile, >81.1% highest tertile. Table 6.1 displays characteristics 
of participants based on sedentary time levels.  
 
Increased likelihood of MetS and MetS components according to tertiles of sedentary time 
Older age in male participants was associated with increased sedentary time (p<0.0001) 
(Table 1). Participants in the highest sedentary time tertile had a higher prevalence of MetS, 
approaching significance, (p=0.06) compared to participants in the middle and the lowest 
tertiles (Table 6.2).  


Table 6.2 shows the prevalence of MetS and MetS components (plasma glucose levels, 
abdominal obesity, HDL-C, TG levels and higher blood pressure) among participants with 
MetS according to tertiles of sedentary time. The fasting glucose component (fasting glucose 
≥ 100 mg/dL) of MetS was significantly higher among participants in the highest sedentary 
time tertile in comparison with participants the lowest sedentary time tertile (p=0.003) but did 
not differ from participants in the middle tertile. No significant differences were found across 
tertiles for the following MetS components: abdominal obesity, HDL-C, triglycerides, and 
blood pressure. 
Table 6.3 shows significantly higher overall odds of MetS (p=0.002) and higher likelihood for 
abnormal plasma glucose levels (p=0.007) among participants with higher amounts of 
sedentary time. Specifically, for each standard deviation increase in sedentary time, overall 
odds of MetS and plasma glucose were 22% and 19% higher, respectively.  This logistic 
regression model was adjusted for sex, age, ethnicity, and BMI according to tertiles of 
sedentary time.  
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Statistical analyses 
Demographic and clinical characteristics were summarized across sedentary time tertiles 
using means and standard deviations for continuous variables and frequencies and 
percentages for categorical variables. Means were compared across tertiles using one-way 
analysis of variance, and categorical proportions (including MetS and MetS components) 
across tertiles were compared using Wald chi-square tests from unadjusted logistic regression 
models. The odds of classification to MetS or MetS components by standardized sedentary 
time measures were estimated using logistic regression models adjusted for age, sex, and 
race/ethnicity. Next, models were repeated with additional adjustment for BMI. All analyses 
were performed using SAS v 9.3 (SAS Institute, Cary, NC). Statistical tests were performed 
assuming a Type I error rate of 0.05, and pairwise comparisons across tertiles were deemed 
significant at a Bonferroni-adjusted p=0.0167 level. 
 
Results 
Baseline characteristics of participants 
From the total of 1635 participants, 359 participants were excluded due to missing or 
insufficient accelerometry data and a further 78 participants lacked sufficient information for 
determining MetS status. The participants excluded from these analyses only differed from 
the study sample with respect to the Modified Mini-Mental State (3MS) scores (0-100 scale). 
Specifically, excluded participants had significantly lower 3MS scores (<80) than participants 
in our study sample (91.5±5.5) [19], which may have affected their ability to adhere to the 
accelerometry protocol. This led to a sample size of 1198 participants in the present study. 
The mean (± SD) age of included participants was 78.7 ± 5.3 years, 33.8% were men, and 
23.0% were racial/ethnic minorities (nonwhite). Average BMI of the participants was 30.2 ± 
6.0 kg/m2. Participants were divided into tertiles of sedentary time based on mean percent 
daily sedentary time measured over valid wear days as follows: ≤74.2% lowest tertile, 
>74.2% but ≤81.1% middle tertile, >81.1% highest tertile. Table 6.1 displays characteristics 
of participants based on sedentary time levels.  
 
Increased likelihood of MetS and MetS components according to tertiles of sedentary time 
Older age in male participants was associated with increased sedentary time (p<0.0001) 
(Table 1). Participants in the highest sedentary time tertile had a higher prevalence of MetS, 
approaching significance, (p=0.06) compared to participants in the middle and the lowest 
tertiles (Table 6.2).  


Table 6.2 shows the prevalence of MetS and MetS components (plasma glucose levels, 
abdominal obesity, HDL-C, TG levels and higher blood pressure) among participants with 
MetS according to tertiles of sedentary time. The fasting glucose component (fasting glucose 
≥ 100 mg/dL) of MetS was significantly higher among participants in the highest sedentary 
time tertile in comparison with participants the lowest sedentary time tertile (p=0.003) but did 
not differ from participants in the middle tertile. No significant differences were found across 
tertiles for the following MetS components: abdominal obesity, HDL-C, triglycerides, and 
blood pressure. 
Table 6.3 shows significantly higher overall odds of MetS (p=0.002) and higher likelihood for 
abnormal plasma glucose levels (p=0.007) among participants with higher amounts of 
sedentary time. Specifically, for each standard deviation increase in sedentary time, overall 
odds of MetS and plasma glucose were 22% and 19% higher, respectively.  This logistic 
regression model was adjusted for sex, age, ethnicity, and BMI according to tertiles of 
sedentary time.  
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Discussion 
The present investigation examined whether the amount of time spent in sedentary behavior 
in functionally limited older adults with mobility limitations was related to MetS and MetS 
components. The major finding of our investigation is that higher amounts of sedentary time 
were associated with higher odds of MetS. In addition, we found that higher levels of 
sedentary time were related to higher prevalence of specific components of MetS, including 
plasma glucose levels and low HDL-C levels. We also found extremely high levels of 
sedentary time in this population based on objective accelerometry measurement. 
Specifically, participants spent ~ 11 hours per day in sedentary activities. Moreover, levels of 
sedentary time increased with age, and we also observed higher prevalence of MetS with 
increasing age.  
In line with findings in teenagers and middle-age adults, [12, 20] we found that sedentary 
time was positively associated with occurrence of MetS among older adults with mobility 
limitations participating in the LIFE study. Specifically, the present study found that 
participants with the highest odds of MetS spent approximately three more hours per day 
engaged in sedentary time than participants with the lowest odds (12 hours versus 9 hours of 
awake time). Our findings suggest that higher amounts of sedentary time may increase the 
probability of MetS, even among sedentary older adults. Thus, our findings add to the 
literature by demonstrating a strong positive association between sedentary time and 
likelihood of MetS in an older adult population with mobility limitations. 
Our study extends the previous literature [12, 21] by showing that there is also a strong 
positive association between sedentary time and plasma glucose levels in older adults with 
MetS, suggesting that high levels of sedentary time may independently impair regulation of 
glycemia across all adult populations. Compared to participants with lower levels of sedentary 
time, participants with higher levels of sedentary time were also observed to have lower levels 
of HDL-C and increased waist circumference (Table 6.1) which have both been found to 
increase cardiometabolic dysfunction probability in older adults [22-24]. Our results are in 
accordance with an epidemiological study conducted by Kim et al, which measured activity 
levels objectively and reported that prevalence of dyslipidemia in a Japanese population was 
higher in a more sedentary group compared to a less sedentary group (>5.4hours/day versus 
<3.5 hours/day of sedentary time)[12].   
We report a higher percentage of sedentary time [~85% (12 hours/day) vs. 68% (9 hours/day) 
of awake time] in this sample of older adults with mobility limitations than what has been 
reported in middle-age adults [~63% (~9 hours/day) of awake time][25]. The participants in 
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Discussion 
The present investigation examined whether the amount of time spent in sedentary behavior 
in functionally limited older adults with mobility limitations was related to MetS and MetS 
components. The major finding of our investigation is that higher amounts of sedentary time 
were associated with higher odds of MetS. In addition, we found that higher levels of 
sedentary time were related to higher prevalence of specific components of MetS, including 
plasma glucose levels and low HDL-C levels. We also found extremely high levels of 
sedentary time in this population based on objective accelerometry measurement. 
Specifically, participants spent ~ 11 hours per day in sedentary activities. Moreover, levels of 
sedentary time increased with age, and we also observed higher prevalence of MetS with 
increasing age.  
In line with findings in teenagers and middle-age adults, [12, 20] we found that sedentary 
time was positively associated with occurrence of MetS among older adults with mobility 
limitations participating in the LIFE study. Specifically, the present study found that 
participants with the highest odds of MetS spent approximately three more hours per day 
engaged in sedentary time than participants with the lowest odds (12 hours versus 9 hours of 
awake time). Our findings suggest that higher amounts of sedentary time may increase the 
probability of MetS, even among sedentary older adults. Thus, our findings add to the 
literature by demonstrating a strong positive association between sedentary time and 
likelihood of MetS in an older adult population with mobility limitations. 
Our study extends the previous literature [12, 21] by showing that there is also a strong 
positive association between sedentary time and plasma glucose levels in older adults with 
MetS, suggesting that high levels of sedentary time may independently impair regulation of 
glycemia across all adult populations. Compared to participants with lower levels of sedentary 
time, participants with higher levels of sedentary time were also observed to have lower levels 
of HDL-C and increased waist circumference (Table 6.1) which have both been found to 
increase cardiometabolic dysfunction probability in older adults [22-24]. Our results are in 
accordance with an epidemiological study conducted by Kim et al, which measured activity 
levels objectively and reported that prevalence of dyslipidemia in a Japanese population was 
higher in a more sedentary group compared to a less sedentary group (>5.4hours/day versus 
<3.5 hours/day of sedentary time)[12].   
We report a higher percentage of sedentary time [~85% (12 hours/day) vs. 68% (9 hours/day) 
of awake time] in this sample of older adults with mobility limitations than what has been 
reported in middle-age adults [~63% (~9 hours/day) of awake time][25]. The participants in 
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the current study were specifically recruited because they were not achieving current national 
recommendations for physical activity. 
An important strength of this study is the use of objective measurements to obtain estimates 
of sedentary time in a large study sample of older adults. Other objective studies investigating 
the impact of sedentary time on the association with MetS were based on self-report [4, 26] or 
used smaller study samples in younger and middle-aged adults [12, 25]. Our sample also 
consisted of older adults with a high prevalence of MetS components, allowing for a more 
comprehensive evaluation of the connection between sedentary time and likelihood of MetS 
[15]. 
The present findings are limited by the cross-sectional nature of our analyses. Another 
limitation is that sedentary time was measured during relatively brief time periods (i.e., 3 – 7 
days). This might have led to an under- or overestimation of actual sedentary time of the 
participants and associations between sedentary time and physical activity in their daily life. 
However, given that MetS, sedentary behavior, and functional limitations are quite prevalent 
in the general population, our results are likely generalizable to most older adults. Finally, a 
sizable percentage (~22%) of participants were excluded due to lack of accelerometry data, 
and ~5% lacked sufficient information for determining MetS status. 
 
Conclusion 
In conclusion, the results from the present investigation indicate that older adults with 
mobility limitations spend a large proportion of their time engaged in sedentary behavior, and 
that time spent being sedentary was strongly related to higher likelihood of MetS. Our 
findings suggest that sedentary time represents an important risk factor for the development of 
MetS in older adults with mobility limitations, and thus deserves further investigation. 
Prospective studies are needed, however, to further investigate the effects that sedentary time 
has on likelihood of MetS in this population, as well as whether reducing sedentary time in 
older adults may lower probability of MetS. 
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recommendations for physical activity. 
An important strength of this study is the use of objective measurements to obtain estimates 
of sedentary time in a large study sample of older adults. Other objective studies investigating 
the impact of sedentary time on the association with MetS were based on self-report [4, 26] or 
used smaller study samples in younger and middle-aged adults [12, 25]. Our sample also 
consisted of older adults with a high prevalence of MetS components, allowing for a more 
comprehensive evaluation of the connection between sedentary time and likelihood of MetS 
[15]. 
The present findings are limited by the cross-sectional nature of our analyses. Another 
limitation is that sedentary time was measured during relatively brief time periods (i.e., 3 – 7 
days). This might have led to an under- or overestimation of actual sedentary time of the 
participants and associations between sedentary time and physical activity in their daily life. 
However, given that MetS, sedentary behavior, and functional limitations are quite prevalent 
in the general population, our results are likely generalizable to most older adults. Finally, a 
sizable percentage (~22%) of participants were excluded due to lack of accelerometry data, 
and ~5% lacked sufficient information for determining MetS status. 
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In conclusion, the results from the present investigation indicate that older adults with 
mobility limitations spend a large proportion of their time engaged in sedentary behavior, and 
that time spent being sedentary was strongly related to higher likelihood of MetS. Our 
findings suggest that sedentary time represents an important risk factor for the development of 
MetS in older adults with mobility limitations, and thus deserves further investigation. 
Prospective studies are needed, however, to further investigate the effects that sedentary time 
has on likelihood of MetS in this population, as well as whether reducing sedentary time in 
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
General discussion and main findings  
 
In this dissertation, we investigated alternative strategies to improve the beneficial 
physiological effects of exercise, extend health and life span and reduce the risk for pathology 
and disability while aging. Based on a review of the literature (chapter 5) and a large cross-
sectional study in sedentary elderly people (chapter 6) we showed that the levels of sedentary 
behaviour in aging populations seem to accelerate mobility disability and are likely to 
contribute to a reduced health and life span. Individually tailored exercise interventions and 
potentially also dietary co-interventions may counteract or attenuate some of the negative side 
effects of an inactive and sedentary lifestyle. According to the free radical theory of aging, 
progressive accumulation of oxidative stress also plays a role in aging-associated sarcopenia. 
From this perspective it would make sense to use anti-oxidants. However, our extensive 
literature review, described in chapter 1, indicates that some antioxidant nutritional 
interventions can be counterproductive, whilst others may have a positive effect on exercise 
performance. In accordance, alternative and more tailor-made strategies to counteract the 
diminished exercise tolerance and improve the beneficial effects of exercise are warranted. 
Our literature research shows that such interventions should preferably be tested before being 
prescribed or advised to an individual with established disease or increased risk for chronic 
disease and disability.  
In part 2 of the present thesis, we investigated a novel strategy to test whether an individual 
subject or patient may be responsive to increased oxygen availability during exercise. 
Although our novel strategy could only be tested in a population of healthy subjects and 
patients with type 2 diabetes, the different studies indicate that manipulating inspiratory 
oxygen fraction (FiO2) might serve as a validation (chapter 2), a diagnostic (chapter 3) and 
potentially also a therapeutic (chapter 4) tool. Measurements of oxygen uptake recovery and 
muscle tissue reoxygenation kinetics under different FiO2 conditions can be easily and cost-
effectively applied in a clinical setting to assess oxygen delivery dysfunction and determine 
whether there might be need for supplemental oxygen to improve exercise tolerance in aging 
populations. Additionally, we also found that assessment of heart rate variability (HRV) 
during exercise can probably replace costly spiro-ergometry equipment for training design 
and monitoring to individualize and improve exercise interventions in clinical settings. As our 
HRV-based decision algorithms have only been tested in a healthy young population, more 
work is needed to validate its application in elderly and chronic disease populations who 
might be suffering from cardiac autonomic dysfunction. 
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General discussion and main findings  
 
In this dissertation, we investigated alternative strategies to improve the beneficial 
physiological effects of exercise, extend health and life span and reduce the risk for pathology 
and disability while aging. Based on a review of the literature (chapter 5) and a large cross-
sectional study in sedentary elderly people (chapter 6) we showed that the levels of sedentary 
behaviour in aging populations seem to accelerate mobility disability and are likely to 
contribute to a reduced health and life span. Individually tailored exercise interventions and 
potentially also dietary co-interventions may counteract or attenuate some of the negative side 
effects of an inactive and sedentary lifestyle. According to the free radical theory of aging, 
progressive accumulation of oxidative stress also plays a role in aging-associated sarcopenia. 
From this perspective it would make sense to use anti-oxidants. However, our extensive 
literature review, described in chapter 1, indicates that some antioxidant nutritional 
interventions can be counterproductive, whilst others may have a positive effect on exercise 
performance. In accordance, alternative and more tailor-made strategies to counteract the 
diminished exercise tolerance and improve the beneficial effects of exercise are warranted. 
Our literature research shows that such interventions should preferably be tested before being 
prescribed or advised to an individual with established disease or increased risk for chronic 
disease and disability.  
In part 2 of the present thesis, we investigated a novel strategy to test whether an individual 
subject or patient may be responsive to increased oxygen availability during exercise. 
Although our novel strategy could only be tested in a population of healthy subjects and 
patients with type 2 diabetes, the different studies indicate that manipulating inspiratory 
oxygen fraction (FiO2) might serve as a validation (chapter 2), a diagnostic (chapter 3) and 
potentially also a therapeutic (chapter 4) tool. Measurements of oxygen uptake recovery and 
muscle tissue reoxygenation kinetics under different FiO2 conditions can be easily and cost-
effectively applied in a clinical setting to assess oxygen delivery dysfunction and determine 
whether there might be need for supplemental oxygen to improve exercise tolerance in aging 
populations. Additionally, we also found that assessment of heart rate variability (HRV) 
during exercise can probably replace costly spiro-ergometry equipment for training design 
and monitoring to individualize and improve exercise interventions in clinical settings. As our 
HRV-based decision algorithms have only been tested in a healthy young population, more 
work is needed to validate its application in elderly and chronic disease populations who 
might be suffering from cardiac autonomic dysfunction. 
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Approaching low levels of physical activity, increased risk for chronic diseases and 
disability with exercise and nutritional interventions 
Despite globally increasing levels of consciousness regarding the importance of physical 
activity and healthy nutritional habits, the metabolic syndrome pandemic keeps on expanding 
through all ages. The metabolic syndrome and its components lead to development of chronic 
diseases and increase the risk for disability in older age. Therefore, it is a great challenge for 
exercise physiologists and nutritionists to improve the effectiveness of exercise interventions 
regarding training modalities, effective strategies for faster post-exercise recovery and 
preventing some of the deleterious effects of oxidative stress. 
Overall, exercise is beneficial to maintain the physiological homeostasis [1]. Some reports 
confirm the effectiveness of either endurance[2, 3], strength (muscle quality and strength) [3]. 
However, combined exercise training interventions to effectively decrease the risk for the 
metabolic syndrome appear most effectively [4]. Additionally, application of the most 
suitable exercise training types can target the reduction of the metabolic risk factors, such as 
insulin resistance, chronic inflammation, and attenuate associated pathologies such as muscle 
loss (sarcopenia) (chapter 5). The combined endurance and strength training interventions 
occur as the most effective in improving metabolic health and functional capacity during 
aging (chapter 5). Current reports showed that muscle quality and muscle strength are 
directly related to the levels of body composition changes (adipose tissue levels) and 
functional capacity during aging [5]. Age-related decline in muscle quality may be amplified 
by excess adipose tissue and associated chronic inflammation [6, 7]. However, some studies 
suggest that fat mass may also have a health-protective function [8]. Additionally, high levels 
of adipose tissue and low muscle quality are associated with higher risk of disability and 
development of the metabolic syndrome and its components in older age. Therefore, future 
studies should focus on developing interventions that will help decrease fat mass levels and 
maintain muscle quality levels. In particular, a growing body of evidence suggests strength 
training should be an integral part of interventions for sarcopenic older adults and those who 
are at risk for the metabolic syndrome. Individualization, effectiveness, and combinations of 
training methods and modalities need to be further investigated in older adults with the 
metabolic syndrome and sarcopenic populations (chapter 5). 
 
Both the aging process and an exercise stimulus itself increase the formation rate of reactive 
oxygen species (ROS). Over-production (oxidative stress) of ROS can be deleterious for 
structure and function of cells and tissues, especially in frail elderly people (chapter 1). On 


the other hand, ‘appropriate’ formation level of ROS productions induces adaptive 
mechanisms to obtain beneficial effects of exercise (improved insulin sensitivity increased 
endogenous, muscle hypertrophy, antioxidative enzymes activity and mitochondrial 
biogenesis) [9-12]. A number of recent reports debated on potential blunting effects of dietary 
supplements in conjunction with exercise training [11, 13, 14]. However, available data on the 
blunting effects of dietary antioxidants in conjunction with endurance training are equivocal. 
Additionally, chapter 1 draws attention of high consumption levels of most popular 
antioxidants (vitamins C and E). Based on the U.S. population the doses are not well 
regulated. For example, a maximal dose of vitamin C per day equals 3000mg, whereas recent 
studies using 500mg of vitamin C suggest potential harming prooxidant effects on e.g. risk for 
cataract [15, 16] and blunting exercise effects e.g. decreased mitochondrial biogenesis [11]. 
The literature review presented in chapter 1 showed that there is no strong evidence on 
adverse or beneficial effects of antioxidant supplements (Vitamins C and E, α -lipoic acid and 
resveratrol) in conjunction with endurance exercise training. As such, we concluded that there 
is currently lack of clarity and a need for future studies on the optimal doses and 
combinations of commonly used antioxidant supplements (vitamins C and E, α-lipoic acid). 
Additionally, future studies warrant selecting training modalities for the most beneficial 
physiological effects of dietary antioxidants in conjunction with endurance training in aging 
population (chapter 1). Controversy, presented in separate reports on healthy subjects, 
around resveratrol and its potential beneficial function in deficient populations (e.g. to treat 
sarcopenia and hypertension) warrant future dose-response studies with different training 
modalities e.g. strength and interval or endurance type of training.   
It is well known that recommended levels of physical activity are crucial to lower the risk for 
the metabolic syndrome, its components and disability progression during the aging process 
[1]. We showed, using objective methods, that high levels of sedentary time in the awake time 
are associated with higher risk for the metabolic syndrome and its components. In the study of 
Matthews et al. it has been shown that despite reported regular physical activity, high levels 
of sedentary time did not compensate for the higher amount of sedentary time [17]. 
Additionally, even short bouts of moderate intensity type of exercise appear insufficient to 
lower the risk for cardiovascular disease when sedentary time levels are high [17]. Chapter 6 
extends on this study by showing that in elderly with mobility limitations even small 
reductions of sedentary time lower the likelihood of the metabolic syndrome. 
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Approaching low levels of physical activity, increased risk for chronic diseases and 
disability with exercise and nutritional interventions 
Despite globally increasing levels of consciousness regarding the importance of physical 
activity and healthy nutritional habits, the metabolic syndrome pandemic keeps on expanding 
through all ages. The metabolic syndrome and its components lead to development of chronic 
diseases and increase the risk for disability in older age. Therefore, it is a great challenge for 
exercise physiologists and nutritionists to improve the effectiveness of exercise interventions 
regarding training modalities, effective strategies for faster post-exercise recovery and 
preventing some of the deleterious effects of oxidative stress. 
Overall, exercise is beneficial to maintain the physiological homeostasis [1]. Some reports 
confirm the effectiveness of either endurance[2, 3], strength (muscle quality and strength) [3]. 
However, combined exercise training interventions to effectively decrease the risk for the 
metabolic syndrome appear most effectively [4]. Additionally, application of the most 
suitable exercise training types can target the reduction of the metabolic risk factors, such as 
insulin resistance, chronic inflammation, and attenuate associated pathologies such as muscle 
loss (sarcopenia) (chapter 5). The combined endurance and strength training interventions 
occur as the most effective in improving metabolic health and functional capacity during 
aging (chapter 5). Current reports showed that muscle quality and muscle strength are 
directly related to the levels of body composition changes (adipose tissue levels) and 
functional capacity during aging [5]. Age-related decline in muscle quality may be amplified 
by excess adipose tissue and associated chronic inflammation [6, 7]. However, some studies 
suggest that fat mass may also have a health-protective function [8]. Additionally, high levels 
of adipose tissue and low muscle quality are associated with higher risk of disability and 
development of the metabolic syndrome and its components in older age. Therefore, future 
studies should focus on developing interventions that will help decrease fat mass levels and 
maintain muscle quality levels. In particular, a growing body of evidence suggests strength 
training should be an integral part of interventions for sarcopenic older adults and those who 
are at risk for the metabolic syndrome. Individualization, effectiveness, and combinations of 
training methods and modalities need to be further investigated in older adults with the 
metabolic syndrome and sarcopenic populations (chapter 5). 
 
Both the aging process and an exercise stimulus itself increase the formation rate of reactive 
oxygen species (ROS). Over-production (oxidative stress) of ROS can be deleterious for 
structure and function of cells and tissues, especially in frail elderly people (chapter 1). On 


the other hand, ‘appropriate’ formation level of ROS productions induces adaptive 
mechanisms to obtain beneficial effects of exercise (improved insulin sensitivity increased 
endogenous, muscle hypertrophy, antioxidative enzymes activity and mitochondrial 
biogenesis) [9-12]. A number of recent reports debated on potential blunting effects of dietary 
supplements in conjunction with exercise training [11, 13, 14]. However, available data on the 
blunting effects of dietary antioxidants in conjunction with endurance training are equivocal. 
Additionally, chapter 1 draws attention of high consumption levels of most popular 
antioxidants (vitamins C and E). Based on the U.S. population the doses are not well 
regulated. For example, a maximal dose of vitamin C per day equals 3000mg, whereas recent 
studies using 500mg of vitamin C suggest potential harming prooxidant effects on e.g. risk for 
cataract [15, 16] and blunting exercise effects e.g. decreased mitochondrial biogenesis [11]. 
The literature review presented in chapter 1 showed that there is no strong evidence on 
adverse or beneficial effects of antioxidant supplements (Vitamins C and E, α -lipoic acid and 
resveratrol) in conjunction with endurance exercise training. As such, we concluded that there 
is currently lack of clarity and a need for future studies on the optimal doses and 
combinations of commonly used antioxidant supplements (vitamins C and E, α-lipoic acid). 
Additionally, future studies warrant selecting training modalities for the most beneficial 
physiological effects of dietary antioxidants in conjunction with endurance training in aging 
population (chapter 1). Controversy, presented in separate reports on healthy subjects, 
around resveratrol and its potential beneficial function in deficient populations (e.g. to treat 
sarcopenia and hypertension) warrant future dose-response studies with different training 
modalities e.g. strength and interval or endurance type of training.   
It is well known that recommended levels of physical activity are crucial to lower the risk for 
the metabolic syndrome, its components and disability progression during the aging process 
[1]. We showed, using objective methods, that high levels of sedentary time in the awake time 
are associated with higher risk for the metabolic syndrome and its components. In the study of 
Matthews et al. it has been shown that despite reported regular physical activity, high levels 
of sedentary time did not compensate for the higher amount of sedentary time [17]. 
Additionally, even short bouts of moderate intensity type of exercise appear insufficient to 
lower the risk for cardiovascular disease when sedentary time levels are high [17]. Chapter 6 
extends on this study by showing that in elderly with mobility limitations even small 
reductions of sedentary time lower the likelihood of the metabolic syndrome. 
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In accordance with these scientific data, we recommend to aim for reduced levels of sedentary 
time and increased levels of light physical activity (e.g. walking, house-keeping, gardening) 
as the latter may also improve health span and decrease levels of disability in older age.  
 
Cost-effective training individualization and monitoring 
The population of older adults is still increasing, which also means that the number of eligible 
people who may benefit from well-structured exercise interventions is rising as well. Cost-
effective and non-invasive exercise testing methods and monitoring to optimize and tailor 
exercise training interventions for large groups is therefore challenging. In chapter 2 we 
showed that the heart rate variability measurements appear to be a good alternative for time-
consuming, costly or invasive spiro-ergometry and lactate measurements, which was recently 
also shown by other authors [18, 19]. Determining anaerobic thresholds is crucial for 
designing and monitoring endurance training process in order to obtain the best health 
promoting benefits (improved exercise performance, blood glucose level regulation, fat 
burning, oxidative enzymes activity). The current study showed acceptably precise agreement 
between the HRV and spiro-ergometry methods (chapter 2). Although further studies are 
needed to validate the long-term application in different types of exercise training program for 
different types of populations, that the present study indicates that the exercise based HRV 
assessment method of the second AT may have clinical relevance for larger scale applications 
to optimize the benefits of well-structured exercise programs.  
 
Different FiO2 conditions as a potential diagnostic and treatment strategy for improved 
exercise effects in deficient populations 
Exercise scientists and physiologists have been looking for non-invasive and easier methods 
to improve effects of exercise training alone in healthy and patient populations. Number of 
reports showed effectiveness of exercise training interventions under low (altitude training) 
[20, 21] and high FiO2 (hyperoxia) [22, 23] conditions. Hypoxic conditions (even at 580 m 
[24] challenge the physiological system during a single or multiple bouts of exercise 
(hyperemic response, decrement in VO2) and this has been the rationale behind hypoxic 
training as a method to subsequently improve exercise tolerance (onset and offset oxygen 
uptake kinetics at sea level [19]. In chapter 3 we used the challenging effects of hypoxic 
exercise to test the sensitivity of oxygen uptake and muscle oxygenation methods during the 
recovery kinetics following a submaximal exercise bout. For example, NIRS measurements 
can be influenced by interpersonal response levels [20] to different FiO2 and adipose tissue 


thickness [25]. Significantly slower recovery kinetics showed sufficient sensitivity of  
and NIRS measuring methods to detect potential improvements in the recovery kinetics under 
hyperoxic conditions. Additionally, other authors showed significant reliability of the NIRS 
measurements up to an adipose tissue thickness of 16mm [25]. Our subjects in chapter 3 had 
an average adipose tissue thickness of 6.1mm, which could cause marginal or no influence on 
the muscle oxygenation measurements.  
In chapter 3 we demonstrated that hyperoxic conditions (FiO2= 35%) did not accelerate the 
recovery oxygen uptake kinetics in healthy subjects without known oxygen delivery 
limitations. The concept of using both hypoxic and hyperoxic conditions during acute 
submaximal exercise may therefore be applied as a cost-effective and noninvasive method in 
a clinical setting for older adults and patients with CHF, COPD and DM2 (chapter 3). In 
particular, acute hypoxic exercise bout can determine individual sensitivity to the 
measurement methods. Additionally, acute hyperoxic exercise can establish what level of 
FiO2 can improve oxygen delivery deficit (if any) and be further applied in training 
conditions. In accordance with our findings, future studies should be focused on investigating 
low and high FiO2 as a diagnostic strategy for oxygen delivery limitations during acute 
exercise bout. Subsequently, established effective high FiO2 levels should be investigated in 
exercise training in subjects with detected oxygen delivery limitations. 
Although our experiments described in chapter 4 were a feasibility study, they indicate the 
practical usefulness of such an approach by applying 3 levels of flows of hyperoxic air in a 
group of advanced-stage and deconditioned type 2 diabetes patients with a high 
cardiovascular risk profile. Using a set up that can be easily applied in a clinical training 
center, we found that a flow of 15 L.min-1 increased the arterial oxygen pressure to sufficient 
high levels in this deconditioned population. Nevertheless, considering the interpersonal 
variability in dose-response to hyperoxic exercise [20, 26], we suggest to perform a dose-
response test for an individual hyperoxic air concentration before designing and prescribing 
exercise training under hyperoxic conditions. Although future studies are warranted, NIRS or 
 uptake recovery kinetics could have added value as well to find an optimal flow and 
concentration of oxygen. 
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In accordance with these scientific data, we recommend to aim for reduced levels of sedentary 
time and increased levels of light physical activity (e.g. walking, house-keeping, gardening) 
as the latter may also improve health span and decrease levels of disability in older age.  
 
Cost-effective training individualization and monitoring 
The population of older adults is still increasing, which also means that the number of eligible 
people who may benefit from well-structured exercise interventions is rising as well. Cost-
effective and non-invasive exercise testing methods and monitoring to optimize and tailor 
exercise training interventions for large groups is therefore challenging. In chapter 2 we 
showed that the heart rate variability measurements appear to be a good alternative for time-
consuming, costly or invasive spiro-ergometry and lactate measurements, which was recently 
also shown by other authors [18, 19]. Determining anaerobic thresholds is crucial for 
designing and monitoring endurance training process in order to obtain the best health 
promoting benefits (improved exercise performance, blood glucose level regulation, fat 
burning, oxidative enzymes activity). The current study showed acceptably precise agreement 
between the HRV and spiro-ergometry methods (chapter 2). Although further studies are 
needed to validate the long-term application in different types of exercise training program for 
different types of populations, that the present study indicates that the exercise based HRV 
assessment method of the second AT may have clinical relevance for larger scale applications 
to optimize the benefits of well-structured exercise programs.  
 
Different FiO2 conditions as a potential diagnostic and treatment strategy for improved 
exercise effects in deficient populations 
Exercise scientists and physiologists have been looking for non-invasive and easier methods 
to improve effects of exercise training alone in healthy and patient populations. Number of 
reports showed effectiveness of exercise training interventions under low (altitude training) 
[20, 21] and high FiO2 (hyperoxia) [22, 23] conditions. Hypoxic conditions (even at 580 m 
[24] challenge the physiological system during a single or multiple bouts of exercise 
(hyperemic response, decrement in VO2) and this has been the rationale behind hypoxic 
training as a method to subsequently improve exercise tolerance (onset and offset oxygen 
uptake kinetics at sea level [19]. In chapter 3 we used the challenging effects of hypoxic 
exercise to test the sensitivity of oxygen uptake and muscle oxygenation methods during the 
recovery kinetics following a submaximal exercise bout. For example, NIRS measurements 
can be influenced by interpersonal response levels [20] to different FiO2 and adipose tissue 
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thickness [25]. Significantly slower recovery kinetics showed sufficient sensitivity of  
and NIRS measuring methods to detect potential improvements in the recovery kinetics under 
hyperoxic conditions. Additionally, other authors showed significant reliability of the NIRS 
measurements up to an adipose tissue thickness of 16mm [25]. Our subjects in chapter 3 had 
an average adipose tissue thickness of 6.1mm, which could cause marginal or no influence on 
the muscle oxygenation measurements.  
In chapter 3 we demonstrated that hyperoxic conditions (FiO2= 35%) did not accelerate the 
recovery oxygen uptake kinetics in healthy subjects without known oxygen delivery 
limitations. The concept of using both hypoxic and hyperoxic conditions during acute 
submaximal exercise may therefore be applied as a cost-effective and noninvasive method in 
a clinical setting for older adults and patients with CHF, COPD and DM2 (chapter 3). In 
particular, acute hypoxic exercise bout can determine individual sensitivity to the 
measurement methods. Additionally, acute hyperoxic exercise can establish what level of 
FiO2 can improve oxygen delivery deficit (if any) and be further applied in training 
conditions. In accordance with our findings, future studies should be focused on investigating 
low and high FiO2 as a diagnostic strategy for oxygen delivery limitations during acute 
exercise bout. Subsequently, established effective high FiO2 levels should be investigated in 
exercise training in subjects with detected oxygen delivery limitations. 
Although our experiments described in chapter 4 were a feasibility study, they indicate the 
practical usefulness of such an approach by applying 3 levels of flows of hyperoxic air in a 
group of advanced-stage and deconditioned type 2 diabetes patients with a high 
cardiovascular risk profile. Using a set up that can be easily applied in a clinical training 
center, we found that a flow of 15 L.min-1 increased the arterial oxygen pressure to sufficient 
high levels in this deconditioned population. Nevertheless, considering the interpersonal 
variability in dose-response to hyperoxic exercise [20, 26], we suggest to perform a dose-
response test for an individual hyperoxic air concentration before designing and prescribing 
exercise training under hyperoxic conditions. Although future studies are warranted, NIRS or 
 uptake recovery kinetics could have added value as well to find an optimal flow and 
concentration of oxygen. 
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General conclusions 
 
1. There is currently no strong evidence on adverse effects of antioxidant supplements in 
conjunction with endurance training on exercise adaptation in healthy subjects. 
However, potential health benefits of dietary antioxidants in subjects with vitamin and 
cardiovascular deficiencies warrant investigating suitable types, combinations of 
antioxidants and different training modalities (chapter 1).  
2. Non-invasive and cost-effective HRVT2 assessments showed clinically acceptable 
reliability in comparison with the ‘gold standard’ VT2 method. The HRVT method 
may be easier applied in numerous rehabilitation patient groups for individualized 
training design and monitoring (chapter 2). 
3. Hyperoxic conditions did not improve the oxygen uptake kinetics in healthy young 
adults (chapter 3). However, supplemental oxygen may improve exercise tolerance in 
subjects with oxygen delivery limitations e.g. type 2 diabetes, chronic heart failure as 
higher flow of oxygen in inspired air elevates arterial oxygen levels (chapter 4). 
4. Increased levels of sedentary time and inactivity are associated with higher likelihood 
for the metabolic syndrome and its components in older adults (chapter 6). Training 
interventions focused on reducing adipose tissue levels and improving muscle quality 
will prevent progression of the metabolic syndrome, sarcopenic changes and disability 
at earlier age (chapter 5). 
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Summary 
 
It is certain that the aging process leads to death, but decreasing the levels of pathology 
throughout life improves the quality of life and extends life span. Therefore, this dissertation 
focuses on alternative strategies that may contribute to improving the aging process and 
associated common pathologies. In particular, this work presents exercise as the foundation of 
healthy aging and discusses potential strategies to improve existing suboptimal interventions 
to improve the aging process. 
 
The introductory chapter defines the aging process and its main pathologies. The dissertation 
presents how non-invasive and more cost-effective interventions may ameliorate the aging 
process. 
Chapter 1 addresses the current controversy around the effects of dietary antioxidants in 
conjunction with endurance training. Based on some pre-clinical and clinical work, reduced 
formation of reactive oxygen species may blunt health benefits of endurance type of exercise 
training. However, the evidence is still not robust and number of reports do not show adverse 
effects of popular dietary antioxidants combined with endurance training. Additionally, it is 
possible that some dietary supplements (e.g. resveratrol) may improve effects of endurance 
training in subjects with e.g. vitamin deficiencies and cardiovascular dysfunction. Therefore, 
the lack of clarity warrants future studies on doses, types and combinations of dietary 
antioxidants and different exercise training modalities. Next to nutritional strategies, there is 
need for alternative interventions that will improve effects of exercise non-invasively and 
cost-effectively. 
Chapter 2 presents a validation study comparing 2 methods for the 2nd anaerobic threshold 
(AT2) during an incremental exercise test. AT2 assessment based on heart rate variability 
(HRVT) is a non-invasive and more cost-effective method than assessment based on the 
spiro-ergometry output or a lactate curve. Our results show that HRVT is sufficiently valid 
and accurate, but its application in rehabilitation patient groups still warrants separate 
validation studies. Nevertheless, our results indicate that it has potential application for 
individualized training design and monitoring. 
Chapter 3 and 4 describe a novel strategy to improve exercise tolerance by oxygen 
supplementation during exercise. Using a set up that can be easily applied in a clinical 
training center, chapter 4 shows that a 100% oxygen flow of 15 L.min-1 applied through a 
mask increased the arterial oxygen pressure to sufficient high levels in deconditioned type 2 


diabetes patients. This feasibility study shows that higher oxygen availability may improve 
oxygen delivery to exercising muscles and improve exercise tolerance, if needed. The novel 
experimental method described in chapter 3 showed that recovery and muscle 
oxygenation kinetics following a submaximal bout of exercise under both hypoxic, normoxic 
and hyperoxic conditions may be useful to test whether supplemental oxygen is beneficial or 
not. Our results indicate that for submaximal exercise bouts healthy subjects will not benefit 
from supplementary oxygen. Nevertheless, performing acute exercise bouts under hyperoxic 
conditions may help detecting oxygen delivery limitations. Additionally, acute exercise tests 
under hyperoxic conditons will help establishing doses supplemental oxygen for better 
exercise training effects in deficient subjects e.g. older adults, CHF and COPD patients. 
Chapter 5 and 6 address the topics of increased sedentary time, physical activity level 
decline and its consequences (sarcopenia) in older adults. Chapter 6 shows higher likelihood 
for the metabolic syndrome and its components in most sedentary and inactive older adults. In 
aging populations at risk or with the metabolic syndrome (chapter 5) inactivity and sedentary 
behavior lead to its progression together with the muscle quality loss. In particular, low levels 
of muscle quality and high levels of adipose tissue are associated with a functional capacity 
decline and progression of the metabolic syndrome. Taken together, the lack of light, 
moderate-to-vigorous physical activity and resistance training increase the risk of chronic 
diseases (type 2 diabetes and cardiovascular disease) and disability at relatively younger age. 
Finally, in the general discussion we discuss our new insights and findings and make 
recommendations for future research and alternative strategies that may prevent aging related 
pathologies and improve the beneficial effects of exercise throughout life.
2OV
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Samenvatting 
 
Het ‘leven is eindig’ en ‘ouderdom komt met gebreken’, zijn vaak gehoorde gezegden in de 
Nederlandse taal. Het is dan ook algemeen geaccepteerd dat het verouderingsproces van ons 
lichaam uiteindelijk tot de dood leidt. Echter, het reduceren van de snelheid waarmee ons 
lichaam veroudert vermindert de kans op ziekten en leidt over het algemeen tot een beter 
kwaliteit van leven en toename van het aantal (gezonde) levensjaren. Gezien de wereldwijde 
toename van een vergrijzende bevolking richt dit proefschrift zich op alternatieve strategieën 
die kunnen bijdragen aan de verbetering van het verouderingsproces en de hiermee 
samenhangende ziekteprocessen. Het uitgangspunt van dit proefschrift berust op de kennis dat 
voldoende en gestructureerde lichaamsbeweging een goede basis vormt voor een gezond 
verouderingsproces.  Daarnaast worden potentiële strategieën besproken en onderzocht die 
bestaande beweeginterventieprogramma’s verder zouden kunnen verbeteren. 
 
De inleiding van dit proefschrift definieert de verschillende fysiologische aspecten van het 
verouderingsproces alsmede de belangrijkste hiemee samenhangende ziekteprocessen. Het 
hoofdstuk beschrijft hoe in theorie niet-invasieve en meer kosten-effectieve interventies het 
verouderingsproces aanzienlijk zouden kunnen verbeteren. 
Hoofdstuk 1 richt zich vervolgens op de huidige controverse rond de effecten van 
antioxidanten, zoals hoge doses vitamine C en E, met name wanneer deze worden toegepast 
in combinatie met duurtraining. Op basis van een aantal pre-klinische en klinische studies is 
bekend dat een reductie  van inspanningsgerelateerde zuurstofradicalen bepaalde 
gezondheidsvoordelen van duurtraining kunnen verminderen. Echter, het bewijs hiervoor is 
nog niet geleverd aangezien voorlopige resultaten van een aantal interventiestudies dit 
tegenspreken. Bovendien zijn er zelfs aanwijzingen dat bepaalde typen voedingssupplementen 
zoals resveratrol de effecten van duurtraining verbeteren, met name bij patiënten met 
bijvoorbeeld vitamine tekorten of een slecht functionerend hartvaatstelsel.Gezien alle 
onduidelijkheid en de populariteit van bepaalde type anti-oxidanten en vitamines om 
veroudering tegen te gaan, zijn meer studies gerechtvaardigd ten aanzien van dosering, typen, 
combinaties van antioxidanten, bij de  verschillende vormen van fysieke training. Echter, 
naast onderzoek naar bepaalde voedingsinterventies, is er ook behoefte aan alternatieve 
interventies die de effectiveit van lichaamsbeweging op het verouderingsproces verder 
kunnen verbeteren. Hoofdstuk 2 beschrijft een validatiestudie naar 2 methoden om de 2de 
anaerobe drempel (AT2) te bepalen tijdens eem oplopend inspanningsprotocol. De 2de 


anaerobe drempel wordt gebruikt om de trainingsintensiteit bij een sport- of 
revalidatieprogramma te bepalen, maar vergt normaliter bepaling van een lactaatcurve dan 
wel vrij kostbare ademgasanalyse-apparatuur. In dit onderzoek werde de klassieke 
ademgasanalyse methode vergeleken met een nieuwe methode gebaseerd op 
hartslagvariabiliteit (HRVT). Onze resultaten laten zien dat de methode op basis van 
hartslagvariabiliteit bij gezonden afdoende valide en nauwkeurig zijn. Dit opent deuren voor 
vervolgstudies naar validatie en gebruik voor bepaalde patientenpopulaties waarbij een 
geindividualiseerd trainingsprogramma dient te worden opgesteld of waarbij de 
trainingsprogressie dient te worden gemonitord.  
In hoofdstuk 3 en 4 wordt vervolgens een aantal nieuwe methodieken gepresenteerd om de 
meerwaarde van zuurstof suppletie tijdens inspanning vast te stellen. Met behulp van een 
opstelling die vrij eenvoudig kan worden toegepast in een revalidatiesetting tonen we aan  
inhalatie van 15 L per min 100% zuurstof toegediend via een masker de zuurstofconcentratie 
in het slagaderlijke bloed tot een voldoende hoog niveau verhoogd in  gedeconditioneerde 
patiënten met type 2 diabetes. Deze haalbaarheidsstudie suggereert dat een hogere 
beschikbaarheid van zuurstof de zuurstofspanning in de skeletspier tijdens matig intensieve 
inspanning verbetert en mogelijk ook de  inspanningstolerantie verhoogt. Aan de hand van 
een nieuwe experimentele methode beschreven in hoofdstuk 3 tonen we aan dat het herstel 
van zuurstofopname en spierweefseloxygenatie kinetiek, onder verlaagde, normale en 
verhoogde zuurstofcondities, nuttig kan zijn om te bepalen of extra toediening van zuurstof 
bij matig-intensieve inspanning gunstig is of niet. Ofschoon onze resultaten laten zien dat 
extra zuurstof bij gezonde proefpersonen geen meerwaarde heeft zou deze nieuwe methode 
mogelijk wel nuttig kunnen zijn bij patienten met een chronische aandiening (COPD, Type 2 
diabetes, hartfalen).  
Hoofdstuk 5 en 6 gaat vervolgens in op de problematiek van de toename in zittijd, afname 
van het fysieke activiteitenniveau en de gevolgen daarvan (sarcopenie) bij de ouder wordende 
mens. De resultaten van een grootschalig onderzoek, beschreven in hoofdstuk 6 laten zien dat 
het metabool syndroom en zijn componenten frequenter aanwezig is bij de  meeste sedentaire 
en inactieve groep ouderen. Op basis van de een uitgebreide literatuur studie (hoofdstuk 5)  
wordt duidelijk dat het metabool syndroom, in combinatie met chronische inactiviteit en 
sedentair gedrag het verlies van spiermassa en spierkracht verder versnellen. Het verlies van 
functioneel spierweefsel in combinatie met vetstapeling en overgewicht leidt vervolgens weer 
tot een verdere achteruitgang van de functionele capaciteit en toename van het metabool 
syndroom. Deze vicieuze cirkel van gebrek aan fysieke inspanning en afname van spiermassa 
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verhoogt vervolgens het risico op chronische ziekten zoals hart-en vaatziekten en type 2 
diabetes en leiden uiteindelijk tot vervroegde invaliditeit. 
Aan de hand van de nieuw verkregen inzichten wordt in de algemene discussie ingegaan op 
de in dit proefschrift gepresenteerde resultaten en worden tenslotte aanbevelingen gedaan 
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Research at the University of Florida in Gainesville, FL, the 
United States of America 
• Active participation in departmental research meetings. 
• Attending seminars and symposia. 
• Secondary data analysis resulting in a co-authored scientific 
article. 
• Co-authored relevant review article. 
 
Mar 2014 – to date Independent consultant at Pure&Well – Fitness and Wellness 
Consultancy 
• Lifestyle and Wellness coaching with individual clients. 
• Corporate wellness programmes. 
• Consulting in the area of sport science, exercise physiology, 
medical personal training. 
 
 


Jan - Dec 2014 Assignment - Fitness Department Manager at Inprime 
Corporate Wellness Programs 
• Recruitment of fitness and body&mind professionals for 
corporate wellness projects.  
• Strategic planning for the department of wellness programs 
including recommendations for budgetary implications.  
• Informing upper management of key activities and delivering 
periodic progress reports.  
 
Sep 2011 - to date  Erasmus University Medical Centre in Rotterdam, Netherlands 
Doctoral Scientific Researcher (hospitality agreement) 
• Designing a doctoral research project.  
• Leading a research project at the Department of Rehabilitation 
Medicine and Physical Therapy, subdivision of Sports 
Medicine. 
• Teaching duties – 3rd year medical students (exercise 
physiology). 
• Supervising Master’s research projects of medical students. 
• Active participation in weekly departmental research meetings. 
• Presenting research findings at international scientific seminars 
and conferences (conference shortlist upon request).  
 
Jan 2011 - to date  Get Fit Stay Fit – Personal Fitness Solutions, The Hague, 
Netherlands       
Medical Personal Trainer at Get Fit Stay Fit, a personal fitness 
organisation specialised in serving individual clients and companies. 
• Establishing individual health programmes with clients in order 
to achieve desired goals.  
• Leading and supervising training processes. 
• Developing long-term professional relationships with clients. 
 
 
Mankowski_BW.indd   165 04-08-15   15:43
Curriculum Vitae
166


Apr 2012 - to date  Volunteer board member of the Erasmus PhD Association 
Rotterdam (EPAR), Netherlands 
• Regular meetings with the University Council of the Erasmus 
University in Rotterdam. 
• Co-operation with the National PhD Association (Dutch: 
Promovendi Netwerk Nederland - PNN). 
• Organising events for PhD candidates (educational workshops, 
professional fairs, awards, social events). 
 
Jun – Aug 2010  Volunteer counsellor at summer camps for type 1 diabetes 
children.          
Summer diabetes camps organised by the Polish Diabetes 
Association in Dzwirzyno, Poland 
• Member of the camp staff responsible for daily physical activity 
and organisation of camp events. 
• Involved in medical support and daily education of the diabetes 
camp participants (diet, physical activity). 
• Research data collection (influence of daily physical activity on 
glycaemic profile in type 1 diabetes children). 
 
Key skills 
• Project design – Developed a doctoral research project under the supervision of a senior 
research fellow. This included designing a research proposal and developing intra- and inter-
academic co-operation. Supervising medical students in the design and implementation of 
Master’s research projects.  
• Project management – Had the lead in a scientific research trial. This involves managing 
administrative and ethical issues and the inclusion of subjects, as well as leading the research 
team.  
• Analytical skills – Solving methodological and feasibility issues of research trials. 
Problem identification, analysing and solving. 
• Communication skills – An academic teacher, scientific conference speaker as well as a 
lifestyle & fitness coach. Presentation skills and public speaking. Experienced as a personal 
trainer in interpersonal communication with individual clients.    


• Organisational skills – Board member of the Erasmus PhD Association Rotterdam (EPAR). 
This involves the organisation of informative, educational and social events for PhD 
candidates (fairs, workshops, social networking meetings) and awards (PhD of The Year 
Award). 
• Business relationship building – Developing a long-term relationship with coaching clients 
with a high level of professional seniority. Setting individual goals leading to desired 
outcomes and to establishing new challenges for business relationship continuity.  
• Languages – Speaks two foreign languages, in addition to his native Polish: English 
(professional and academic environment) and Dutch (obtained B1-level certification after 1.5 
years of residency in the Netherlands).  
      
Hobbies 
Novel fitness training methods, endurance sports – marathons, MTB, kayaking, Toastmasters 
International (public speaking), travelling. 
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Apr 2012 - to date  Volunteer board member of the Erasmus PhD Association 
Rotterdam (EPAR), Netherlands 
• Regular meetings with the University Council of the Erasmus 
University in Rotterdam. 
• Co-operation with the National PhD Association (Dutch: 
Promovendi Netwerk Nederland - PNN). 
• Organising events for PhD candidates (educational workshops, 
professional fairs, awards, social events). 
 
Jun – Aug 2010  Volunteer counsellor at summer camps for type 1 diabetes 
children.          
Summer diabetes camps organised by the Polish Diabetes 
Association in Dzwirzyno, Poland 
• Member of the camp staff responsible for daily physical activity 
and organisation of camp events. 
• Involved in medical support and daily education of the diabetes 
camp participants (diet, physical activity). 
• Research data collection (influence of daily physical activity on 
glycaemic profile in type 1 diabetes children). 
 
Key skills 
• Project design – Developed a doctoral research project under the supervision of a senior 
research fellow. This included designing a research proposal and developing intra- and inter-
academic co-operation. Supervising medical students in the design and implementation of 
Master’s research projects.  
• Project management – Had the lead in a scientific research trial. This involves managing 
administrative and ethical issues and the inclusion of subjects, as well as leading the research 
team.  
• Analytical skills – Solving methodological and feasibility issues of research trials. 
Problem identification, analysing and solving. 
• Communication skills – An academic teacher, scientific conference speaker as well as a 
lifestyle & fitness coach. Presentation skills and public speaking. Experienced as a personal 
trainer in interpersonal communication with individual clients.    


• Organisational skills – Board member of the Erasmus PhD Association Rotterdam (EPAR). 
This involves the organisation of informative, educational and social events for PhD 
candidates (fairs, workshops, social networking meetings) and awards (PhD of The Year 
Award). 
• Business relationship building – Developing a long-term relationship with coaching clients 
with a high level of professional seniority. Setting individual goals leading to desired 
outcomes and to establishing new challenges for business relationship continuity.  
• Languages – Speaks two foreign languages, in addition to his native Polish: English 
(professional and academic environment) and Dutch (obtained B1-level certification after 1.5 
years of residency in the Netherlands).  
      
Hobbies 
Novel fitness training methods, endurance sports – marathons, MTB, kayaking, Toastmasters 
International (public speaking), travelling. 
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PhD Portfolio Summary 
Summary of PhD training and teaching activities 
Name PhD student: Robert Mankowski 
Erasmus MC Department: Rehabilitation 
Medicine 
Research School: N/A 
PhD period: 2012-2015 
Promotor(s): Prof. H.J. Stam; Prof. C. 
Leeuwenburgh 
Supervisor: Dr. S.F.E. Praet 
1. PhD training 
 Year Workload 
(Hours) 
General academic skills  
- Biomedical English Writing and Communication 
- Scientific Integrity and Data Management 
Practises 
- Career Development Workshop (PhD Day) 
(Presentation Skills; Storytelling, Personal 
Branding, Networking) 
 
2014/2015 
2012 
2013 
 
56 
5 
8 
Research skills 
- Biostatistics for Clinicians (NIHES) 
- Introduction to Clinical Research (NIHES) 
 
2011 
2011 
 
20 
20 
In-depth courses (e.g. Research school, Medical 
Training) 
- MiP School (Mitochondrial Biology) 
 
2015 
 
50 
Presentations 
- Poster ACSM Orlando 
- Poster IPE Miami 
 
2014 
2014 
 
8 
8 
International conferences 
- ACSM San Francisco 
- Sport Nutrition Conference Oxford 
- ACSM Orlando 
- IPE Miami 
 
2012 
2012 
2014 
2014 
 
40 
20 
40 
30 
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Other 
- Research visit – Institute on Aging, UF, FL, USA 
- Reserch meeting – Department of Rehabilitaion 
Medicine 
 
Apr-Jul 
2014 
2011-2015 
 
700 
100 
2. Teaching activities 
 Year Workload 
(Hours/ECTS) 
Lecturing 
- Minor class – Rehabilitation and Sport 
- Minor class – Rehabilitation and Sport 
- Minor class – Rehabilitation and Sport 
 
2012 
2012 
2012 
 
10 
10 
10 
Supervising practicals and excursions 
- Exercise training design 
- Exercise training design 
 
2013 
2014 
 
50 
50 
Supervising Master’s theses 
- Medical Student (L. Spraakman) 
- Exercise Science (S. Stokla) 
 
2013-2014 
2014-2015 
 
200 
50 
Other 
- Board member of Erasmus PhD Association 
Rotterdam (EPAR) : organizing a PhD Day at 
Erasmus University; organizing The PhD of The 
Year Award. 
 
Total 
 
2012-2013 
 
100 
 
 
 
 
1485 hours 
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